{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Automated Question-Answer Generation from Pharmaceutical Data\n",
    "\n",
    "This notebook systematically generates question-answer pairs from pharmaceutical data sources including:\n",
    "1. PubMed target passages\n",
    "2. DrugBank tables\n",
    "3. Related pharmaceutical data\n",
    "\n",
    "Each QA pair will include:\n",
    "- Question\n",
    "- Answer\n",
    "- Source text/passage\n",
    "- Related table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Import required libraries\n",
    "import os\n",
    "import pandas as pd\n",
    "import json\n",
    "from pathlib import Path\n",
    "from openai import OpenAI\n",
    "import csv\n",
    "from tqdm import tqdm\n",
    "from collections import defaultdict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Configuration and paths\n",
    "PUBMED_TARGETS_DIR = 'inputs/pubmed-targets'\n",
    "DRUGBANK_TABLES_DIR = 'inputs/drugbank-tables'\n",
    "MAPPING_FILE = 'inputs/pubmed-drugbank-tables.gt'\n",
    "OUTPUT_FILE = 'table_output.gt'\n",
    "\n",
    "# Initialize your LLM API key if needed\n",
    "# os.environ[\"OPENAI_API_KEY\"]\n",
    "client = OpenAI()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_passage_table_mapping():\n",
    "    \"\"\"Load the mapping between passages and their relevant tables\"\"\"\n",
    "    mapping = defaultdict(list)\n",
    "    with open(MAPPING_FILE, 'r') as f:\n",
    "        for line in f:\n",
    "            passage_id, table_name = line.strip().split(',')\n",
    "            mapping[passage_id].append(table_name)\n",
    "    # print(\"mapping\", mapping)\n",
    "    return mapping\n",
    "\n",
    "def load_target_passages():\n",
    "    \"\"\"Load all target passages from the pubmed-targets directory\"\"\"\n",
    "    passages = {}\n",
    "    target_files = Path(PUBMED_TARGETS_DIR).glob('Target-*')\n",
    "    \n",
    "    for file_path in target_files:\n",
    "        target_id = file_path.name\n",
    "        with open(file_path, 'r') as f:\n",
    "            passages[target_id] = f.read()\n",
    "    # print(\"passages\", passages)\n",
    "    return passages\n",
    "\n",
    "def load_drugbank_tables():\n",
    "    \"\"\"Load all relevant DrugBank tables\"\"\"\n",
    "    tables = {}\n",
    "    csv_files = Path(DRUGBANK_TABLES_DIR).glob('*.csv')\n",
    "    \n",
    "    for file_path in csv_files:\n",
    "        table_name = file_path.stem\n",
    "        tables[table_name] = pd.read_csv(file_path)\n",
    "    \n",
    "    # print(\"tables\", tables)\n",
    "    return tables"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_relevant_table_content(tables, table_names, max_rows=5):\n",
    "    \"\"\"Extract relevant content from tables for context\"\"\"\n",
    "    print(\"Debug - Available tables:\", tables.keys())\n",
    "    print(\"Debug - Looking for table_names:\", table_names)\n",
    "\n",
    "    table_content = {}\n",
    "    for table_name in table_names:\n",
    "        # Remove .csv extension if present\n",
    "        base_table_name = table_name.replace('.csv', '')\n",
    "        \n",
    "        if base_table_name in tables:\n",
    "            df = tables[base_table_name]\n",
    "            table_content[base_table_name] = {\n",
    "                'columns': list(df.columns),\n",
    "                'sample': df.head(max_rows).to_dict('records')\n",
    "            }\n",
    "        else:\n",
    "            print(f\"Debug - Table '{base_table_name}' not found in available tables\")\n",
    "    return table_content\n",
    "\n",
    "def generate_questions_for_passage(passage_id, passage_text, tables, relevant_table_names, model=\"gpt-4o\"):\n",
    "    \"\"\"Generate questions for a given passage and its relevant tables using LLM\"\"\"\n",
    "\n",
    "    # print(\"tables\", tables)\n",
    "    # print(\"relevant_table_names\", relevant_table_names)\n",
    "    \n",
    "    # Limit passage length if too long (e.g., first 1000 characters)\n",
    "    passage_text = passage_text[:1000] + \"...\" if len(passage_text) > 1000 else passage_text\n",
    "    \n",
    "    # Limit to maximum 3 relevant tables\n",
    "    relevant_table_names = relevant_table_names[:3]\n",
    "    \n",
    "    # Get relevant table content\n",
    "    table_content = get_relevant_table_content(tables, relevant_table_names)\n",
    "\n",
    "    \n",
    "    prompt = f\"\"\"\n",
    "    Given the following passage and related tables, generate 3-5 meaningful question-answer pairs.\n",
    "    IMPORTANT: Each question MUST be answerable using information from ONLY the tables.\n",
    "    Only generate questions that require information from the tables.\n",
    "    \n",
    "    You are a pharmaceutical educator creating realistic questions that a medical student, pharmacist, or healthcare professional might ask. Focus on clinically relevant information such as:\n",
    "    - Drug mechanisms, indications, and therapeutic uses\n",
    "    - Dosing considerations and administration routes\n",
    "    - Side effects and contraindications\n",
    "    - Drug interactions and pharmacological properties\n",
    "    \n",
    "    AVOID generating questions about:\n",
    "    - Database-specific information (primary keys, IDs, URLs)\n",
    "    - Technical metadata that wouldn't be useful in clinical practice\n",
    "    - Questions that simply ask to list information without clinical context\n",
    "    \n",
    "    Examples of BAD questions to AVOID:\n",
    "    - \"What drug is linked to the FDA label with the URL ending in '1265922800,' and what is its state?\"\n",
    "    - \"What is the primary key for the drug Denileukin diftitox, and what is its marketed mixture name?\"\n",
    "    \n",
    "    Related Tables:\n",
    "    {json.dumps(table_content, indent=2)}\n",
    "    \n",
    "    Generate questions in the following format:\n",
    "    1. question: [specific question about drug/treatment that would be asked in clinical practice]\n",
    "       answer: [detailed answer combining information from the tables]\n",
    "       text: None\n",
    "       table: [table name if information from table was used (e.g. drugbank-drug)]\n",
    "    \n",
    "    Ensure every question is clinically relevant and would be asked by real healthcare professionals.\n",
    "    \"\"\"\n",
    "    \n",
    "    # Call your LLM here with the prompt\n",
    "    response = client.chat.completions.create(\n",
    "        model=model,\n",
    "        messages=[\n",
    "            {\"role\": \"system\", \"content\": \"You are a medical and pharmaceutical expert tasked with generating detailed question-answer pairs about drugs and treatments.\"},\n",
    "            {\"role\": \"user\", \"content\": prompt}\n",
    "        ],\n",
    "        temperature=0.7\n",
    "    )\n",
    "\n",
    "    print(response.choices[0].message.content)\n",
    "    \n",
    "    # Parse the response into structured QA pairs\n",
    "    qa_pairs = parse_llm_response(response.choices[0].message.content, passage_id)\n",
    "    return qa_pairs\n",
    "\n",
    "def parse_llm_response(response_text, passage_id):\n",
    "    \"\"\"Parse the LLM response into structured QA pairs\"\"\"\n",
    "    qa_pairs = []\n",
    "    \n",
    "    # Split the response into individual QA entries\n",
    "    entries = response_text.strip().split('\\n\\n')\n",
    "    \n",
    "    for entry in entries:\n",
    "        if not entry.strip():\n",
    "            continue\n",
    "            \n",
    "        lines = entry.strip().split('\\n')\n",
    "        current_qa = {\n",
    "            'question': '',\n",
    "            'answer': '',\n",
    "            'text': passage_id,\n",
    "            'table': 'None'  # Default value\n",
    "        }\n",
    "        \n",
    "        for line in lines:\n",
    "            line = line.strip()\n",
    "            # Skip empty lines and numbering\n",
    "            if not line or line.replace('.', '').strip().isdigit():\n",
    "                continue\n",
    "                \n",
    "            # Parse each field using more robust splitting\n",
    "            if 'question:' in line:\n",
    "                current_qa['question'] = line.split('question:', 1)[1].strip()\n",
    "            elif 'answer:' in line:\n",
    "                current_qa['answer'] = line.split('answer:', 1)[1].strip()\n",
    "            elif 'text:' in line:\n",
    "                current_qa['text'] = line.split('text:', 1)[1].strip()\n",
    "            elif 'table:' in line:\n",
    "                table_value = line.split('table:', 1)[1].strip()\n",
    "                # Handle NA, N/A, None cases\n",
    "                current_qa['table'] = 'None' if table_value.upper() in ['NA', 'N/A', 'NONE'] else table_value\n",
    "        \n",
    "        # Only add complete QA pairs that have both question and answer\n",
    "        if current_qa['question'] and current_qa['answer']:\n",
    "            qa_pairs.append(current_qa.copy())  # Use copy to avoid reference issues\n",
    "    \n",
    "    return qa_pairs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def main():\n",
    "    # Load mappings and data\n",
    "    print(\"Loading passage-table mappings...\")\n",
    "    passage_table_mapping = load_passage_table_mapping()\n",
    "    \n",
    "    print(\"Loading target passages...\")\n",
    "    passages = load_target_passages()\n",
    "    \n",
    "    print(\"Loading DrugBank tables...\")\n",
    "    tables = load_drugbank_tables()\n",
    "    \n",
    "    # Initialize output list\n",
    "    qa_pairs = []\n",
    "    \n",
    "    # Process each passage with its relevant tables\n",
    "    for passage_id, passage_text in tqdm(list(passages.items())[:200]):\n",
    "        if passage_id in passage_table_mapping:\n",
    "            relevant_tables = passage_table_mapping[passage_id]\n",
    "            # print(passage_id, passage_text, tables, relevant_tables)\n",
    "            \n",
    "            # Generate QA pairs using the passage and its relevant tables\n",
    "            new_qa_pairs = generate_questions_for_passage(\n",
    "                passage_id,\n",
    "                passage_text,\n",
    "                tables,\n",
    "                relevant_tables\n",
    "            )\n",
    "            # new_qa_pairs = []\n",
    "            print(new_qa_pairs)\n",
    "            qa_pairs.extend(new_qa_pairs)\n",
    "        else:\n",
    "            print(f\"No table mapping found for passage {passage_id}\")\n",
    "    \n",
    "    # Save results\n",
    "    with open(OUTPUT_FILE, 'w', newline='') as f:\n",
    "        writer = csv.writer(f, quoting=csv.QUOTE_ALL)\n",
    "        writer.writerow(['question', 'answer', 'text', 'table'])  # header\n",
    "        for qa_pair in qa_pairs:\n",
    "            writer.writerow([\n",
    "                qa_pair['question'],\n",
    "                qa_pair['answer'],\n",
    "                qa_pair['text'],\n",
    "                qa_pair['table']\n",
    "            ])\n",
    "        \n",
    "    print(f\"Generated {len(qa_pairs)} question-answer pairs\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading passage-table mappings...\n",
      "Loading target passages...\n",
      "Loading DrugBank tables...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_35724/2028544267.py:30: DtypeWarning: Columns (5,6) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  tables[table_name] = pd.read_csv(file_path)\n",
      "  0%|          | 0/200 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 1/200 [00:07<23:15,  7.01s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab and which receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding fragment antigen-binding (FAB), targeting the EGFR in humans. Its mechanism of action involves binding to the N-terminal portion of human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What are the components of Etanercept and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug is associated with the FDA label titled \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension\"?\n",
      "   answer: The drug associated with the FDA label titled \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension\" is linked to the parent key DB00007.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "4. question: For which drug is Prothrombin a known target, and what is the organism associated with this target?\n",
      "   answer: Prothrombin is a known target for the drug Lepirudin, and the organism associated with this target is humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the state of the drug Dornase alfa, and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is in a liquid state. Its primary therapeutic use involves the enzymatic breakdown of extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab and which receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding fragment antigen-binding (FAB), targeting the EGFR in humans. Its mechanism of action involves binding to the N-terminal portion of human EGFR.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the components of Etanercept and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is associated with the FDA label titled \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension\"?', 'answer': 'The drug associated with the FDA label titled \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension\" is linked to the parent key DB00007.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'For which drug is Prothrombin a known target, and what is the organism associated with this target?', 'answer': 'Prothrombin is a known target for the drug Lepirudin, and the organism associated with this target is humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the state of the drug Dornase alfa, and what is its primary therapeutic use?', 'answer': 'Dornase alfa is in a liquid state. Its primary therapeutic use involves the enzymatic breakdown of extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  1%|          | 2/200 [00:14<23:41,  7.18s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) on human cells. By targeting this receptor, Cetuximab inhibits the growth and survival of tumor cells that rely on the EGFR signaling pathway. This mechanism is confirmed by its known action on the EGFR in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the target organism for Lepirudin and what is its known action?\n",
      "   answer: The target organism for Lepirudin is humans, and its known action is to inhibit prothrombin, a key protein in the blood coagulation process.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the main therapeutic use of Dornase alfa, and how does it achieve this effect?\n",
      "   answer: Dornase alfa is primarily used in individuals with cystic fibrosis. It works by enzymatically breaking down extracellular DNA in the mucus, reducing its viscosity and improving lung function. This is achieved through its action as a biosynthetic form of the human enzyme deoxyribonuclease I (DNase I).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': 'Cetuximab is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) on human cells. By targeting this receptor, Cetuximab inhibits the growth and survival of tumor cells that rely on the EGFR signaling pathway. This mechanism is confirmed by its known action on the EGFR in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the target organism for Lepirudin and what is its known action?', 'answer': 'The target organism for Lepirudin is humans, and its known action is to inhibit prothrombin, a key protein in the blood coagulation process.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the main therapeutic use of Dornase alfa, and how does it achieve this effect?', 'answer': 'Dornase alfa is primarily used in individuals with cystic fibrosis. It works by enzymatically breaking down extracellular DNA in the mucus, reducing its viscosity and improving lung function. This is achieved through its action as a biosynthetic form of the human enzyme deoxyribonuclease I (DNase I).', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-15686733\n",
      "No table mapping found for passage Target-19852077\n",
      "No table mapping found for passage Target-8214760\n",
      "No table mapping found for passage Target-16276979\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  4%|▎         | 7/200 [00:19<07:13,  2.25s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its primary target in humans?\n",
      "   answer: Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) in humans. This binding inhibits the receptor's activity, which is involved in the progression of certain types of cancer.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is produced using genetically modified Chinese hamster ovary (CHO) cells, and what is its primary use in clinical settings?\n",
      "   answer: Dornase alfa is produced using genetically modified Chinese hamster ovary (CHO) cells through recombinant DNA technology. It is primarily used in clinical settings to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the composition and production method of Etanercept and its therapeutic role.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. Etanercept is used therapeutically to interfere with tumor necrosis factor (TNF) activity, which plays a role in inflammatory and autoimmune diseases.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the unique structural characteristic of Lepirudin compared to natural hirudin, and when did its production cease?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. The production of Lepirudin (Refludan) ceased on May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its primary target in humans?', 'answer': \"Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) in humans. This binding inhibits the receptor's activity, which is involved in the progression of certain types of cancer.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is produced using genetically modified Chinese hamster ovary (CHO) cells, and what is its primary use in clinical settings?', 'answer': 'Dornase alfa is produced using genetically modified Chinese hamster ovary (CHO) cells through recombinant DNA technology. It is primarily used in clinical settings to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of Etanercept and its therapeutic role.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. Etanercept is used therapeutically to interfere with tumor necrosis factor (TNF) activity, which plays a role in inflammatory and autoimmune diseases.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique structural characteristic of Lepirudin compared to natural hirudin, and when did its production cease?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. The production of Lepirudin (Refludan) ceased on May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  4%|▍         | 8/200 [00:25<09:10,  2.87s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, where it binds to the N-terminal portion of the receptor, inhibiting its action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the clinical use of Dornase alfa and its mechanism of action in cystic fibrosis patients?\n",
      "   answer: Dornase alfa is used in cystic fibrosis patients to reduce sputum viscosity and viscoelasticity by enzymatically breaking down extracellular DNA released by degenerating leukocytes during inflammatory responses.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug targets the Epidermal growth factor receptor (EGFR) and what is its known action?\n",
      "   answer: Cetuximab targets the Epidermal growth factor receptor (EGFR) in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: How is Etanercept produced and what is its composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action of Cetuximab?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, where it binds to the N-terminal portion of the receptor, inhibiting its action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the clinical use of Dornase alfa and its mechanism of action in cystic fibrosis patients?', 'answer': 'Dornase alfa is used in cystic fibrosis patients to reduce sputum viscosity and viscoelasticity by enzymatically breaking down extracellular DNA released by degenerating leukocytes during inflammatory responses.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets the Epidermal growth factor receptor (EGFR) and what is its known action?', 'answer': 'Cetuximab targets the Epidermal growth factor receptor (EGFR) in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Etanercept produced and what is its composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  4%|▍         | 9/200 [00:30<10:29,  3.30s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and under what brand name is it marketed?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB, composed of variable regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, with human IgG1 heavy and kappa light chain constant regions. It is marketed under the brand name Erbitux by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What is the therapeutic use of Dornase alfa, and in what condition is it primarily used?\n",
      "   answer: Dornase alfa is used to cleave extracellular DNA into 5´-phosphodinucleotide and 5´-phosphooligonucleotide end products, thereby reducing sputum viscosity and viscoelasticity. It is primarily used in individuals with cystic fibrosis to manage the accumulation of extracellular DNA released by degenerating leukocytes during inflammatory responses to infections.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Etanercept produced, and what is its structural composition?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, containing the CH2 domain, the CH3 domain, and hinge region, but not the CH1 domain of IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the FDA-approved formulation of Dornase alfa, and what is its primary use?\n",
      "   answer: The FDA-approved formulations of Dornase alfa include Pulmozyme and Pulmozyme 1mg/ml. Dornase alfa is primarily used to reduce sputum viscosity in patients with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and under what brand name is it marketed?', 'answer': 'Cetuximab is an epidermal growth factor receptor binding FAB, composed of variable regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, with human IgG1 heavy and kappa light chain constant regions. It is marketed under the brand name Erbitux by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the therapeutic use of Dornase alfa, and in what condition is it primarily used?', 'answer': 'Dornase alfa is used to cleave extracellular DNA into 5´-phosphodinucleotide and 5´-phosphooligonucleotide end products, thereby reducing sputum viscosity and viscoelasticity. It is primarily used in individuals with cystic fibrosis to manage the accumulation of extracellular DNA released by degenerating leukocytes during inflammatory responses to infections.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what is its structural composition?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, containing the CH2 domain, the CH3 domain, and hinge region, but not the CH1 domain of IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved formulation of Dornase alfa, and what is its primary use?', 'answer': 'The FDA-approved formulations of Dornase alfa include Pulmozyme and Pulmozyme 1mg/ml. Dornase alfa is primarily used to reduce sputum viscosity in patients with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  5%|▌         | 10/200 [00:43<17:31,  5.53s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Dornase alfa, and how is it relevant in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. This is particularly beneficial in treating cystic fibrosis, as it helps break down the thick mucus that accumulates in the lungs due to the presence of extracellular DNA released by degenerating leukocytes during inflammatory responses to infections.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What is the marketed mixture name for Cetuximab, and what is its primary therapeutic use?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux. It is an epidermal growth factor receptor (EGFR) binding FAB used primarily in the treatment of certain types of cancer, as it targets the N-terminal portion of human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "3. question: What is the significance of lepirudin's structural difference from natural hirudin, and under what brand name is it marketed?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end and the absence of a sulfate group on the tyrosine at position 63. These modifications are significant as they may alter the drug's binding properties or pharmacokinetics. Lepirudin is marketed under the brand name Refludan, although Bayer ceased its production as of May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "4. question: Describe the composition of Etanercept and its production method.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75-kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system and consists of 934 amino acids. This composition allows Etanercept to effectively neutralize tumor necrosis factor (TNF), a cytokine involved in systemic inflammation.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Dornase alfa, and how is it relevant in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. This is particularly beneficial in treating cystic fibrosis, as it helps break down the thick mucus that accumulates in the lungs due to the presence of extracellular DNA released by degenerating leukocytes during inflammatory responses to infections.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed mixture name for Cetuximab, and what is its primary therapeutic use?', 'answer': 'Cetuximab is marketed under the brand name Erbitux. It is an epidermal growth factor receptor (EGFR) binding FAB used primarily in the treatment of certain types of cancer, as it targets the N-terminal portion of human EGFR.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': \"What is the significance of lepirudin's structural difference from natural hirudin, and under what brand name is it marketed?\", 'answer': \"Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end and the absence of a sulfate group on the tyrosine at position 63. These modifications are significant as they may alter the drug's binding properties or pharmacokinetics. Lepirudin is marketed under the brand name Refludan, although Bayer ceased its production as of May 31, 2012.\", 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Describe the composition of Etanercept and its production method.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75-kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system and consists of 934 amino acids. This composition allows Etanercept to effectively neutralize tumor necrosis factor (TNF), a cytokine involved in systemic inflammation.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  6%|▌         | 11/200 [00:50<18:39,  5.92s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. Its primary target is the epidermal growth factor receptor in humans, where it acts by binding to the receptor and inhibiting its activity.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: Which drug is known to target Prothrombin in humans, and what is its state?\n",
      "   answer: Lepirudin is known to target Prothrombin in humans, and it is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "3. question: What is the composition and production method of Dornase alfa?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its sequence is identical to the endogenous human enzyme.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the unique characteristic of Lepirudin compared to natural hirudin, and what is its production method?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Describe the molecular composition of Etanercept and its production system.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. Its primary target is the epidermal growth factor receptor in humans, where it acts by binding to the receptor and inhibiting its activity.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'Which drug is known to target Prothrombin in humans, and what is its state?', 'answer': 'Lepirudin is known to target Prothrombin in humans, and it is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the composition and production method of Dornase alfa?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its sequence is identical to the endogenous human enzyme.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique characteristic of Lepirudin compared to natural hirudin, and what is its production method?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the molecular composition of Etanercept and its production system.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  6%|▌         | 12/200 [01:02<23:30,  7.50s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary target of Cetuximab, and what is its known action in humans?\n",
      "   answer: The primary target of Cetuximab is the Epidermal growth factor receptor (EGFr) in humans, and its known action is confirmed as \"yes,\" indicating that it binds to this receptor.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What are the different marketed forms of Leuprolide acetate, and how are they administered?\n",
      "   answer: Leuprolide acetate is marketed in several forms: Lupaneta Pack for intramuscular and oral use, Lupron Depot as a depot suspension, Lupron Depot-Ped as a depot suspension, and Fensolvi as a suspension. These forms are administered intramuscularly or as depot suspensions.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "3. question: Describe the mechanism of action of Dornase alfa in the treatment of cystic fibrosis.\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to 5′-phosphodinucleotide and 5′-phosphooligonucleotide end products without affecting intracellular DNA. In cystic fibrosis patients, it helps reduce sputum viscosity and viscoelasticity by breaking down extracellular DNA released by degenerating leukocytes during inflammatory responses.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is composed of the Fv regions of the 225 murine EGFr monoclonal antibody and what is its brand name?\n",
      "   answer: Cetuximab is composed of the Fv regions of the 225 murine EGFr monoclonal antibody and is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the therapeutic use of Lepirudin, and why was its production ceased?\n",
      "   answer: Lepirudin is identical to natural hirudin and used as an anticoagulant. Its production by Bayer was ceased effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary target of Cetuximab, and what is its known action in humans?', 'answer': 'The primary target of Cetuximab is the Epidermal growth factor receptor (EGFr) in humans, and its known action is confirmed as \"yes,\" indicating that it binds to this receptor.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the different marketed forms of Leuprolide acetate, and how are they administered?', 'answer': 'Leuprolide acetate is marketed in several forms: Lupaneta Pack for intramuscular and oral use, Lupron Depot as a depot suspension, Lupron Depot-Ped as a depot suspension, and Fensolvi as a suspension. These forms are administered intramuscularly or as depot suspensions.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Describe the mechanism of action of Dornase alfa in the treatment of cystic fibrosis.', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to 5′-phosphodinucleotide and 5′-phosphooligonucleotide end products without affecting intracellular DNA. In cystic fibrosis patients, it helps reduce sputum viscosity and viscoelasticity by breaking down extracellular DNA released by degenerating leukocytes during inflammatory responses.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is composed of the Fv regions of the 225 murine EGFr monoclonal antibody and what is its brand name?', 'answer': 'Cetuximab is composed of the Fv regions of the 225 murine EGFr monoclonal antibody and is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the therapeutic use of Lepirudin, and why was its production ceased?', 'answer': 'Lepirudin is identical to natural hirudin and used as an anticoagulant. Its production by Bayer was ceased effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  6%|▋         | 13/200 [01:08<22:25,  7.20s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with P-glycoprotein 1 as a transporter, and what is known about its action?\n",
      "   answer: P-glycoprotein 1 is associated with the drug identified by the parent key DB00027. The known action of this transporter in relation to the drug is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab, and when was it last updated in the drugbank database?\n",
      "   answer: Cetuximab is in a liquid state and was last updated in the drugbank database on July 1, 2020.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What FDA-approved drug products are associated with the parent key DB00007, and what form of administration do they include?\n",
      "   answer: The FDA-approved drug products associated with the parent key DB00007 include \"Lupaneta Pack for intramuscular and oral use\", \"Lupron Depot\", \"Lupron Depot-Ped\", and \"Fensolvi\". These products include intramuscular and oral forms of administration.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "4. question: Which drug is associated with the Canalicular multispecific organic anion transporter 1, and what organism is it from?\n",
      "   answer: The Canalicular multispecific organic anion transporter 1 is associated with the drug with parent key DB00067, and the organism is Humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "5. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drug is associated with P-glycoprotein 1 as a transporter, and what is known about its action?', 'answer': 'P-glycoprotein 1 is associated with the drug identified by the parent key DB00027. The known action of this transporter in relation to the drug is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and when was it last updated in the drugbank database?', 'answer': 'Cetuximab is in a liquid state and was last updated in the drugbank database on July 1, 2020.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What FDA-approved drug products are associated with the parent key DB00007, and what form of administration do they include?', 'answer': 'The FDA-approved drug products associated with the parent key DB00007 include \"Lupaneta Pack for intramuscular and oral use\", \"Lupron Depot\", \"Lupron Depot-Ped\", and \"Fensolvi\". These products include intramuscular and oral forms of administration.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Which drug is associated with the Canalicular multispecific organic anion transporter 1, and what organism is it from?', 'answer': 'The Canalicular multispecific organic anion transporter 1 is associated with the drug with parent key DB00067, and the organism is Humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-8627562\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  8%|▊         | 15/200 [01:16<17:47,  5.77s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with P-glycoprotein 1 as a transporter, and what is known about its action?\n",
      "   answer: The drug associated with P-glycoprotein 1 as a transporter is Lepirudin (DB00027). The known action of this transporter in relation to Lepirudin is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the primary pharmaceutical use of Cetuximab, and what is unique about its composition?\n",
      "   answer: Cetuximab is used as an epidermal growth factor receptor (EGFR) binding FAB. It is unique because it is composed of the variable regions of the 225 murine EGFR monoclonal antibody specific for the N-terminal portion of human EGFR, combined with the human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the main components of Denileukin diftitox, and how is it produced?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug's description involves the production in Chinese hamster ovary cells, and what is its mechanism of action?\n",
      "   answer: Dornase alfa is the drug produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its mechanism of action involves cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the FDA-approved use of Lupron Depot, and what is its active ingredient?\n",
      "   answer: Lupron Depot is FDA-approved for use as a depot suspension formulation of leuprolide acetate. It is listed under several FDA drug product labels, indicating its use in various formulations and dosages.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'Which drug is associated with P-glycoprotein 1 as a transporter, and what is known about its action?', 'answer': 'The drug associated with P-glycoprotein 1 as a transporter is Lepirudin (DB00027). The known action of this transporter in relation to Lepirudin is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the primary pharmaceutical use of Cetuximab, and what is unique about its composition?', 'answer': 'Cetuximab is used as an epidermal growth factor receptor (EGFR) binding FAB. It is unique because it is composed of the variable regions of the 225 murine EGFR monoclonal antibody specific for the N-terminal portion of human EGFR, combined with the human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the main components of Denileukin diftitox, and how is it produced?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': \"Which drug's description involves the production in Chinese hamster ovary cells, and what is its mechanism of action?\", 'answer': 'Dornase alfa is the drug produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its mechanism of action involves cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved use of Lupron Depot, and what is its active ingredient?', 'answer': 'Lupron Depot is FDA-approved for use as a depot suspension formulation of leuprolide acetate. It is listed under several FDA drug product labels, indicating its use in various formulations and dosages.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  8%|▊         | 16/200 [01:24<19:44,  6.44s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and how is it classified?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFr) binding FAB. It is classified as a biotech drug. Cetuximab is composed of the Fv regions of the 225 murine EGFr monoclonal antibody, specific for the N-terminal portion of human EGFr, with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: Which drug interacts with the transporter \"P-glycoprotein 1\" in humans?\n",
      "   answer: The drug associated with the transporter \"P-glycoprotein 1\" in humans includes those with parent keys DB00027 and DB00091.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What are the transporters involved with the drug having the parent key \"DB00091\"?\n",
      "   answer: The transporters involved with the drug having the parent key \"DB00091\" are \"P-glycoprotein 1,\" \"Bile salt export pump,\" and \"Ileal sodium/bile acid cotransporter.\"\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: What is the state of Dornase alfa, and how is it produced?\n",
      "   answer: Dornase alfa is in a liquid state. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Identify the organism for the transporter \"Canalicular multispecific organic anion transporter 1\" associated with drug parent key \"DB00067.\"\n",
      "   answer: The organism for the transporter \"Canalicular multispecific organic anion transporter 1\" associated with the drug parent key \"DB00067\" is humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and how is it classified?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFr) binding FAB. It is classified as a biotech drug. Cetuximab is composed of the Fv regions of the 225 murine EGFr monoclonal antibody, specific for the N-terminal portion of human EGFr, with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug interacts with the transporter \"P-glycoprotein 1\" in humans?', 'answer': 'The drug associated with the transporter \"P-glycoprotein 1\" in humans includes those with parent keys DB00027 and DB00091.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What are the transporters involved with the drug having the parent key \"DB00091\"?', 'answer': 'The transporters involved with the drug having the parent key \"DB00091\" are \"P-glycoprotein 1,\" \"Bile salt export pump,\" and \"Ileal sodium/bile acid cotransporter.\"', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of Dornase alfa, and how is it produced?', 'answer': 'Dornase alfa is in a liquid state. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Identify the organism for the transporter \"Canalicular multispecific organic anion transporter 1\" associated with drug parent key \"DB00067.\"', 'answer': 'The organism for the transporter \"Canalicular multispecific organic anion transporter 1\" associated with the drug parent key \"DB00067\" is humans.', 'text': 'None', 'table': 'drugbank-transporters'}]\n",
      "No table mapping found for passage Target-11888331\n",
      "No table mapping found for passage Target-19660006\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 10%|▉         | 19/200 [01:29<11:57,  3.96s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the therapeutic use of Dornase alfa, and what is the brand name under which it is marketed?\n",
      "   answer: Dornase alfa is used to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It is marketed under the brand name Pulmozyme.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-drug_mixtures\n",
      "\n",
      "2. question: How is Cetuximab produced and what is its main mechanism of action?\n",
      "   answer: Cetuximab is produced as an epidermal growth factor receptor binding FAB. It consists of the variable regions of the murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition and production method of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What are the unique modifications that differentiate Lepirudin from natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Under what brand name is Denileukin diftitox marketed, and what is its composition?\n",
      "   answer: Denileukin diftitox is marketed under the brand name Ontak. It is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-drug_mixtures\n",
      "[{'question': 'What is the therapeutic use of Dornase alfa, and what is the brand name under which it is marketed?', 'answer': 'Dornase alfa is used to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It is marketed under the brand name Pulmozyme.', 'text': 'None', 'table': 'drugbank-drug, drugbank-drug_mixtures'}, {'question': 'How is Cetuximab produced and what is its main mechanism of action?', 'answer': 'Cetuximab is produced as an epidermal growth factor receptor binding FAB. It consists of the variable regions of the murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition and production method of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the unique modifications that differentiate Lepirudin from natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Under what brand name is Denileukin diftitox marketed, and what is its composition?', 'answer': 'Denileukin diftitox is marketed under the brand name Ontak. It is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug, drugbank-drug_mixtures'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 10%|█         | 20/200 [01:39<15:26,  5.15s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the molecular target of Cetuximab, and is its action known?\n",
      "   answer: The molecular target of Cetuximab is the Epidermal growth factor receptor (EGFR) in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: How is Lepirudin produced, and what is a significant manufacturing update regarding this drug?\n",
      "   answer: Lepirudin is produced via yeast cells and is identical to natural hirudin with specific substitutions. Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition of Etanercept, and which technological method is used for its production?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton TNF receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug marketed under the brand Erbitux targets the Epidermal growth factor receptor?\n",
      "   answer: Cetuximab, marketed under the brand Erbitux, targets the Epidermal growth factor receptor.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the organism source for the target Prothrombin associated with Lepirudin, and is the action known?\n",
      "   answer: The target Prothrombin associated with Lepirudin is sourced from humans, and the action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the molecular target of Cetuximab, and is its action known?', 'answer': 'The molecular target of Cetuximab is the Epidermal growth factor receptor (EGFR) in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Lepirudin produced, and what is a significant manufacturing update regarding this drug?', 'answer': 'Lepirudin is produced via yeast cells and is identical to natural hirudin with specific substitutions. Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition of Etanercept, and which technological method is used for its production?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton TNF receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug marketed under the brand Erbitux targets the Epidermal growth factor receptor?', 'answer': 'Cetuximab, marketed under the brand Erbitux, targets the Epidermal growth factor receptor.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the organism source for the target Prothrombin associated with Lepirudin, and is the action known?', 'answer': 'The target Prothrombin associated with Lepirudin is sourced from humans, and the action is known.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 10%|█         | 21/200 [01:44<15:06,  5.07s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab and which specific receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB that targets the epidermal growth factor receptor (EGFR) in humans. Its variable regions are specific for the N-terminal portion of human EGFR, making it effective in blocking the receptor's action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the primary therapeutic function of Dornase alfa, and how is it produced?\n",
      "   answer: Dornase alfa functions primarily as an enzyme that cleaves extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What type of protein is Denileukin diftitox, and through what system is it produced?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences from diphtheria toxin and interleukin-2. It is produced using an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug targets prothrombin in humans, and what is the known action of this drug?\n",
      "   answer: Lepirudin targets prothrombin in humans, and it is known to have a direct action on this target, as indicated by its \"known action\" status.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: Describe the composition and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor (p75) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab and which specific receptor does it target?', 'answer': \"Cetuximab is an epidermal growth factor receptor binding FAB that targets the epidermal growth factor receptor (EGFR) in humans. Its variable regions are specific for the N-terminal portion of human EGFR, making it effective in blocking the receptor's action.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the primary therapeutic function of Dornase alfa, and how is it produced?', 'answer': 'Dornase alfa functions primarily as an enzyme that cleaves extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What type of protein is Denileukin diftitox, and through what system is it produced?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences from diphtheria toxin and interleukin-2. It is produced using an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets prothrombin in humans, and what is the known action of this drug?', 'answer': 'Lepirudin targets prothrombin in humans, and it is known to have a direct action on this target, as indicated by its \"known action\" status.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the composition and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor (p75) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 11%|█         | 22/200 [01:50<15:36,  5.26s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the therapeutic target of Cetuximab, and what is its action on this target?\n",
      "   answer: Cetuximab targets the Epidermal Growth Factor Receptor (EGFR) in humans, and it has a known action on this target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is produced via recombinant DNA technology in Chinese hamster ovary (CHO) cells, and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is produced via recombinant DNA technology in Chinese hamster ovary (CHO) cells. It is primarily used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What are the primary characteristics of Etanercept, including its structure and production method?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Identify a drug that has ceased production and provide a brief description of its structure.\n",
      "   answer: Lepirudin ceased production effective May 31, 2012. It is a biotech drug identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the therapeutic target of Cetuximab, and what is its action on this target?', 'answer': 'Cetuximab targets the Epidermal Growth Factor Receptor (EGFR) in humans, and it has a known action on this target.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is produced via recombinant DNA technology in Chinese hamster ovary (CHO) cells, and what is its primary therapeutic use?', 'answer': 'Dornase alfa is produced via recombinant DNA technology in Chinese hamster ovary (CHO) cells. It is primarily used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the primary characteristics of Etanercept, including its structure and production method?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Identify a drug that has ceased production and provide a brief description of its structure.', 'answer': 'Lepirudin ceased production effective May 31, 2012. It is a biotech drug identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 12%|█▏        | 23/200 [01:58<17:38,  5.98s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which human receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, with a known action on this receptor.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the molecular composition of Lepirudin, and how does it differ from natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the primary production method for Dornase alfa, and what is its therapeutic use in cystic fibrosis?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used therapeutically in cystic fibrosis to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Etanercept produced, and what are the components of its molecular structure?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which targets are associated with Cetuximab, and is the action on these targets known?\n",
      "   answer: Cetuximab is associated with several targets, including the epidermal growth factor receptor, low affinity immunoglobulin gamma Fc region receptor III-B, complement C1q subcomponent subunit A, and complement C1q subcomponent subunit B. The action is known for the epidermal growth factor receptor but unknown for the other targets.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which human receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, with a known action on this receptor.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the molecular composition of Lepirudin, and how does it differ from natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary production method for Dornase alfa, and what is its therapeutic use in cystic fibrosis?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used therapeutically in cystic fibrosis to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what are the components of its molecular structure?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which targets are associated with Cetuximab, and is the action on these targets known?', 'answer': 'Cetuximab is associated with several targets, including the epidermal growth factor receptor, low affinity immunoglobulin gamma Fc region receptor III-B, complement C1q subcomponent subunit A, and complement C1q subcomponent subunit B. The action is known for the epidermal growth factor receptor but unknown for the other targets.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 12%|█▏        | 24/200 [02:02<16:27,  5.61s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This mechanism is confirmed to have a known action in inhibiting the receptor's activity, which can be overexpressed in certain types of cancer.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the therapeutic use of Dornase alfa?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It achieves this by cleaving extracellular DNA, which is released by degenerating leukocytes during inflammatory responses to infections.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug targets prothrombin and what is the organism associated with this action?\n",
      "   answer: Lepirudin targets prothrombin, and the organism associated with this action is humans. It is used in anticoagulation therapy.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Describe the production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein produced in an E. coli expression system. It is composed of amino acid sequences for diphtheria toxin fragments followed by sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the components of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This mechanism is confirmed to have a known action in inhibiting the receptor's activity, which can be overexpressed in certain types of cancer.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the therapeutic use of Dornase alfa?', 'answer': 'Dornase alfa is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It achieves this by cleaving extracellular DNA, which is released by degenerating leukocytes during inflammatory responses to infections.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets prothrombin and what is the organism associated with this action?', 'answer': 'Lepirudin targets prothrombin, and the organism associated with this action is humans. It is used in anticoagulation therapy.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein produced in an E. coli expression system. It is composed of amino acid sequences for diphtheria toxin fragments followed by sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 12%|█▎        | 25/200 [02:12<19:47,  6.78s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab in cancer treatment?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans. It binds to the extracellular domain of EGFR, which is known to play a role in tumor growth and progression. By inhibiting this receptor, Cetuximab can prevent cancer cell proliferation and survival.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is used to reduce sputum viscosity in cystic fibrosis patients, and what is its mechanism?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA into smaller phosphodinucleotides and phosphooligonucleotides, thus reducing the viscosity and viscoelasticity of sputum.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the components of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human p75 tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the primary target of Lepirudin and its action in the body?\n",
      "   answer: Lepirudin primarily targets prothrombin in humans, and it acts by inhibiting thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is crucial in the coagulation pathway.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action for Cetuximab in cancer treatment?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans. It binds to the extracellular domain of EGFR, which is known to play a role in tumor growth and progression. By inhibiting this receptor, Cetuximab can prevent cancer cell proliferation and survival.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is used to reduce sputum viscosity in cystic fibrosis patients, and what is its mechanism?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA into smaller phosphodinucleotides and phosphooligonucleotides, thus reducing the viscosity and viscoelasticity of sputum.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human p75 tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary target of Lepirudin and its action in the body?', 'answer': 'Lepirudin primarily targets prothrombin in humans, and it acts by inhibiting thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is crucial in the coagulation pathway.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-10223928\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 14%|█▎        | 27/200 [02:17<13:39,  4.74s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in humans?\n",
      "   answer: Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) on human cells, as indicated in the drug target table. This interaction is a known action and is fundamental to its therapeutic effects.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is indicated for the reduction of sputum viscosity in individuals with cystic fibrosis, and what is its mechanism?\n",
      "   answer: Dornase alfa is indicated for reducing sputum viscosity in individuals with cystic fibrosis. It works by cleaving extracellular DNA without affecting intracellular DNA, thus reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the unique molecular characteristic of Lepirudin compared to natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in humans?', 'answer': 'Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) on human cells, as indicated in the drug target table. This interaction is a known action and is fundamental to its therapeutic effects.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is indicated for the reduction of sputum viscosity in individuals with cystic fibrosis, and what is its mechanism?', 'answer': 'Dornase alfa is indicated for reducing sputum viscosity in individuals with cystic fibrosis. It works by cleaving extracellular DNA without affecting intracellular DNA, thus reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique molecular characteristic of Lepirudin compared to natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 14%|█▍        | 28/200 [02:23<15:01,  5.24s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab and which receptor does it target in humans?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the epidermal growth factor receptor in humans, which is known to be involved in the mechanism of action for this drug.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is related to the treatment of cystic fibrosis and what is its mechanism of action?\n",
      "   answer: Dornase alfa is related to the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity, aiding patients with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the production method for Etanercept, and what does its structure include?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is a cytotoxic protein derived from recombinant DNA and what are its components?\n",
      "   answer: Denileukin diftitox is a cytotoxic protein derived from recombinant DNA. It is composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the known action of Cetuximab on its target, and how many potential targets are listed in the data?\n",
      "   answer: Cetuximab has a known action on its primary target, the epidermal growth factor receptor (EGFR) in humans. There are a total of five potential targets listed for Cetuximab in the data, with known and unknown actions.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action for Cetuximab and which receptor does it target in humans?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the epidermal growth factor receptor in humans, which is known to be involved in the mechanism of action for this drug.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is related to the treatment of cystic fibrosis and what is its mechanism of action?', 'answer': 'Dornase alfa is related to the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity, aiding patients with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the production method for Etanercept, and what does its structure include?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is a cytotoxic protein derived from recombinant DNA and what are its components?', 'answer': 'Denileukin diftitox is a cytotoxic protein derived from recombinant DNA. It is composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Cetuximab on its target, and how many potential targets are listed in the data?', 'answer': 'Cetuximab has a known action on its primary target, the epidermal growth factor receptor (EGFR) in humans. There are a total of five potential targets listed for Cetuximab in the data, with known and unknown actions.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 14%|█▍        | 29/200 [02:30<15:40,  5.50s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in humans?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This is a known action and is specifically targeted to the N-terminal portion of human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which biotech drug is composed of a dimeric fusion protein linked to the Fc portion of human IgG1?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the primary known target of Lepirudin in humans?\n",
      "   answer: The primary known target of Lepirudin in humans is Prothrombin.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: Identify a biotech drug that has been discontinued by its manufacturer and state the reason.\n",
      "   answer: Lepirudin, marketed as Refludan, was ceased in production by Bayer as of May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in humans?', 'answer': 'Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This is a known action and is specifically targeted to the N-terminal portion of human EGFR.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which biotech drug is composed of a dimeric fusion protein linked to the Fc portion of human IgG1?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary known target of Lepirudin in humans?', 'answer': 'The primary known target of Lepirudin in humans is Prothrombin.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Identify a biotech drug that has been discontinued by its manufacturer and state the reason.', 'answer': 'Lepirudin, marketed as Refludan, was ceased in production by Bayer as of May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 15%|█▌        | 30/200 [02:37<16:40,  5.88s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which target does it bind to?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets and binds to the epidermal growth factor receptor in humans.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: Which drug is linked to the inhibition of prothrombin in humans?\n",
      "   answer: Lepirudin is linked to the inhibition of prothrombin in humans. It acts on prothrombin as a known action target.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "3. question: What is the clinical application of Dornase alfa, and how does it affect extracellular DNA?\n",
      "   answer: Dornase alfa is used in the treatment of cystic fibrosis. It enzymatically cleaves extracellular DNA into smaller fragments, which reduces sputum viscosity and viscoelasticity, facilitating easier clearance from the lungs.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What production method is used for Denileukin diftitox, and what are its main components?\n",
      "   answer: Denileukin diftitox is produced using a recombinant DNA-derived method in an E. coli expression system. It is composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the structural composition of Etanercept, and in which expression system is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which target does it bind to?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets and binds to the epidermal growth factor receptor in humans.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'Which drug is linked to the inhibition of prothrombin in humans?', 'answer': 'Lepirudin is linked to the inhibition of prothrombin in humans. It acts on prothrombin as a known action target.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the clinical application of Dornase alfa, and how does it affect extracellular DNA?', 'answer': 'Dornase alfa is used in the treatment of cystic fibrosis. It enzymatically cleaves extracellular DNA into smaller fragments, which reduces sputum viscosity and viscoelasticity, facilitating easier clearance from the lungs.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What production method is used for Denileukin diftitox, and what are its main components?', 'answer': 'Denileukin diftitox is produced using a recombinant DNA-derived method in an E. coli expression system. It is composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the structural composition of Etanercept, and in which expression system is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-18311418\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 16%|█▌        | 32/200 [02:46<14:43,  5.26s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary therapeutic target of Cetuximab and its mechanism of action?\n",
      "   answer: Cetuximab primarily targets the epidermal growth factor receptor (EGFR) in humans. The known action of Cetuximab is to bind to the EGFR, which is crucial in the signaling pathways that lead to cell growth and proliferation. By binding to EGFR, Cetuximab inhibits the receptor's activation and downstream signaling, which can help control tumor growth.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the main clinical use of Dornase alfa and how does it work?\n",
      "   answer: Dornase alfa is used to treat cystic fibrosis. It is a biosynthetic form of the human DNase I enzyme that cleaves extracellular DNA, which reduces sputum viscosity and viscoelasticity. This action helps to clear the thick mucus in the lungs of individuals with cystic fibrosis, thereby improving lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Can you describe the composition and production method of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein made up of the extracellular ligand-binding portion of the human p75 tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This protein consists of 934 amino acids and is used as a treatment for autoimmune diseases by inhibiting tumor necrosis factor (TNF).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is associated with the target Prothrombin, and what does this suggest about its therapeutic application?\n",
      "   answer: The drug Lepirudin is associated with the target Prothrombin in humans. This suggests that Lepirudin is used as an anticoagulant, as it targets and inhibits thrombin, an enzyme in the blood coagulation pathway, thereby preventing clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the primary therapeutic target of Cetuximab and its mechanism of action?', 'answer': \"Cetuximab primarily targets the epidermal growth factor receptor (EGFR) in humans. The known action of Cetuximab is to bind to the EGFR, which is crucial in the signaling pathways that lead to cell growth and proliferation. By binding to EGFR, Cetuximab inhibits the receptor's activation and downstream signaling, which can help control tumor growth.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the main clinical use of Dornase alfa and how does it work?', 'answer': 'Dornase alfa is used to treat cystic fibrosis. It is a biosynthetic form of the human DNase I enzyme that cleaves extracellular DNA, which reduces sputum viscosity and viscoelasticity. This action helps to clear the thick mucus in the lungs of individuals with cystic fibrosis, thereby improving lung function.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Can you describe the composition and production method of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein made up of the extracellular ligand-binding portion of the human p75 tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This protein consists of 934 amino acids and is used as a treatment for autoimmune diseases by inhibiting tumor necrosis factor (TNF).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is associated with the target Prothrombin, and what does this suggest about its therapeutic application?', 'answer': 'The drug Lepirudin is associated with the target Prothrombin in humans. This suggests that Lepirudin is used as an anticoagulant, as it targets and inhibits thrombin, an enzyme in the blood coagulation pathway, thereby preventing clot formation.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-12534644\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 17%|█▋        | 34/200 [02:51<12:01,  4.35s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and which specific target does it bind to?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding Fab. It targets the epidermal growth factor receptor in humans, which is known to be involved in the mechanism of action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is associated with the target Prothrombin in humans, and what is its primary drug type?\n",
      "   answer: Lepirudin is associated with the target Prothrombin in humans. It is classified as a biotech drug.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: Describe the composition and primary production method of the drug Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the specific FDA-approved use for Lupron Depot, and what is its active ingredient?\n",
      "   answer: Lupron Depot is approved for use as a depot suspension of leuprolide acetate, which is used in various hormonal treatments, including prostate cancer and endometriosis.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and which specific target does it bind to?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding Fab. It targets the epidermal growth factor receptor in humans, which is known to be involved in the mechanism of action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is associated with the target Prothrombin in humans, and what is its primary drug type?', 'answer': 'Lepirudin is associated with the target Prothrombin in humans. It is classified as a biotech drug.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the composition and primary production method of the drug Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the specific FDA-approved use for Lupron Depot, and what is its active ingredient?', 'answer': 'Lupron Depot is approved for use as a depot suspension of leuprolide acetate, which is used in various hormonal treatments, including prostate cancer and endometriosis.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-10722500\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 18%|█▊        | 36/200 [02:57<10:37,  3.88s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in treating cancer?\n",
      "   answer: Cetuximab binds to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and confirmed, suggesting that Cetuximab works by inhibiting the growth and survival signaling pathways mediated by EGFR, which are crucial for cancer cell proliferation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What type of therapeutic agent is Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a biotech drug classified as a dimeric fusion protein. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system, and it consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the main target of Lepirudin, and how does it act on this target?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action is known. It acts by inhibiting thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is crucial in the blood clotting process.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Which drug mentioned in the tables is used in the form of a liquid state and is known for targeting the epidermal growth factor receptor?\n",
      "   answer: Cetuximab is used in the liquid state and is known for targeting the epidermal growth factor receptor (EGFR) in humans.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the production characteristics of Dornase alfa, and what is its therapeutic use?\n",
      "   answer: Dornase alfa is a biotech drug produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used therapeutically in individuals with cystic fibrosis to cleave extracellular DNA, thereby reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in treating cancer?', 'answer': 'Cetuximab binds to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and confirmed, suggesting that Cetuximab works by inhibiting the growth and survival signaling pathways mediated by EGFR, which are crucial for cancer cell proliferation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of therapeutic agent is Etanercept, and how is it produced?', 'answer': 'Etanercept is a biotech drug classified as a dimeric fusion protein. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system, and it consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the main target of Lepirudin, and how does it act on this target?', 'answer': 'Lepirudin targets prothrombin in humans, and its action is known. It acts by inhibiting thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is crucial in the blood clotting process.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug mentioned in the tables is used in the form of a liquid state and is known for targeting the epidermal growth factor receptor?', 'answer': 'Cetuximab is used in the liquid state and is known for targeting the epidermal growth factor receptor (EGFR) in humans.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the production characteristics of Dornase alfa, and what is its therapeutic use?', 'answer': 'Dornase alfa is a biotech drug produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used therapeutically in individuals with cystic fibrosis to cleave extracellular DNA, thereby reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-11602509\n",
      "No table mapping found for passage Target-8667235\n",
      "No table mapping found for passage Target-16584282\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 20%|██        | 40/200 [03:03<06:55,  2.60s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which organism is targeted?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR), which is found in humans. This interaction is known and serves to inhibit the receptor's activity.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the primary therapeutic use of Dornase alfa and how is it produced?\n",
      "   answer: Dornase alfa is used to treat cystic fibrosis by reducing sputum viscosity and viscoelasticity through the enzymatic breakdown of extracellular DNA. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug is linked to the target \"Prothrombin\" and what is its known action?\n",
      "   answer: The drug Lepirudin targets Prothrombin in humans, and its action is known to inhibit thrombin, thus acting as an anticoagulant.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Describe the composition and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the clinical significance of the FDA-approved Lupron Depot and its related formulations?\n",
      "   answer: Lupron Depot, along with related formulations like Lupron Depot-Ped and Fensolvi, are depot suspensions of leuprolide acetate used for various indications including hormone-related disorders. These formulations are administered via depot injection to provide a sustained release of the drug.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which organism is targeted?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR), which is found in humans. This interaction is known and serves to inhibit the receptor's activity.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the primary therapeutic use of Dornase alfa and how is it produced?', 'answer': 'Dornase alfa is used to treat cystic fibrosis by reducing sputum viscosity and viscoelasticity through the enzymatic breakdown of extracellular DNA. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is linked to the target \"Prothrombin\" and what is its known action?', 'answer': 'The drug Lepirudin targets Prothrombin in humans, and its action is known to inhibit thrombin, thus acting as an anticoagulant.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the composition and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the clinical significance of the FDA-approved Lupron Depot and its related formulations?', 'answer': 'Lupron Depot, along with related formulations like Lupron Depot-Ped and Fensolvi, are depot suspensions of leuprolide acetate used for various indications including hormone-related disorders. These formulations are administered via depot injection to provide a sustained release of the drug.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 20%|██        | 41/200 [03:09<08:25,  3.18s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab in humans?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, which means it targets and binds to the EGFR on human cells. This binding is known to occur and is a part of its mechanism of action to inhibit cell growth.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the state of the drug Lepirudin and how is it produced?\n",
      "   answer: Lepirudin is in a liquid state and is produced via yeast cells. It is identical to natural hirudin, with a few substitutions in its molecular structure.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the production and composition of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which human protein is Lepirudin known to act upon?\n",
      "   answer: Lepirudin is known to act upon Prothrombin in humans, which is part of its mechanism of action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: How does Dornase alfa function in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is an enzyme that cleaves extracellular DNA into 5ʹ-phosphodinucleotide and 5ʹ-phosphooligonucleotide end products, reducing the viscosity and viscoelasticity of sputum in individuals with cystic fibrosis. This enzymatic breakdown helps in managing the condition by reducing the accumulation of degenerating leukocytes, which contribute to the viscosity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab in humans?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, which means it targets and binds to the EGFR on human cells. This binding is known to occur and is a part of its mechanism of action to inhibit cell growth.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the state of the drug Lepirudin and how is it produced?', 'answer': 'Lepirudin is in a liquid state and is produced via yeast cells. It is identical to natural hirudin, with a few substitutions in its molecular structure.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the production and composition of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which human protein is Lepirudin known to act upon?', 'answer': 'Lepirudin is known to act upon Prothrombin in humans, which is part of its mechanism of action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How does Dornase alfa function in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is an enzyme that cleaves extracellular DNA into 5ʹ-phosphodinucleotide and 5ʹ-phosphooligonucleotide end products, reducing the viscosity and viscoelasticity of sputum in individuals with cystic fibrosis. This enzymatic breakdown helps in managing the condition by reducing the accumulation of degenerating leukocytes, which contribute to the viscosity.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-23516440\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 22%|██▏       | 43/200 [03:15<08:02,  3.07s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which target does it bind to?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It binds specifically to the N-terminal portion of the human EGFR. This interaction is confirmed as a known action against the target organism, humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the main therapeutic use of Dornase alfa, and how does it achieve its clinical effect?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in individuals with cystic fibrosis. It achieves its clinical effect by enzymatically cleaving extracellular DNA, which is highly viscous, into smaller fragments that reduce sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the key structural components of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the composition and production method of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is composed of amino acid sequences from diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the FDA-approved form of leuprolide acetate marketed under the name Fensolvi?\n",
      "   answer: The FDA-approved form of leuprolide acetate marketed under the name Fensolvi is in the form of a suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which target does it bind to?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It binds specifically to the N-terminal portion of the human EGFR. This interaction is confirmed as a known action against the target organism, humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the main therapeutic use of Dornase alfa, and how does it achieve its clinical effect?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in individuals with cystic fibrosis. It achieves its clinical effect by enzymatically cleaving extracellular DNA, which is highly viscous, into smaller fragments that reduce sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the key structural components of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition and production method of Denileukin diftitox?', 'answer': 'Denileukin diftitox is composed of amino acid sequences from diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved form of leuprolide acetate marketed under the name Fensolvi?', 'answer': 'The FDA-approved form of leuprolide acetate marketed under the name Fensolvi is in the form of a suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 22%|██▏       | 44/200 [03:20<09:10,  3.53s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the target organism for the drug Lepirudin, and what is its known action?\n",
      "   answer: The target organism for the drug Lepirudin is humans, specifically targeting Prothrombin, with a known action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the mechanism of action of Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans, which is its known target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: How is Dornase alfa produced, and what condition is it primarily used to treat?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is primarily used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the mechanism of action of Denileukin diftitox, and how is it produced?\n",
      "   answer: Denileukin diftitox is a cytotoxic protein composed of diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the molecular composition of Etanercept, and how is it expressed?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is expressed using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the target organism for the drug Lepirudin, and what is its known action?', 'answer': 'The target organism for the drug Lepirudin is humans, specifically targeting Prothrombin, with a known action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the mechanism of action of Cetuximab, and which receptor does it target?', 'answer': 'Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans, which is its known target.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Dornase alfa produced, and what condition is it primarily used to treat?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is primarily used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the mechanism of action of Denileukin diftitox, and how is it produced?', 'answer': 'Denileukin diftitox is a cytotoxic protein composed of diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the molecular composition of Etanercept, and how is it expressed?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is expressed using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-16445595\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 23%|██▎       | 46/200 [03:28<09:21,  3.65s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary target for Cetuximab, and what is its known action in humans?\n",
      "   answer: The primary target for Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is composed of a cytotoxic protein with sequences of diphtheria toxin and interleukin-2, and what organism is it produced in?\n",
      "   answer: Denileukin diftitox is composed of a cytotoxic protein with sequences of diphtheria toxin and interleukin-2, and it is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the state of Etanercept, and what technology is used for its production?\n",
      "   answer: Etanercept is in a liquid state and is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Lepirudin different from natural hirudin, and why did its production cease?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. Its production ceased because Bayer stopped producing lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the marketed brand name for Cetuximab, and which company markets it?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary target for Cetuximab, and what is its known action in humans?', 'answer': 'The primary target for Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is composed of a cytotoxic protein with sequences of diphtheria toxin and interleukin-2, and what organism is it produced in?', 'answer': 'Denileukin diftitox is composed of a cytotoxic protein with sequences of diphtheria toxin and interleukin-2, and it is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the state of Etanercept, and what technology is used for its production?', 'answer': 'Etanercept is in a liquid state and is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Lepirudin different from natural hirudin, and why did its production cease?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. Its production ceased because Bayer stopped producing lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed brand name for Cetuximab, and which company markets it?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 24%|██▎       | 47/200 [03:33<10:05,  3.96s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which human transporter is associated with the drug Dornase alfa, and what is its known action?\n",
      "   answer: Dornase alfa is associated with the transporter P-glycoprotein 1 in humans, and its known action is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the primary therapeutic application of Cetuximab based on its mechanism of action?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, which suggests its therapeutic application in targeting EGFR-related pathways, often used in the treatment of certain cancers.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the components and production method of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced using a recombinant DNA technology in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which transporter is linked to the drug with the DrugBank ID DB00091, and what is its organism?\n",
      "   answer: The drug with DrugBank ID DB00091 is linked to three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. All these transporters are from humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "5. question: What is the state of the drug Etanercept, and where is it produced?\n",
      "   answer: Etanercept is in a liquid state and is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which human transporter is associated with the drug Dornase alfa, and what is its known action?', 'answer': 'Dornase alfa is associated with the transporter P-glycoprotein 1 in humans, and its known action is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the primary therapeutic application of Cetuximab based on its mechanism of action?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, which suggests its therapeutic application in targeting EGFR-related pathways, often used in the treatment of certain cancers.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components and production method of Denileukin diftitox?', 'answer': 'Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced using a recombinant DNA technology in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which transporter is linked to the drug with the DrugBank ID DB00091, and what is its organism?', 'answer': 'The drug with DrugBank ID DB00091 is linked to three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. All these transporters are from humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Etanercept, and where is it produced?', 'answer': 'Etanercept is in a liquid state and is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 24%|██▍       | 48/200 [03:39<10:44,  4.24s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, targeting the EGFR in humans. It is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the method of production and the therapeutic indication of Dornase alfa?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme and is indicated for reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Etanercept produced, and what is its primary structural composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, which includes the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the unique structural difference between Lepirudin and natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the known action of Cetuximab on the Complement C1q subcomponent subunit B, and is it the primary target?\n",
      "   answer: The known action of Cetuximab on the Complement C1q subcomponent subunit B is unknown, and it is not the primary target. Its primary target is the epidermal growth factor receptor (EGFR).\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, targeting the EGFR in humans. It is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the method of production and the therapeutic indication of Dornase alfa?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme and is indicated for reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what is its primary structural composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, which includes the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique structural difference between Lepirudin and natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Cetuximab on the Complement C1q subcomponent subunit B, and is it the primary target?', 'answer': 'The known action of Cetuximab on the Complement C1q subcomponent subunit B is unknown, and it is not the primary target. Its primary target is the epidermal growth factor receptor (EGFR).', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 24%|██▍       | 49/200 [03:44<11:23,  4.53s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and what are its known targets?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the N-terminal portion of the human EGFR. Known targets include the Epidermal Growth Factor Receptor (EGFR) in humans.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: Which drug is noted for its use in reducing sputum viscosity in cystic fibrosis, and how is it produced?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the production details and molecular components of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system and consists of 934 amino acids.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Lepirudin different from natural hirudin, and what is its production status?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and what are its known targets?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the N-terminal portion of the human EGFR. Known targets include the Epidermal Growth Factor Receptor (EGFR) in humans.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'Which drug is noted for its use in reducing sputum viscosity in cystic fibrosis, and how is it produced?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the production details and molecular components of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system and consists of 934 amino acids.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Lepirudin different from natural hirudin, and what is its production status?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 25%|██▌       | 50/200 [03:49<11:46,  4.71s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab as it relates to its target?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans. It binds to the EGFR, which is a known action, and this interaction is part of its mechanism to exert therapeutic effects.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What type of drug is Dornase alfa and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is a biotech drug that is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. Its primary therapeutic use is to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the known action of Lepirudin and what target does it affect?\n",
      "   answer: Lepirudin is known to affect prothrombin in humans. The drug is used clinically for its action on this target, which is part of its anticoagulant properties.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Which drug is associated with the FDA label titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension,\" and what is its primary key?\n",
      "   answer: The FDA label titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension\" is associated with the drug having the primary key DB00007.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "5. question: How is Etanercept produced and what is its structural composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab as it relates to its target?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans. It binds to the EGFR, which is a known action, and this interaction is part of its mechanism to exert therapeutic effects.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of drug is Dornase alfa and what is its primary therapeutic use?', 'answer': 'Dornase alfa is a biotech drug that is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. Its primary therapeutic use is to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Lepirudin and what target does it affect?', 'answer': 'Lepirudin is known to affect prothrombin in humans. The drug is used clinically for its action on this target, which is part of its anticoagulant properties.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is associated with the FDA label titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension,\" and what is its primary key?', 'answer': 'The FDA label titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension\" is associated with the drug having the primary key DB00007.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'How is Etanercept produced and what is its structural composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-8216357\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 26%|██▌       | 52/200 [03:56<09:56,  4.03s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the role of P-glycoprotein 1 in drug transport for Lepirudin?\n",
      "   answer: P-glycoprotein 1 is involved in drug transport for Lepirudin, although the specific action of this transporter remains unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: Which FDA-approved formulations of leuprolide acetate are linked to the drug with the primary key DB00007?\n",
      "   answer: The drug with the primary key DB00007 is linked to several FDA-approved formulations of leuprolide acetate, including Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "3. question: What is the organism source for the Canalicular multispecific organic anion transporter 1 associated with the drug DB00067?\n",
      "   answer: The organism source for the Canalicular multispecific organic anion transporter 1 associated with the drug DB00067 is humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: How is Dornase alfa produced, and what is its function in cystic fibrosis treatment?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It functions by cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the role of P-glycoprotein 1 in drug transport for Lepirudin?', 'answer': 'P-glycoprotein 1 is involved in drug transport for Lepirudin, although the specific action of this transporter remains unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Which FDA-approved formulations of leuprolide acetate are linked to the drug with the primary key DB00007?', 'answer': 'The drug with the primary key DB00007 is linked to several FDA-approved formulations of leuprolide acetate, including Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What is the organism source for the Canalicular multispecific organic anion transporter 1 associated with the drug DB00067?', 'answer': 'The organism source for the Canalicular multispecific organic anion transporter 1 associated with the drug DB00067 is humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'How is Dornase alfa produced, and what is its function in cystic fibrosis treatment?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It functions by cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-15268978\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 27%|██▋       | 54/200 [04:16<15:15,  6.27s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor, which is involved in the signaling pathways that regulate cell growth and survival, making it a target for cancer treatment.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the method of production for Etanercept, and what is its structural composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug targets Prothrombin in its mechanism of action?\n",
      "   answer: Lepirudin targets Prothrombin, as indicated by its known action in humans. This makes Lepirudin an anticoagulant used to inhibit thrombin, thereby preventing blood clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: For which drug is the state of the product described as 'liquid' and is produced using genetically modified Chinese hamster ovary (CHO) cells?\n",
      "   answer: Dornase alfa is described as being in a liquid state and is produced using genetically modified Chinese hamster ovary (CHO) cells. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the known side effects or contraindications related to the use of Denileukin diftitox?\n",
      "   answer: While the specific side effects or contraindications are not listed in the tables, Denileukin diftitox is a recombinant DNA-derived cytotoxic protein, which suggests potential immunogenicity or hypersensitivity reactions. The molecule includes sequences for interleukin-2 (IL-2), which could also contribute to immune system-related side effects.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action for Cetuximab?', 'answer': 'Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor, which is involved in the signaling pathways that regulate cell growth and survival, making it a target for cancer treatment.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the method of production for Etanercept, and what is its structural composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets Prothrombin in its mechanism of action?', 'answer': 'Lepirudin targets Prothrombin, as indicated by its known action in humans. This makes Lepirudin an anticoagulant used to inhibit thrombin, thereby preventing blood clot formation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': \"For which drug is the state of the product described as 'liquid' and is produced using genetically modified Chinese hamster ovary (CHO) cells?\", 'answer': 'Dornase alfa is described as being in a liquid state and is produced using genetically modified Chinese hamster ovary (CHO) cells. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the known side effects or contraindications related to the use of Denileukin diftitox?', 'answer': 'While the specific side effects or contraindications are not listed in the tables, Denileukin diftitox is a recombinant DNA-derived cytotoxic protein, which suggests potential immunogenicity or hypersensitivity reactions. The molecule includes sequences for interleukin-2 (IL-2), which could also contribute to immune system-related side effects.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 28%|██▊       | 55/200 [04:21<14:33,  6.02s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary therapeutic application of Dornase alfa, and under what brand name is it marketed?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA. It is marketed under the brand name Pulmozyme.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "2. question: What is the mechanism of action of Cetuximab, and which company markets it under the brand name Erbitux?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB that targets the N-terminal portion of human EGFR. It is marketed under the brand name Erbitux by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What specific protein components make up Etanercept, and what is its production method?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is marketed as Refludan, and what is its unique structural characteristic compared to natural hirudin?\n",
      "   answer: Lepirudin is marketed as Refludan and is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "5. question: Describe the production system and composition of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of sequences for diphtheria toxin fragments and interleukin-2. It is produced using an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary therapeutic application of Dornase alfa, and under what brand name is it marketed?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA. It is marketed under the brand name Pulmozyme.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'What is the mechanism of action of Cetuximab, and which company markets it under the brand name Erbitux?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB that targets the N-terminal portion of human EGFR. It is marketed under the brand name Erbitux by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What specific protein components make up Etanercept, and what is its production method?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is marketed as Refludan, and what is its unique structural characteristic compared to natural hirudin?', 'answer': 'Lepirudin is marketed as Refludan and is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Describe the production system and composition of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of sequences for diphtheria toxin fragments and interleukin-2. It is produced using an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 28%|██▊       | 56/200 [04:28<15:06,  6.30s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the known mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab has a known mechanism of action as it binds to the epidermal growth factor receptor (EGFR) in humans, which is involved in the regulation of cell growth and differentiation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What are the FDA-approved uses of Leuprolide acetate formulations according to the available links?\n",
      "   answer: The FDA-approved uses of Leuprolide acetate formulations include Lupron Depot, Lupron Depot-Ped, and Fensolvi, all of which are depot suspensions indicated for different clinical uses.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "3. question: Which drug targets Prothrombin, and what is its primary use?\n",
      "   answer: Lepirudin targets Prothrombin in humans. It is an anticoagulant used to prevent blood clots by inhibiting thrombin, making it useful in conditions like heparin-induced thrombocytopenia.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Describe the composition and production method of Dornase alfa.\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It cleaves extracellular DNA to reduce sputum viscosity in cystic fibrosis patients.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the method of synthesis for Etanercept?\n",
      "   answer: Etanercept is synthesized using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It involves linking the extracellular ligand-binding portion of the human tumor necrosis factor receptor to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the known mechanism of action for Cetuximab?', 'answer': 'Cetuximab has a known mechanism of action as it binds to the epidermal growth factor receptor (EGFR) in humans, which is involved in the regulation of cell growth and differentiation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the FDA-approved uses of Leuprolide acetate formulations according to the available links?', 'answer': 'The FDA-approved uses of Leuprolide acetate formulations include Lupron Depot, Lupron Depot-Ped, and Fensolvi, all of which are depot suspensions indicated for different clinical uses.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Which drug targets Prothrombin, and what is its primary use?', 'answer': 'Lepirudin targets Prothrombin in humans. It is an anticoagulant used to prevent blood clots by inhibiting thrombin, making it useful in conditions like heparin-induced thrombocytopenia.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the composition and production method of Dornase alfa.', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It cleaves extracellular DNA to reduce sputum viscosity in cystic fibrosis patients.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the method of synthesis for Etanercept?', 'answer': 'Etanercept is synthesized using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It involves linking the extracellular ligand-binding portion of the human tumor necrosis factor receptor to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 28%|██▊       | 57/200 [04:36<16:04,  6.74s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab binds to the epidermal growth factor receptor (EGFR) on human cells, inhibiting the receptor's activity. This mechanism of action is confirmed by its known action on the epidermal growth factor receptor, as indicated in the drugbank-targets table.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug targets Prothrombin in humans?\n",
      "   answer: Lepirudin targets Prothrombin in humans. This is indicated in the drugbank-targets table where Prothrombin is listed as a target with a known action for Lepirudin.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the molecular structure characteristic of Cetuximab that contributes to its function?\n",
      "   answer: Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. This structure allows it to bind to the epidermal growth factor receptor and inhibit its activity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which organism is the source of the recombinant production of Dornase alfa?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. This is detailed in the drugbank-drug table.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the updated FDA label detail for Lupron Depot?\n",
      "   answer: The FDA label for Lupron Depot (leuprolide acetate) depot suspension was updated in 2019, as reflected in the drugbank-drugs_links table. The updated label provides current information regarding its use and administration.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': \"Cetuximab binds to the epidermal growth factor receptor (EGFR) on human cells, inhibiting the receptor's activity. This mechanism of action is confirmed by its known action on the epidermal growth factor receptor, as indicated in the drugbank-targets table.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug targets Prothrombin in humans?', 'answer': 'Lepirudin targets Prothrombin in humans. This is indicated in the drugbank-targets table where Prothrombin is listed as a target with a known action for Lepirudin.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the molecular structure characteristic of Cetuximab that contributes to its function?', 'answer': 'Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. This structure allows it to bind to the epidermal growth factor receptor and inhibit its activity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which organism is the source of the recombinant production of Dornase alfa?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. This is detailed in the drugbank-drug table.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the updated FDA label detail for Lupron Depot?', 'answer': 'The FDA label for Lupron Depot (leuprolide acetate) depot suspension was updated in 2019, as reflected in the drugbank-drugs_links table. The updated label provides current information regarding its use and administration.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-976190\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 30%|██▉       | 59/200 [04:42<12:03,  5.13s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what receptor does it target?\n",
      "   answer: Cetuximab functions as an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor, inhibiting its action in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the main therapeutic use of Dornase alfa, and how does it function?\n",
      "   answer: Dornase alfa is used in individuals with cystic fibrosis. It functions by cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity, thereby aiding in the management of cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug targets Prothrombin in humans, and is its action known?\n",
      "   answer: Lepirudin targets Prothrombin in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Describe the structural composition of Etanercept and the technology used in its production.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what receptor does it target?', 'answer': 'Cetuximab functions as an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor, inhibiting its action in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the main therapeutic use of Dornase alfa, and how does it function?', 'answer': 'Dornase alfa is used in individuals with cystic fibrosis. It functions by cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity, thereby aiding in the management of cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets Prothrombin in humans, and is its action known?', 'answer': 'Lepirudin targets Prothrombin in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the structural composition of Etanercept and the technology used in its production.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-7909721\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 30%|███       | 61/200 [04:49<10:49,  4.68s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB, which targets the epidermal growth factor receptor (EGFR) in humans. The known action involves binding to the EGFR, thereby inhibiting its function.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What are the components of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the primary therapeutic form of Dornase alfa, and how does it affect patients with cystic fibrosis?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA into 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products, reducing sputum viscosity and viscoelasticity in patients with cystic fibrosis by breaking down extracellular DNA from degenerating leukocytes.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is associated with the target Prothrombin, and what organism is this target found in?\n",
      "   answer: The drug associated with the target Prothrombin is Lepirudin, and this target is found in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: How is Cetuximab marketed in the United States, and what is its approximate cost for an eight-week course?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company in the United States. The approximate cost for an eight-week course is $30,790.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor binding FAB, which targets the epidermal growth factor receptor (EGFR) in humans. The known action involves binding to the EGFR, thereby inhibiting its function.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What are the components of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary therapeutic form of Dornase alfa, and how does it affect patients with cystic fibrosis?', 'answer': \"Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA into 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products, reducing sputum viscosity and viscoelasticity in patients with cystic fibrosis by breaking down extracellular DNA from degenerating leukocytes.\", 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is associated with the target Prothrombin, and what organism is this target found in?', 'answer': 'The drug associated with the target Prothrombin is Lepirudin, and this target is found in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Cetuximab marketed in the United States, and what is its approximate cost for an eight-week course?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company in the United States. The approximate cost for an eight-week course is $30,790.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-8591723\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 32%|███▏      | 63/200 [04:58<10:22,  4.54s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and under what brand name is it marketed?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is composed of the Fv regions (variable; antigen-binding) of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, combined with human IgG1 heavy and kappa light chain constant regions. Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What is the therapeutic use of Dornase alfa, and how is it produced?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme and is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug is marketed as Ontak, and what is its composition?\n",
      "   answer: The drug marketed as Ontak is Denileukin diftitox. It is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "4. question: What is the production method for Etanercept, and what structural components does it consist of?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the FDA status of Lupaneta Pack, and what is its administration route?\n",
      "   answer: Lupaneta Pack is FDA approved for intramuscular and oral use. The label information confirms its approval status and administration routes.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and under what brand name is it marketed?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is composed of the Fv regions (variable; antigen-binding) of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, combined with human IgG1 heavy and kappa light chain constant regions. Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the therapeutic use of Dornase alfa, and how is it produced?', 'answer': 'Dornase alfa is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme and is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is marketed as Ontak, and what is its composition?', 'answer': 'The drug marketed as Ontak is Denileukin diftitox. It is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'What is the production method for Etanercept, and what structural components does it consist of?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA status of Lupaneta Pack, and what is its administration route?', 'answer': 'Lupaneta Pack is FDA approved for intramuscular and oral use. The label information confirms its approval status and administration routes.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 32%|███▏      | 64/200 [05:05<11:17,  4.98s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding fragment antigen-binding (FAB). Its primary target is the epidermal growth factor receptor in humans, and it is known to have an action on this target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What are the unique production characteristics of Dornase alfa, and what condition is it primarily indicated for?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is primarily indicated for the treatment of cystic fibrosis, where it helps reduce sputum viscosity by breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the structure and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug targets Prothrombin, and what is its state of matter?\n",
      "   answer: The drug Lepirudin targets Prothrombin in humans, and its state of matter is liquid.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the FDA-approved use for the Lupron Depot formulations, and what active ingredient do they contain?\n",
      "   answer: The FDA-approved use for Lupron Depot formulations includes various indications such as prostate cancer and endometriosis. They contain the active ingredient leuprolide acetate, which is administered as a depot suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding fragment antigen-binding (FAB). Its primary target is the epidermal growth factor receptor in humans, and it is known to have an action on this target.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the unique production characteristics of Dornase alfa, and what condition is it primarily indicated for?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is primarily indicated for the treatment of cystic fibrosis, where it helps reduce sputum viscosity by breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structure and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets Prothrombin, and what is its state of matter?', 'answer': 'The drug Lepirudin targets Prothrombin in humans, and its state of matter is liquid.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the FDA-approved use for the Lupron Depot formulations, and what active ingredient do they contain?', 'answer': 'The FDA-approved use for Lupron Depot formulations includes various indications such as prostate cancer and endometriosis. They contain the active ingredient leuprolide acetate, which is administered as a depot suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-15509185\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 33%|███▎      | 66/200 [05:11<09:30,  4.25s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and under what brand name is it marketed?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB, composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions. It is marketed under the brand name Erbitux by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: How is Dornase alfa produced, and what is its clinical application?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme, clinically used to reduce sputum viscosity in cystic fibrosis patients by cleaving extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition of Denileukin diftitox, and which brand is it marketed under?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments and interleukin-2. It is marketed under the brand name Ontak.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the function and molecular target of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It targets tumor necrosis factor (TNF) to reduce inflammation.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the production method of Lepirudin and what happened to its commercial production?\n",
      "   answer: Lepirudin is produced via yeast cells and is identical to natural hirudin except for specific substitutions. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and under what brand name is it marketed?', 'answer': 'Cetuximab is an epidermal growth factor receptor binding FAB, composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions. It is marketed under the brand name Erbitux by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Dornase alfa produced, and what is its clinical application?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme, clinically used to reduce sputum viscosity in cystic fibrosis patients by cleaving extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition of Denileukin diftitox, and which brand is it marketed under?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments and interleukin-2. It is marketed under the brand name Ontak.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the function and molecular target of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It targets tumor necrosis factor (TNF) to reduce inflammation.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the production method of Lepirudin and what happened to its commercial production?', 'answer': 'Lepirudin is produced via yeast cells and is identical to natural hirudin except for specific substitutions. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-15094758\n",
      "No table mapping found for passage Target-8818569\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 34%|███▍      | 69/200 [05:21<08:20,  3.82s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Dornase alfa, and what condition is it primarily used to treat?\n",
      "   answer: Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA to 5′-phosphodinucleotide and 5′-phosphooligonucleotide end products without affecting intracellular DNA. This enzymatic breakdown of extracellular DNA reduces sputum viscosity and viscoelasticity, which is particularly beneficial in individuals with cystic fibrosis, as it aids in the management of pulmonary secretions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: Which transporter is associated with the drug identified by the primary key \"DB00091,\" and what is the organism involved?\n",
      "   answer: The drug with the primary key \"DB00091\" is associated with three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter, all of which are found in humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the state of the drug Cetuximab and what is its primary therapeutic use?\n",
      "   answer: Cetuximab is in a liquid state and is primarily used as a treatment for cancers, particularly those that are epidermal growth factor receptor (EGFR) positive, as it binds to the EGFR.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the FDA label URL for the drug with the primary key \"DB00004,\" and what is its main composition?\n",
      "   answer: The FDA label URL for the drug with the primary key \"DB00004\" (Denileukin diftitox) is \"//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00004.pdf?1265922800\". Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B along with interleukin-2 (IL-2) sequences.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug is associated with the transporter \"Canalicular multispecific organic anion transporter 1\" and what is its known action?\n",
      "   answer: The drug associated with the transporter \"Canalicular multispecific organic anion transporter 1\" is identified by the primary key \"DB00067,\" and the known action of this transporter is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "[{'question': 'What is the mechanism of action of Dornase alfa, and what condition is it primarily used to treat?', 'answer': 'Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA to 5′-phosphodinucleotide and 5′-phosphooligonucleotide end products without affecting intracellular DNA. This enzymatic breakdown of extracellular DNA reduces sputum viscosity and viscoelasticity, which is particularly beneficial in individuals with cystic fibrosis, as it aids in the management of pulmonary secretions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which transporter is associated with the drug identified by the primary key \"DB00091,\" and what is the organism involved?', 'answer': 'The drug with the primary key \"DB00091\" is associated with three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter, all of which are found in humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab and what is its primary therapeutic use?', 'answer': 'Cetuximab is in a liquid state and is primarily used as a treatment for cancers, particularly those that are epidermal growth factor receptor (EGFR) positive, as it binds to the EGFR.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA label URL for the drug with the primary key \"DB00004,\" and what is its main composition?', 'answer': 'The FDA label URL for the drug with the primary key \"DB00004\" (Denileukin diftitox) is \"//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00004.pdf?1265922800\". Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B along with interleukin-2 (IL-2) sequences.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is associated with the transporter \"Canalicular multispecific organic anion transporter 1\" and what is its known action?', 'answer': 'The drug associated with the transporter \"Canalicular multispecific organic anion transporter 1\" is identified by the primary key \"DB00067,\" and the known action of this transporter is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}]\n",
      "No table mapping found for passage Target-19951121\n",
      "No table mapping found for passage Target-16192110\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 36%|███▌      | 72/200 [05:28<07:04,  3.31s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which transporter is associated with the drug identified by the primary key DB00091?\n",
      "   answer: The drug identified by the primary key DB00091 is associated with three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter, all of which are found in humans with unknown actions.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab, and what is its type?\n",
      "   answer: Cetuximab is in a liquid state, and it is classified as a biotech drug.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What type of drug is Dornase alfa, and how is it produced?\n",
      "   answer: Dornase alfa is a biotech drug produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What are the FDA-approved products related to Leuprolide acetate, and what administration routes do they cover?\n",
      "   answer: The FDA-approved products related to Leuprolide acetate include Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension. These products cover intramuscular and oral administration routes.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'Which transporter is associated with the drug identified by the primary key DB00091?', 'answer': 'The drug identified by the primary key DB00091 is associated with three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter, all of which are found in humans with unknown actions.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and what is its type?', 'answer': 'Cetuximab is in a liquid state, and it is classified as a biotech drug.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What type of drug is Dornase alfa, and how is it produced?', 'answer': 'Dornase alfa is a biotech drug produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the FDA-approved products related to Leuprolide acetate, and what administration routes do they cover?', 'answer': 'The FDA-approved products related to Leuprolide acetate include Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension. These products cover intramuscular and oral administration routes.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 36%|███▋      | 73/200 [05:40<09:56,  4.69s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding prevents the receptor from interacting with its natural ligands, thereby inhibiting cell growth and proliferation. Cetuximab is a chimeric monoclonal antibody composed of murine and human elements, specifically targeting the N-terminal portion of human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the primary therapeutic indication for Dornase alfa?\n",
      "   answer: Dornase alfa is primarily indicated for use in patients with cystic fibrosis. It acts by enzymatically cleaving extracellular DNA in the sputum, which is released by degenerating leukocytes during inflammatory responses, thus reducing sputum viscosity and improving lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug is associated with the inhibition of Prothrombin?\n",
      "   answer: Lepirudin is associated with the inhibition of Prothrombin. It is a recombinant hirudin that directly inhibits thrombin, which is essential for the conversion of fibrinogen to fibrin in the blood coagulation cascade.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What is the unique feature of Denileukin diftitox's structure and its biological significance?\n",
      "   answer: Denileukin diftitox is uniquely structured as a recombinant cytotoxic protein that combines diphtheria toxin fragments A and B with interleukin-2. This structure allows it to target and deliver the cytotoxic effect specifically to cells expressing the interleukin-2 receptor, making it useful in treating certain hematologic malignancies.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: How is Etanercept produced, and what is its primary structural characteristic?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human p75 tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. This structure allows it to act as a decoy receptor for tumor necrosis factor, reducing inflammation in conditions like rheumatoid arthritis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': 'Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding prevents the receptor from interacting with its natural ligands, thereby inhibiting cell growth and proliferation. Cetuximab is a chimeric monoclonal antibody composed of murine and human elements, specifically targeting the N-terminal portion of human EGFR.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the primary therapeutic indication for Dornase alfa?', 'answer': 'Dornase alfa is primarily indicated for use in patients with cystic fibrosis. It acts by enzymatically cleaving extracellular DNA in the sputum, which is released by degenerating leukocytes during inflammatory responses, thus reducing sputum viscosity and improving lung function.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is associated with the inhibition of Prothrombin?', 'answer': 'Lepirudin is associated with the inhibition of Prothrombin. It is a recombinant hirudin that directly inhibits thrombin, which is essential for the conversion of fibrinogen to fibrin in the blood coagulation cascade.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': \"What is the unique feature of Denileukin diftitox's structure and its biological significance?\", 'answer': 'Denileukin diftitox is uniquely structured as a recombinant cytotoxic protein that combines diphtheria toxin fragments A and B with interleukin-2. This structure allows it to target and deliver the cytotoxic effect specifically to cells expressing the interleukin-2 receptor, making it useful in treating certain hematologic malignancies.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what is its primary structural characteristic?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human p75 tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. This structure allows it to act as a decoy receptor for tumor necrosis factor, reducing inflammation in conditions like rheumatoid arthritis.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 37%|███▋      | 74/200 [05:58<14:38,  6.98s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action for Cetuximab, and what target does it bind to?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, targeting the EGFR on human cells. Its known action is confirmed, and it is specifically designed to bind to the N-terminal portion of the human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is associated with the treatment of cystic fibrosis by breaking down extracellular DNA, and how is it produced?\n",
      "   answer: Dornase alfa is used in the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology, to cleave extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition and production method of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His, followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the structural components of Etanercept and its method of production.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action for Cetuximab, and what target does it bind to?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, targeting the EGFR on human cells. Its known action is confirmed, and it is specifically designed to bind to the N-terminal portion of the human EGFR.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is associated with the treatment of cystic fibrosis by breaking down extracellular DNA, and how is it produced?', 'answer': 'Dornase alfa is used in the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology, to cleave extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition and production method of Denileukin diftitox?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His, followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structural components of Etanercept and its method of production.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 38%|███▊      | 75/200 [06:09<16:20,  7.85s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action of Cetuximab, and what is its target in humans?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. Its primary mechanism of action involves targeting and binding to the epidermal growth factor receptor in humans, which is involved in cancer cell proliferation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: How is Dornase alfa produced, and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary therapeutic use is in the enzymatic breakdown of extracellular DNA in patients with cystic fibrosis, reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition of Etanercept, and what is its primary function?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. Its primary function is to act as a tumor necrosis factor (TNF) inhibitor, which is used in treating autoimmune diseases by reducing inflammation.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action of Cetuximab, and what is its target in humans?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. Its primary mechanism of action involves targeting and binding to the epidermal growth factor receptor in humans, which is involved in cancer cell proliferation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Dornase alfa produced, and what is its primary therapeutic use?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary therapeutic use is in the enzymatic breakdown of extracellular DNA in patients with cystic fibrosis, reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition of Etanercept, and what is its primary function?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. Its primary function is to act as a tumor necrosis factor (TNF) inhibitor, which is used in treating autoimmune diseases by reducing inflammation.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 38%|███▊      | 76/200 [06:15<15:20,  7.42s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab and under what brand name is it marketed?\n",
      "   answer: Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) as an FAB fragment. It is marketed under the brand name Erbitux by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What is the primary therapeutic use of Dornase alfa, and what are its marketed mixture names?\n",
      "   answer: Dornase alfa is used to cleave extracellular DNA to reduce sputum viscosity in individuals with cystic fibrosis. It is marketed under the names Pulmozyme and Pulmozyme 1mg/ml.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "3. question: What is the composition of Denileukin diftitox, and how is it produced?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B linked to interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the marketed mixture name for Lepirudin, and what is its state?\n",
      "   answer: Lepirudin is marketed under the name Refludan, and it is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "5. question: Which drug is composed of a dimeric fusion protein involving the TNF receptor, and how is it produced?\n",
      "   answer: Etanercept is composed of a dimeric fusion protein involving the extracellular ligand-binding portion of the human 75 kilodalton (p75) TNF receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab and under what brand name is it marketed?', 'answer': 'Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) as an FAB fragment. It is marketed under the brand name Erbitux by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary therapeutic use of Dornase alfa, and what are its marketed mixture names?', 'answer': 'Dornase alfa is used to cleave extracellular DNA to reduce sputum viscosity in individuals with cystic fibrosis. It is marketed under the names Pulmozyme and Pulmozyme 1mg/ml.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'What is the composition of Denileukin diftitox, and how is it produced?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B linked to interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed mixture name for Lepirudin, and what is its state?', 'answer': 'Lepirudin is marketed under the name Refludan, and it is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Which drug is composed of a dimeric fusion protein involving the TNF receptor, and how is it produced?', 'answer': 'Etanercept is composed of a dimeric fusion protein involving the extracellular ligand-binding portion of the human 75 kilodalton (p75) TNF receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 38%|███▊      | 77/200 [06:28<17:54,  8.73s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with P-glycoprotein 1 transporter, and what is the implication of this association in clinical practice?\n",
      "   answer: The drug associated with P-glycoprotein 1 transporter is Lepirudin (DB00027). P-glycoprotein 1 is known to be an efflux transporter, which can affect the absorption and disposition of drugs by pumping them out of cells. The association suggests that Lepirudin might be subject to efflux by P-glycoprotein, potentially affecting its bioavailability and therapeutic efficacy.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What transporter is associated with the drug Denileukin diftitox, and what is a potential clinical consideration of this relationship?\n",
      "   answer: Denileukin diftitox (DB00091) is associated with the P-glycoprotein 1 transporter. Clinically, this suggests that Denileukin diftitox could be a substrate of P-glycoprotein, which might influence its distribution and elimination in the body, possibly requiring dose adjustments or monitoring to ensure therapeutic effectiveness.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the marketed name of Cetuximab and its primary mechanism of action?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux®. It functions as an epidermal growth factor receptor (EGFR) binding FAB, which blocks the EGFR signaling pathway, inhibiting tumor cell proliferation and survival.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drugs from the sample are produced using recombinant DNA technology, and what significance does this have in biotechnology?\n",
      "   answer: Dornase alfa (DB00003) and Etanercept (DB00005) are produced using recombinant DNA technology. This technique allows for the production of complex proteins and biologics with high specificity and purity, important for therapeutic applications such as treatment of cystic fibrosis (Dornase alfa) and inflammatory conditions (Etanercept).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the therapeutic indications of Dornase alfa, and what is its mechanism of action?\n",
      "   answer: Dornase alfa is indicated for use in individuals with cystic fibrosis. Its mechanism of action involves cleaving extracellular DNA, which reduces the viscosity and viscoelasticity of sputum, aiding in the clearance of mucus and improving lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drug is associated with P-glycoprotein 1 transporter, and what is the implication of this association in clinical practice?', 'answer': 'The drug associated with P-glycoprotein 1 transporter is Lepirudin (DB00027). P-glycoprotein 1 is known to be an efflux transporter, which can affect the absorption and disposition of drugs by pumping them out of cells. The association suggests that Lepirudin might be subject to efflux by P-glycoprotein, potentially affecting its bioavailability and therapeutic efficacy.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What transporter is associated with the drug Denileukin diftitox, and what is a potential clinical consideration of this relationship?', 'answer': 'Denileukin diftitox (DB00091) is associated with the P-glycoprotein 1 transporter. Clinically, this suggests that Denileukin diftitox could be a substrate of P-glycoprotein, which might influence its distribution and elimination in the body, possibly requiring dose adjustments or monitoring to ensure therapeutic effectiveness.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the marketed name of Cetuximab and its primary mechanism of action?', 'answer': 'Cetuximab is marketed under the brand name Erbitux®. It functions as an epidermal growth factor receptor (EGFR) binding FAB, which blocks the EGFR signaling pathway, inhibiting tumor cell proliferation and survival.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drugs from the sample are produced using recombinant DNA technology, and what significance does this have in biotechnology?', 'answer': 'Dornase alfa (DB00003) and Etanercept (DB00005) are produced using recombinant DNA technology. This technique allows for the production of complex proteins and biologics with high specificity and purity, important for therapeutic applications such as treatment of cystic fibrosis (Dornase alfa) and inflammatory conditions (Etanercept).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the therapeutic indications of Dornase alfa, and what is its mechanism of action?', 'answer': 'Dornase alfa is indicated for use in individuals with cystic fibrosis. Its mechanism of action involves cleaving extracellular DNA, which reduces the viscosity and viscoelasticity of sputum, aiding in the clearance of mucus and improving lung function.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-28697165\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 40%|███▉      | 79/200 [06:32<12:18,  6.10s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which human transporter is associated with the drug having the primary key DB00091?\n",
      "   answer: The drug with the primary key DB00091 is associated with three human transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab, and what type of drug is it classified as?\n",
      "   answer: Cetuximab is in a liquid state and is classified as a biotech drug.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: For the drug with the primary key DB00007, what are the different FDA-approved products related to it?\n",
      "   answer: The drug with the primary key DB00007 is associated with several FDA-approved products, including Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "4. question: Which transporter associated with the drug DB00067 is known to have an unknown action within human organisms?\n",
      "   answer: The transporter associated with the drug DB00067 that has an unknown action within human organisms is the Canalicular multispecific organic anion transporter 1.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "5. question: What is the known action of P-glycoprotein 1 in relation to the drugs DB00027 and DB00091?\n",
      "   answer: The known action of P-glycoprotein 1 in relation to both drugs DB00027 and DB00091 is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "[{'question': 'Which human transporter is associated with the drug having the primary key DB00091?', 'answer': 'The drug with the primary key DB00091 is associated with three human transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and what type of drug is it classified as?', 'answer': 'Cetuximab is in a liquid state and is classified as a biotech drug.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'For the drug with the primary key DB00007, what are the different FDA-approved products related to it?', 'answer': 'The drug with the primary key DB00007 is associated with several FDA-approved products, including Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Which transporter associated with the drug DB00067 is known to have an unknown action within human organisms?', 'answer': 'The transporter associated with the drug DB00067 that has an unknown action within human organisms is the Canalicular multispecific organic anion transporter 1.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the known action of P-glycoprotein 1 in relation to the drugs DB00027 and DB00091?', 'answer': 'The known action of P-glycoprotein 1 in relation to both drugs DB00027 and DB00091 is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 40%|████      | 80/200 [06:38<12:06,  6.06s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action of Cetuximab, and which human receptor does it target?\n",
      "   answer: Cetuximab primarily acts by binding to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and significant for its therapeutic effect.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug targets prothrombin in humans, and what is its known action?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action is known. Lepirudin is used as an anticoagulant by inhibiting thrombin.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the form in which Etanercept is available, and which cell system is used for its production?\n",
      "   answer: Etanercept is available in a liquid state and is produced using a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the main therapeutic application of Dornase alfa, and how does it achieve its clinical effects?\n",
      "   answer: Dornase alfa is used to manage cystic fibrosis by cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity. It achieves this by breaking down DNA released by degenerating leukocytes, thereby aiding in the clearance of mucus.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action of Cetuximab, and which human receptor does it target?', 'answer': 'Cetuximab primarily acts by binding to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and significant for its therapeutic effect.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug targets prothrombin in humans, and what is its known action?', 'answer': 'Lepirudin targets prothrombin in humans, and its action is known. Lepirudin is used as an anticoagulant by inhibiting thrombin.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the form in which Etanercept is available, and which cell system is used for its production?', 'answer': 'Etanercept is available in a liquid state and is produced using a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the main therapeutic application of Dornase alfa, and how does it achieve its clinical effects?', 'answer': 'Dornase alfa is used to manage cystic fibrosis by cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity. It achieves this by breaking down DNA released by degenerating leukocytes, thereby aiding in the clearance of mucus.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 40%|████      | 81/200 [06:43<11:21,  5.72s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug interacts with P-glycoprotein 1 as a transporter, and what is its state?\n",
      "   answer: The drug that interacts with P-glycoprotein 1 as a transporter is Lepirudin, and its state is liquid.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the therapeutic mechanism of Cetuximab, and what is its physical state?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB, and its physical state is liquid.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug has the transporter Canalicular multispecific organic anion transporter 1, and what organism does it belong to?\n",
      "   answer: The drug with the transporter Canalicular multispecific organic anion transporter 1 is associated with Humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: How is Dornase alfa produced, and what is its function?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It functions to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity, aiding individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the role of Denileukin diftitox, and which organism is utilized for its production?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein, and it is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drug interacts with P-glycoprotein 1 as a transporter, and what is its state?', 'answer': 'The drug that interacts with P-glycoprotein 1 as a transporter is Lepirudin, and its state is liquid.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the therapeutic mechanism of Cetuximab, and what is its physical state?', 'answer': 'Cetuximab is an epidermal growth factor receptor binding FAB, and its physical state is liquid.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug has the transporter Canalicular multispecific organic anion transporter 1, and what organism does it belong to?', 'answer': 'The drug with the transporter Canalicular multispecific organic anion transporter 1 is associated with Humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'How is Dornase alfa produced, and what is its function?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It functions to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity, aiding individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the role of Denileukin diftitox, and which organism is utilized for its production?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein, and it is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 41%|████      | 82/200 [06:50<12:04,  6.14s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and what is its known target?\n",
      "   answer: Cetuximab works by binding to the epidermal growth factor receptor (EGFR), which is its known target. This action is confirmed as Cetuximab is an epidermal growth factor receptor binding FAB.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What is the primary difference in the molecular composition of Lepirudin compared to natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin, except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug is associated with the target Prothrombin, and is this interaction known?\n",
      "   answer: The drug associated with the target Prothrombin is Lepirudin, and this interaction is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What recombinant technology is used in the production of Dornase alfa?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: How is Etanercept produced, and what is its structural composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, containing 934 amino acids.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and what is its known target?', 'answer': 'Cetuximab works by binding to the epidermal growth factor receptor (EGFR), which is its known target. This action is confirmed as Cetuximab is an epidermal growth factor receptor binding FAB.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the primary difference in the molecular composition of Lepirudin compared to natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin, except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is associated with the target Prothrombin, and is this interaction known?', 'answer': 'The drug associated with the target Prothrombin is Lepirudin, and this interaction is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What recombinant technology is used in the production of Dornase alfa?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what is its structural composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, containing 934 amino acids.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-20706860\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 42%|████▏     | 84/200 [06:57<09:44,  5.04s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the marketed name for the drug Cetuximab, and what is its primary therapeutic use?\n",
      "   answer: The drug Cetuximab is marketed under the brand name Erbitux. It is used for its ability to bind to the epidermal growth factor receptor (EGFR), making it effective in certain types of cancer treatments.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-drug_mixtures\n",
      "\n",
      "2. question: What is the mechanism of action of Dornase alfa, and for what condition is it commonly prescribed?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. It is commonly prescribed for individuals with cystic fibrosis to help clear airway secretions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the composition and production method of the drug Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What are the key components of Denileukin diftitox, and how is it produced?\n",
      "   answer: Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the brand name of the drug Lepirudin, and what is a significant historical fact about its production?\n",
      "   answer: The brand name of the drug Lepirudin is Refludan. A significant historical fact is that Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-drug_mixtures\n",
      "[{'question': 'What is the marketed name for the drug Cetuximab, and what is its primary therapeutic use?', 'answer': 'The drug Cetuximab is marketed under the brand name Erbitux. It is used for its ability to bind to the epidermal growth factor receptor (EGFR), making it effective in certain types of cancer treatments.', 'text': 'None', 'table': 'drugbank-drug, drugbank-drug_mixtures'}, {'question': 'What is the mechanism of action of Dornase alfa, and for what condition is it commonly prescribed?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. It is commonly prescribed for individuals with cystic fibrosis to help clear airway secretions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of the drug Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the key components of Denileukin diftitox, and how is it produced?', 'answer': 'Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the brand name of the drug Lepirudin, and what is a significant historical fact about its production?', 'answer': 'The brand name of the drug Lepirudin is Refludan. A significant historical fact is that Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug, drugbank-drug_mixtures'}]\n",
      "No table mapping found for passage Target-8312688\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 43%|████▎     | 86/200 [07:04<08:18,  4.37s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of the drug Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It functions by targeting and delivering the diphtheria toxin to cells that express the IL-2 receptor, leading to cell death.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: Which transporters are involved with the drug that has P-glycoprotein 1 as a known transporter?\n",
      "   answer: P-glycoprotein 1 is involved with two drugs in the sample data: DB00027 and DB00091. For DB00091, additional transporters involved include the Bile salt export pump and the Ileal sodium/bile acid cotransporter.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the state of the drug Cetuximab, and how is it administered?\n",
      "   answer: Cetuximab is in a liquid state. As it is a monoclonal antibody, it is typically administered intravenously in a clinical setting.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of the drug Denileukin diftitox?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It functions by targeting and delivering the diphtheria toxin to cells that express the IL-2 receptor, leading to cell death.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which transporters are involved with the drug that has P-glycoprotein 1 as a known transporter?', 'answer': 'P-glycoprotein 1 is involved with two drugs in the sample data: DB00027 and DB00091. For DB00091, additional transporters involved include the Bile salt export pump and the Ileal sodium/bile acid cotransporter.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and how is it administered?', 'answer': 'Cetuximab is in a liquid state. As it is a monoclonal antibody, it is typically administered intravenously in a clinical setting.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-20552178\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 44%|████▍     | 88/200 [07:09<07:08,  3.83s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This receptor is targeted specifically by the variable antigen-binding regions of the murine monoclonal antibody, which are part of Cetuximab's structure.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug listed in the tables is used to reduce sputum viscosity in cystic fibrosis patients?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in patients with cystic fibrosis. It works by enzymatically cleaving extracellular DNA, which is a major contributor to sputum viscosity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is a known target of the drug Lepirudin?\n",
      "   answer: Lepirudin targets prothrombin in humans. This interaction is known and plays a role in its anticoagulant effects.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Which drugs from the tables are in a liquid state?\n",
      "   answer: The drugs Lepirudin, Cetuximab, Dornase alfa, Denileukin diftitox, and Etanercept are all in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What production method is used for Dornase alfa?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This receptor is targeted specifically by the variable antigen-binding regions of the murine monoclonal antibody, which are part of Cetuximab's structure.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug listed in the tables is used to reduce sputum viscosity in cystic fibrosis patients?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in patients with cystic fibrosis. It works by enzymatically cleaving extracellular DNA, which is a major contributor to sputum viscosity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is a known target of the drug Lepirudin?', 'answer': 'Lepirudin targets prothrombin in humans. This interaction is known and plays a role in its anticoagulant effects.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drugs from the tables are in a liquid state?', 'answer': 'The drugs Lepirudin, Cetuximab, Dornase alfa, Denileukin diftitox, and Etanercept are all in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What production method is used for Dornase alfa?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-22909231\n",
      "No table mapping found for passage Target-15258107\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 46%|████▌     | 91/200 [07:15<05:18,  2.92s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is composed of the Fv regions of the murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, along with human IgG1 heavy and kappa light chain constant regions. This indicates that Cetuximab acts by targeting and binding to the epidermal growth factor receptor (EGFR) on human cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: Which drug targets the epidermal growth factor receptor and what is its action known as?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, and its action is known as a \"yes\" known action, indicating a confirmed mechanism of action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the FDA-approved use for Lupron Depot and its administration route?\n",
      "   answer: Lupron Depot, which contains leuprolide acetate, is approved by the FDA as a depot suspension for intramuscular use.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "4. question: How is Dornase alfa produced and what is its therapeutic use?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme and is used to reduce sputum viscosity and viscoelasticity in patients with cystic fibrosis by cleaving extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the components of Denileukin diftitox, and what expression system is used for its production?\n",
      "   answer: Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced using a recombinant DNA-derived expression system in E. coli.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is composed of the Fv regions of the murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, along with human IgG1 heavy and kappa light chain constant regions. This indicates that Cetuximab acts by targeting and binding to the epidermal growth factor receptor (EGFR) on human cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets the epidermal growth factor receptor and what is its action known as?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, and its action is known as a \"yes\" known action, indicating a confirmed mechanism of action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the FDA-approved use for Lupron Depot and its administration route?', 'answer': 'Lupron Depot, which contains leuprolide acetate, is approved by the FDA as a depot suspension for intramuscular use.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'How is Dornase alfa produced and what is its therapeutic use?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme and is used to reduce sputum viscosity and viscoelasticity in patients with cystic fibrosis by cleaving extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components of Denileukin diftitox, and what expression system is used for its production?', 'answer': 'Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced using a recombinant DNA-derived expression system in E. coli.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 46%|████▌     | 92/200 [07:19<05:34,  3.10s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which transporter is associated with the drug identified by the parent key DB00027, and what is its known action?\n",
      "   answer: The transporter associated with the drug identified by the parent key DB00027 is P-glycoprotein 1, and its known action is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab, and how is it produced?\n",
      "   answer: The state of the drug Cetuximab is liquid, and it is produced via recombinant DNA technology using genetically modified Chinese hamster ovary (CHO) cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the components of the drug Denileukin diftitox, and what expression system is used for its production?\n",
      "   answer: The drug Denileukin diftitox is composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is linked with the FDA label in the provided tables, and what is its primary key?\n",
      "   answer: The drug linked with the FDA label in the provided tables is Denileukin diftitox, and its primary key is DB00004.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the organism for the transporter Canalicular multispecific organic anion transporter 1, and with which drug is it associated?\n",
      "   answer: The organism for the transporter Canalicular multispecific organic anion transporter 1 is Humans, and it is associated with the drug identified by the parent key DB00067.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "[{'question': 'Which transporter is associated with the drug identified by the parent key DB00027, and what is its known action?', 'answer': 'The transporter associated with the drug identified by the parent key DB00027 is P-glycoprotein 1, and its known action is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and how is it produced?', 'answer': 'The state of the drug Cetuximab is liquid, and it is produced via recombinant DNA technology using genetically modified Chinese hamster ovary (CHO) cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components of the drug Denileukin diftitox, and what expression system is used for its production?', 'answer': 'The drug Denileukin diftitox is composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is linked with the FDA label in the provided tables, and what is its primary key?', 'answer': 'The drug linked with the FDA label in the provided tables is Denileukin diftitox, and its primary key is DB00004.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the organism for the transporter Canalicular multispecific organic anion transporter 1, and with which drug is it associated?', 'answer': 'The organism for the transporter Canalicular multispecific organic anion transporter 1 is Humans, and it is associated with the drug identified by the parent key DB00067.', 'text': 'None', 'table': 'drugbank-transporters'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 46%|████▋     | 93/200 [07:23<05:56,  3.33s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action of Cetuximab in the human body?\n",
      "   answer: Cetuximab primarily works by binding to the epidermal growth factor receptor (EGFR) in humans, which is confirmed by its known action on this target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is produced using genetically modified Chinese hamster ovary cells and what is its primary function?\n",
      "   answer: Dornase alfa is produced using genetically modified Chinese hamster ovary cells and functions as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which helps reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the marketed brand name of Cetuximab, and which company is responsible for its marketing?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug targets prothrombin in humans, and is this action known or unknown?\n",
      "   answer: Lepirudin targets prothrombin in humans, and this action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the unique structural composition of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action of Cetuximab in the human body?', 'answer': 'Cetuximab primarily works by binding to the epidermal growth factor receptor (EGFR) in humans, which is confirmed by its known action on this target.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is produced using genetically modified Chinese hamster ovary cells and what is its primary function?', 'answer': 'Dornase alfa is produced using genetically modified Chinese hamster ovary cells and functions as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which helps reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed brand name of Cetuximab, and which company is responsible for its marketing?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets prothrombin in humans, and is this action known or unknown?', 'answer': 'Lepirudin targets prothrombin in humans, and this action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the unique structural composition of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 47%|████▋     | 94/200 [07:27<06:21,  3.60s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and which receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the epidermal growth factor receptor in humans, which is involved in the regulation of cell growth and proliferation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is composed of a dimeric fusion protein involving the human tumor necrosis factor receptor, and what is its origin?\n",
      "   answer: Etanercept is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the primary target of Lepirudin and in which organism is it found?\n",
      "   answer: Lepirudin primarily targets Prothrombin in humans. Prothrombin is a key protein in the coagulation cascade, playing a critical role in blood clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What is the role of Dornase alfa in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA. In individuals with cystic fibrosis, this enzymatic action reduces sputum viscosity and viscoelasticity, aiding in the clearance of mucus.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the production origin of Denileukin diftitox, and what components does it consist of?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein produced in an E. coli expression system. It consists of the amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and which receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the epidermal growth factor receptor in humans, which is involved in the regulation of cell growth and proliferation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is composed of a dimeric fusion protein involving the human tumor necrosis factor receptor, and what is its origin?', 'answer': 'Etanercept is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary target of Lepirudin and in which organism is it found?', 'answer': 'Lepirudin primarily targets Prothrombin in humans. Prothrombin is a key protein in the coagulation cascade, playing a critical role in blood clot formation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the role of Dornase alfa in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA. In individuals with cystic fibrosis, this enzymatic action reduces sputum viscosity and viscoelasticity, aiding in the clearance of mucus.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the production origin of Denileukin diftitox, and what components does it consist of?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein produced in an E. coli expression system. It consists of the amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-14642738\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 48%|████▊     | 96/200 [07:33<05:47,  3.35s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and what is its primary target?\n",
      "   answer: Cetuximab works by binding to the epidermal growth factor receptor (EGFR), inhibiting its activity. EGFR is its primary target, and this interaction occurs in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What type of drug is Dornase alfa, and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is a biotech drug and is used as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. Its primary therapeutic use is to cleave extracellular DNA in individuals with cystic fibrosis, reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the administration state of Lepirudin, and what key difference does it have from natural hirudin?\n",
      "   answer: Lepirudin is in a liquid state and is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Identify the organism target for Etanercept and describe its molecular composition.\n",
      "   answer: Etanercept targets humans and is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and what is its primary target?', 'answer': 'Cetuximab works by binding to the epidermal growth factor receptor (EGFR), inhibiting its activity. EGFR is its primary target, and this interaction occurs in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of drug is Dornase alfa, and what is its primary therapeutic use?', 'answer': 'Dornase alfa is a biotech drug and is used as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. Its primary therapeutic use is to cleave extracellular DNA in individuals with cystic fibrosis, reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the administration state of Lepirudin, and what key difference does it have from natural hirudin?', 'answer': 'Lepirudin is in a liquid state and is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Identify the organism target for Etanercept and describe its molecular composition.', 'answer': 'Etanercept targets humans and is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 48%|████▊     | 97/200 [07:52<11:14,  6.55s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in the treatment of cancers?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It binds to the N-terminal portion of the human EGFR, which is a known action in humans, helping to inhibit tumor growth by blocking the growth signals in cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What are the FDA-approved formulations of Leuprolide acetate for medical use?\n",
      "   answer: The FDA-approved formulations of Leuprolide acetate include Lupron Depot, Lupron Depot-Ped, and Fensolvi, all of which are depot suspensions for intramuscular use.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "3. question: What type of drug is Dornase alfa, and what is its primary clinical use?\n",
      "   answer: Dornase alfa is a biotech drug that acts as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It is primarily used in the treatment of cystic fibrosis to reduce sputum viscosity and viscoelasticity by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the structure and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the source organism for the production of Lepirudin, and why was its production ceased?\n",
      "   answer: Lepirudin is produced via yeast cells. Its production was ceased by Bayer effective May 31, 2012, due to unspecified reasons in the provided dataset.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in the treatment of cancers?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It binds to the N-terminal portion of the human EGFR, which is a known action in humans, helping to inhibit tumor growth by blocking the growth signals in cancer cells.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the FDA-approved formulations of Leuprolide acetate for medical use?', 'answer': 'The FDA-approved formulations of Leuprolide acetate include Lupron Depot, Lupron Depot-Ped, and Fensolvi, all of which are depot suspensions for intramuscular use.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What type of drug is Dornase alfa, and what is its primary clinical use?', 'answer': 'Dornase alfa is a biotech drug that acts as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It is primarily used in the treatment of cystic fibrosis to reduce sputum viscosity and viscoelasticity by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structure and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the source organism for the production of Lepirudin, and why was its production ceased?', 'answer': 'Lepirudin is produced via yeast cells. Its production was ceased by Bayer effective May 31, 2012, due to unspecified reasons in the provided dataset.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-12920163\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 50%|████▉     | 99/200 [07:59<09:19,  5.54s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab and which receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, which is known to be involved in cell growth and proliferation.\n",
      "   text: None\n",
      "   table: drugbank-drug and drugbank-targets\n",
      "\n",
      "2. question: Which drug is described as a dimeric fusion protein linked to the Fc portion of human IgG1, and what is its method of production?\n",
      "   answer: The drug Etanercept is described as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What drug is produced via yeast cells and was discontinued by Bayer, and what is its unique action target in humans?\n",
      "   answer: Lepirudin is produced via yeast cells and was discontinued by Bayer on May 31, 2012. Its unique action target in humans is Prothrombin, which is involved in blood coagulation.\n",
      "   text: None\n",
      "   table: drugbank-drug and drugbank-targets\n",
      "\n",
      "4. question: Describe the therapeutic application of Dornase alfa in cystic fibrosis patients.\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity in cystic fibrosis patients. It assists in breaking down the extracellular DNA released by degenerating leukocytes during inflammatory responses to infections.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the primary composition of Denileukin diftitox, and in what expression system is it produced?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab and which receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, which is known to be involved in cell growth and proliferation.', 'text': 'None', 'table': 'drugbank-drug and drugbank-targets'}, {'question': 'Which drug is described as a dimeric fusion protein linked to the Fc portion of human IgG1, and what is its method of production?', 'answer': 'The drug Etanercept is described as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What drug is produced via yeast cells and was discontinued by Bayer, and what is its unique action target in humans?', 'answer': 'Lepirudin is produced via yeast cells and was discontinued by Bayer on May 31, 2012. Its unique action target in humans is Prothrombin, which is involved in blood coagulation.', 'text': 'None', 'table': 'drugbank-drug and drugbank-targets'}, {'question': 'Describe the therapeutic application of Dornase alfa in cystic fibrosis patients.', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity in cystic fibrosis patients. It assists in breaking down the extracellular DNA released by degenerating leukocytes during inflammatory responses to infections.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary composition of Denileukin diftitox, and in what expression system is it produced?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 50%|█████     | 100/200 [08:10<11:09,  6.70s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which transporters are associated with the drug identified by primary key DB00091, and what is their known action?\n",
      "   answer: The drug identified by primary key DB00091 is associated with the transporters \"P-glycoprotein 1,\" \"Bile salt export pump,\" and \"Ileal sodium/bile acid cotransporter.\" All these transporters have an unknown action.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the type and state of the drug named Cetuximab?\n",
      "   answer: Cetuximab is classified as a biotech drug, and it is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the description and production method for the drug Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is described as a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which FDA documents are linked to the drug with primary key DB00007, and what is the drug's name?\n",
      "   answer: The drug with primary key DB00007 is linked to several FDA documents, including those for Lupaneta Pack, Lupron Depot, Lupron Depot-Ped, and Fensolvi. The drug's name is Leuprolide acetate.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'Which transporters are associated with the drug identified by primary key DB00091, and what is their known action?', 'answer': 'The drug identified by primary key DB00091 is associated with the transporters \"P-glycoprotein 1,\" \"Bile salt export pump,\" and \"Ileal sodium/bile acid cotransporter.\" All these transporters have an unknown action.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the type and state of the drug named Cetuximab?', 'answer': 'Cetuximab is classified as a biotech drug, and it is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the description and production method for the drug Denileukin diftitox?', 'answer': 'Denileukin diftitox is described as a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': \"Which FDA documents are linked to the drug with primary key DB00007, and what is the drug's name?\", 'answer': \"The drug with primary key DB00007 is linked to several FDA documents, including those for Lupaneta Pack, Lupron Depot, Lupron Depot-Ped, and Fensolvi. The drug's name is Leuprolide acetate.\", 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 50%|█████     | 101/200 [08:18<11:16,  6.84s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the N-terminal portion of the human EGFR. This interaction is essential for its therapeutic effects in cancer treatment.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What is the clinical use of Dornase alfa, and how does it work?\n",
      "   answer: Dornase alfa is used clinically in individuals with cystic fibrosis. It works by cleaving extracellular DNA, thereby reducing sputum viscosity and viscoelasticity, which helps improve lung function by breaking down the DNA released by degenerating leukocytes.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the source organism for the production of Etanercept, and describe its structural composition?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the composition of Denileukin diftitox and its production method.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the N-terminal portion of the human EGFR. This interaction is essential for its therapeutic effects in cancer treatment.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the clinical use of Dornase alfa, and how does it work?', 'answer': 'Dornase alfa is used clinically in individuals with cystic fibrosis. It works by cleaving extracellular DNA, thereby reducing sputum viscosity and viscoelasticity, which helps improve lung function by breaking down the DNA released by degenerating leukocytes.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the source organism for the production of Etanercept, and describe its structural composition?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition of Denileukin diftitox and its production method.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-2828440\n",
      "No table mapping found for passage Target-21175441\n",
      "No table mapping found for passage Target-22205779\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 52%|█████▎    | 105/200 [08:25<06:19,  3.99s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the main target of Cetuximab and its known action in humans?\n",
      "   answer: The main target of Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is marketed under the name Erbitux and what is its state?\n",
      "   answer: The drug marketed under the name Erbitux is Cetuximab, and it is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Dornase alfa produced, and what is its primary function in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary function in the treatment of cystic fibrosis is to enzymatically cleave extracellular DNA, reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the organism origin and action status of the target for Lepirudin?\n",
      "   answer: The target for Lepirudin, Prothrombin, is of human origin, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the CAS number and state of the drug Etanercept?\n",
      "   answer: The CAS number of Etanercept is 185243-69-0, and it is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the main target of Cetuximab and its known action in humans?', 'answer': 'The main target of Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is marketed under the name Erbitux and what is its state?', 'answer': 'The drug marketed under the name Erbitux is Cetuximab, and it is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Dornase alfa produced, and what is its primary function in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary function in the treatment of cystic fibrosis is to enzymatically cleave extracellular DNA, reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the organism origin and action status of the target for Lepirudin?', 'answer': 'The target for Lepirudin, Prothrombin, is of human origin, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the CAS number and state of the drug Etanercept?', 'answer': 'The CAS number of Etanercept is 185243-69-0, and it is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 53%|█████▎    | 106/200 [08:31<06:47,  4.33s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, and its primary target is the Epidermal Growth Factor Receptor in humans, which is known to play a role in the mechanism of action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: For which drug is Prothrombin a known target, and what is the state of this drug?\n",
      "   answer: Prothrombin is a known target for the drug Lepirudin, which is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the structure and production method of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the composition of Denileukin diftitox and its expression system.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What type of drug is Dornase alfa, and how does it function in cystic fibrosis patients?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which reduces sputum viscosity and viscoelasticity in cystic fibrosis patients by cleaving extracellular DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, and its primary target is the Epidermal Growth Factor Receptor in humans, which is known to play a role in the mechanism of action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'For which drug is Prothrombin a known target, and what is the state of this drug?', 'answer': 'Prothrombin is a known target for the drug Lepirudin, which is in a liquid state.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the structure and production method of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition of Denileukin diftitox and its expression system.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What type of drug is Dornase alfa, and how does it function in cystic fibrosis patients?', 'answer': \"Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which reduces sputum viscosity and viscoelasticity in cystic fibrosis patients by cleaving extracellular DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products.\", 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 54%|█████▎    | 107/200 [08:39<07:41,  4.96s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab binds to the epidermal growth factor receptor (EGFR) on human cells, which is a known target for this drug. By binding to EGFR, Cetuximab inhibits the receptor's activity, which is crucial for controlling cell growth and survival. This makes Cetuximab useful in treating cancers that express EGFR.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: For which drug is Prothrombin a known target?\n",
      "   answer: Prothrombin is a known target for the drug Lepirudin. Lepirudin acts as an anticoagulant by inhibiting thrombin, which is derived from prothrombin, thus preventing clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What type of drug is Etanercept and how is it produced?\n",
      "   answer: Etanercept is a biotech drug, specifically a dimeric fusion protein. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This production method allows it to mimic the action of the human 75-kilodalton tumor necrosis factor receptor (TNFR), linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the FDA label title for the drug with the primary key DB00007?\n",
      "   answer: The FDA label titles for the drug with the primary key DB00007 (Leuprolide acetate) include \"FDA Approved Drug Products: Lupaneta Pack for intramuscular and oral use,\" \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension,\" \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension,\" and \"FDA Approved Drug Products: Fensolvi (leuprolide acetate) suspension.\"\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action for Cetuximab?', 'answer': \"Cetuximab binds to the epidermal growth factor receptor (EGFR) on human cells, which is a known target for this drug. By binding to EGFR, Cetuximab inhibits the receptor's activity, which is crucial for controlling cell growth and survival. This makes Cetuximab useful in treating cancers that express EGFR.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'For which drug is Prothrombin a known target?', 'answer': 'Prothrombin is a known target for the drug Lepirudin. Lepirudin acts as an anticoagulant by inhibiting thrombin, which is derived from prothrombin, thus preventing clot formation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of drug is Etanercept and how is it produced?', 'answer': 'Etanercept is a biotech drug, specifically a dimeric fusion protein. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This production method allows it to mimic the action of the human 75-kilodalton tumor necrosis factor receptor (TNFR), linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA label title for the drug with the primary key DB00007?', 'answer': 'The FDA label titles for the drug with the primary key DB00007 (Leuprolide acetate) include \"FDA Approved Drug Products: Lupaneta Pack for intramuscular and oral use,\" \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension,\" \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension,\" and \"FDA Approved Drug Products: Fensolvi (leuprolide acetate) suspension.\"', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 54%|█████▍    | 108/200 [08:46<08:32,  5.57s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in humans?\n",
      "   answer: Cetuximab binds to the epidermal growth factor receptor (EGFR) in humans, which is its primary target, as indicated by its known action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What kind of protein is Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the known action of Lepirudin, and which human target is involved?\n",
      "   answer: Lepirudin acts on prothrombin in humans, and its known action is confirmed with a \"yes\" in the target table.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: Describe the production method of Dornase alfa and its therapeutic use.\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis by cleaving extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug is produced using an E. coli expression system, and what are its components?\n",
      "   answer: Denileukin diftitox is produced using an E. coli expression system. It is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in humans?', 'answer': 'Cetuximab binds to the epidermal growth factor receptor (EGFR) in humans, which is its primary target, as indicated by its known action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What kind of protein is Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Lepirudin, and which human target is involved?', 'answer': 'Lepirudin acts on prothrombin in humans, and its known action is confirmed with a \"yes\" in the target table.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the production method of Dornase alfa and its therapeutic use.', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis by cleaving extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is produced using an E. coli expression system, and what are its components?', 'answer': 'Denileukin diftitox is produced using an E. coli expression system. It is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-15039299\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 55%|█████▌    | 110/200 [08:51<06:33,  4.37s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This binding prevents the activation of the receptor, which is important for cellular proliferation and survival. Cetuximab is an antibody composed of the Fv regions of a murine EGFR monoclonal antibody, with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What are the known targets of Lepirudin?\n",
      "   answer: The known target of Lepirudin is Prothrombin in humans. Lepirudin is used as an anticoagulant because it directly inhibits thrombin, which plays a central role in blood coagulation.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "3. question: Which drug in the dataset is known to reduce sputum viscosity in cystic fibrosis patients, and what is its mechanism?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, reducing the viscosity and viscoelasticity of sputum.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab?', 'answer': 'Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This binding prevents the activation of the receptor, which is important for cellular proliferation and survival. Cetuximab is an antibody composed of the Fv regions of a murine EGFR monoclonal antibody, with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What are the known targets of Lepirudin?', 'answer': 'The known target of Lepirudin is Prothrombin in humans. Lepirudin is used as an anticoagulant because it directly inhibits thrombin, which plays a central role in blood coagulation.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'Which drug in the dataset is known to reduce sputum viscosity in cystic fibrosis patients, and what is its mechanism?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, reducing the viscosity and viscoelasticity of sputum.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 56%|█████▌    | 111/200 [09:02<08:31,  5.75s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and plays a critical role in the therapeutic effect of the drug.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is a recombinant cytotoxic protein that includes interleukin-2 sequences?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments and interleukin-2 sequences. It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: For which condition is Dornase alfa particularly beneficial, and what is its primary function?\n",
      "   answer: Dornase alfa is beneficial for individuals with cystic fibrosis. Its primary function is to enzymatically break down extracellular DNA, reducing sputum viscosity and viscoelasticity, aiding in the clearance of airway secretions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug listed has a known action on prothrombin in humans?\n",
      "   answer: Lepirudin has a known action on prothrombin in humans, contributing to its anticoagulant effects.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the marketed brand name of Cetuximab, and which company markets it?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': 'Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and plays a critical role in the therapeutic effect of the drug.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is a recombinant cytotoxic protein that includes interleukin-2 sequences?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments and interleukin-2 sequences. It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'For which condition is Dornase alfa particularly beneficial, and what is its primary function?', 'answer': 'Dornase alfa is beneficial for individuals with cystic fibrosis. Its primary function is to enzymatically break down extracellular DNA, reducing sputum viscosity and viscoelasticity, aiding in the clearance of airway secretions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug listed has a known action on prothrombin in humans?', 'answer': 'Lepirudin has a known action on prothrombin in humans, contributing to its anticoagulant effects.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the marketed brand name of Cetuximab, and which company markets it?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 56%|█████▌    | 112/200 [09:08<08:33,  5.84s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which target does it bind to in humans?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding Fv (variable; antigen-binding) region monoclonal antibody. It specifically targets the epidermal growth factor receptor in humans.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What is the primary known action of Lepirudin in humans?\n",
      "   answer: Lepirudin acts on prothrombin in humans, a protein involved in the blood coagulation process.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the therapeutic use of Dornase alfa, and what is its mechanism of action?\n",
      "   answer: Dornase alfa is used to treat cystic fibrosis by enzymatically breaking down extracellular DNA. This reduction in extracellular DNA decreases sputum viscosity and viscoelasticity, improving lung function in patients.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Denileukin diftitox manufactured, and what are its components?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein produced using an E. coli expression system. It is composed of amino acid sequences for diphtheria toxin fragments A and B and sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Describe the structure and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein that includes the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which target does it bind to in humans?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding Fv (variable; antigen-binding) region monoclonal antibody. It specifically targets the epidermal growth factor receptor in humans.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the primary known action of Lepirudin in humans?', 'answer': 'Lepirudin acts on prothrombin in humans, a protein involved in the blood coagulation process.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the therapeutic use of Dornase alfa, and what is its mechanism of action?', 'answer': 'Dornase alfa is used to treat cystic fibrosis by enzymatically breaking down extracellular DNA. This reduction in extracellular DNA decreases sputum viscosity and viscoelasticity, improving lung function in patients.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Denileukin diftitox manufactured, and what are its components?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein produced using an E. coli expression system. It is composed of amino acid sequences for diphtheria toxin fragments A and B and sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structure and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein that includes the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 56%|█████▋    | 113/200 [09:16<09:21,  6.46s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drugs interact with P-glycoprotein 1 as a transporter, and what is the known action of this interaction?\n",
      "   answer: P-glycoprotein 1 interacts with the drugs associated with the parent keys DB00027 and DB00091. The known action of this interaction is unknown according to the drugbank-transporters table.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What transporter is associated with the drug identified by the parent key DB00091, and what is the known action of this transporter?\n",
      "   answer: The drug identified by the parent key DB00091 is associated with the transporters P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. The known action of these transporters is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the state of the drug Cetuximab, and when was its information last updated in the database?\n",
      "   answer: Cetuximab is in a liquid state, and its information was last updated on July 1, 2020.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What specific information is available about the synthesis of Etanercept, and what is its state?\n",
      "   answer: Etanercept is in a liquid state, and its synthesis is referenced in the U.S. Patent US07276477, issued on October 02, 2007, as described by Timothy D. Osslund et al.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which FDA-approved products involving leuprolide acetate have been identified, and what is their route of administration?\n",
      "   answer: FDA-approved products involving leuprolide acetate include Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension. These products have varying routes of administration including intramuscular and depot suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'Which drugs interact with P-glycoprotein 1 as a transporter, and what is the known action of this interaction?', 'answer': 'P-glycoprotein 1 interacts with the drugs associated with the parent keys DB00027 and DB00091. The known action of this interaction is unknown according to the drugbank-transporters table.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What transporter is associated with the drug identified by the parent key DB00091, and what is the known action of this transporter?', 'answer': 'The drug identified by the parent key DB00091 is associated with the transporters P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. The known action of these transporters is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and when was its information last updated in the database?', 'answer': 'Cetuximab is in a liquid state, and its information was last updated on July 1, 2020.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What specific information is available about the synthesis of Etanercept, and what is its state?', 'answer': 'Etanercept is in a liquid state, and its synthesis is referenced in the U.S. Patent US07276477, issued on October 02, 2007, as described by Timothy D. Osslund et al.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which FDA-approved products involving leuprolide acetate have been identified, and what is their route of administration?', 'answer': 'FDA-approved products involving leuprolide acetate include Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension. These products have varying routes of administration including intramuscular and depot suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 57%|█████▋    | 114/200 [09:23<09:18,  6.49s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the target mechanism of Cetuximab in humans?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, which is known to be involved in its mechanism of action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What type of drug is Lepirudin, and what is its state?\n",
      "   answer: Lepirudin is a biotech drug, and it is in liquid form.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the significance of the Fc portion in Etanercept's structure?\n",
      "   answer: The Fc portion of Etanercept is linked to the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) and contains the CH2 domain, the CH3 domain, and hinge region, but not the CH1 domain of IgG1. This structure is crucial for its function as a dimeric fusion protein.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Dornase alfa produced, and what is its clinical application in cystic fibrosis?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Clinically, it is used to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis, where extracellular DNA accumulates due to inflammatory responses.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug targets prothrombin in humans, and what is its known action?\n",
      "   answer: Lepirudin targets prothrombin in humans, and it is known to have a specific action on this target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the target mechanism of Cetuximab in humans?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, which is known to be involved in its mechanism of action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of drug is Lepirudin, and what is its state?', 'answer': 'Lepirudin is a biotech drug, and it is in liquid form.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': \"What is the significance of the Fc portion in Etanercept's structure?\", 'answer': 'The Fc portion of Etanercept is linked to the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) and contains the CH2 domain, the CH3 domain, and hinge region, but not the CH1 domain of IgG1. This structure is crucial for its function as a dimeric fusion protein.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Dornase alfa produced, and what is its clinical application in cystic fibrosis?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Clinically, it is used to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis, where extracellular DNA accumulates due to inflammatory responses.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets prothrombin in humans, and what is its known action?', 'answer': 'Lepirudin targets prothrombin in humans, and it is known to have a specific action on this target.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-9660842\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 58%|█████▊    | 116/200 [09:28<06:35,  4.70s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab functions as an epidermal growth factor receptor (EGFR) binding FAB, targeting the N-terminal portion of the human EGFR. This interaction is known in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug has Prothrombin as its known target, and what type of drug is it?\n",
      "   answer: Lepirudin targets Prothrombin in humans and is classified as a biotech drug.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What are the pharmaceutical characteristics of Dornase alfa, including its state and production method?\n",
      "   answer: Dornase alfa is in a liquid state and is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug listed is produced in an E. coli expression system, and what is its primary function?\n",
      "   answer: Denileukin diftitox is produced in an E. coli expression system and is a recombinant DNA-derived cytotoxic protein that consists of sequences for diphtheria toxin fragments and interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Describe the structure of Etanercept and its method of production.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kDa tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which receptor does it target?', 'answer': 'Cetuximab functions as an epidermal growth factor receptor (EGFR) binding FAB, targeting the N-terminal portion of the human EGFR. This interaction is known in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug has Prothrombin as its known target, and what type of drug is it?', 'answer': 'Lepirudin targets Prothrombin in humans and is classified as a biotech drug.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the pharmaceutical characteristics of Dornase alfa, including its state and production method?', 'answer': 'Dornase alfa is in a liquid state and is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug listed is produced in an E. coli expression system, and what is its primary function?', 'answer': 'Denileukin diftitox is produced in an E. coli expression system and is a recombinant DNA-derived cytotoxic protein that consists of sequences for diphtheria toxin fragments and interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structure of Etanercept and its method of production.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kDa tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 58%|█████▊    | 117/200 [09:33<06:51,  4.95s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the target organism for Cetuximab, and does it have a known action on its target?\n",
      "   answer: The target organism for Cetuximab is humans, and it has a known action on its target, the Epidermal growth factor receptor.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the role of dornase alfa in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA, which reduces sputum viscosity and viscoelasticity in individuals with cystic fibrosis, thus assisting in managing the symptoms associated with the disease.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is lepirudin produced, and what is its primary use?\n",
      "   answer: Lepirudin is produced via yeast cells and is identical to natural hirudin, except for specific molecular substitutions. It is used for its anticoagulant properties, particularly in patients with heparin-induced thrombocytopenia.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the main mechanism of action of Etanercept, and what is its molecular composition?\n",
      "   answer: Etanercept is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It acts by inhibiting the action of tumor necrosis factor (TNF), a substance involved in systemic inflammation.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the target organism for Cetuximab, and does it have a known action on its target?', 'answer': 'The target organism for Cetuximab is humans, and it has a known action on its target, the Epidermal growth factor receptor.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the role of dornase alfa in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA, which reduces sputum viscosity and viscoelasticity in individuals with cystic fibrosis, thus assisting in managing the symptoms associated with the disease.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is lepirudin produced, and what is its primary use?', 'answer': 'Lepirudin is produced via yeast cells and is identical to natural hirudin, except for specific molecular substitutions. It is used for its anticoagulant properties, particularly in patients with heparin-induced thrombocytopenia.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the main mechanism of action of Etanercept, and what is its molecular composition?', 'answer': 'Etanercept is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It acts by inhibiting the action of tumor necrosis factor (TNF), a substance involved in systemic inflammation.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 59%|█████▉    | 118/200 [09:39<06:53,  5.05s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, and its primary target is the Epidermal Growth Factor Receptor in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Why was the production of Lepirudin ceased by Bayer?\n",
      "   answer: The production of Lepirudin, marketed as Refludan, was ceased by Bayer effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Dornase alfa produced, and what is its therapeutic role in cystic fibrosis?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It enzymatically breaks down extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What are the components of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, and its primary target is the Epidermal Growth Factor Receptor in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Why was the production of Lepirudin ceased by Bayer?', 'answer': 'The production of Lepirudin, marketed as Refludan, was ceased by Bayer effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Dornase alfa produced, and what is its therapeutic role in cystic fibrosis?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It enzymatically breaks down extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 60%|█████▉    | 119/200 [09:46<07:42,  5.71s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which specific receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, where it binds to the N-terminal portion of human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: How is Dornase alfa produced, and what is its role in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What organism is used for the production of Lepirudin, and what are its unique structural characteristics compared to natural hirudin?\n",
      "   answer: Lepirudin is produced via yeast cells. It is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug targets the prothrombin in humans, and what is known about its action?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which specific receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, where it binds to the N-terminal portion of human EGFR.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'How is Dornase alfa produced, and what is its role in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What organism is used for the production of Lepirudin, and what are its unique structural characteristics compared to natural hirudin?', 'answer': 'Lepirudin is produced via yeast cells. It is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets the prothrombin in humans, and what is known about its action?', 'answer': 'Lepirudin targets prothrombin in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 60%|██████    | 120/200 [09:54<08:10,  6.13s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its marketed brand name?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions. Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: Which transporter is associated with the drug with parent key DB00091, and what is its known action status?\n",
      "   answer: The drug with parent key DB00091 is associated with three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. All these transporters have an unknown known action status.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the state of the drug Dornase alfa, and what is its primary therapeutic application?\n",
      "   answer: Dornase alfa is in a liquid state. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme used to cleave extracellular DNA, thereby reducing sputum viscosity and viscoelasticity in patients with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the composition of Denileukin diftitox, and what expression system is it produced in?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its marketed brand name?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions. Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which transporter is associated with the drug with parent key DB00091, and what is its known action status?', 'answer': 'The drug with parent key DB00091 is associated with three transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. All these transporters have an unknown known action status.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Dornase alfa, and what is its primary therapeutic application?', 'answer': 'Dornase alfa is in a liquid state. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme used to cleave extracellular DNA, thereby reducing sputum viscosity and viscoelasticity in patients with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition of Denileukin diftitox, and what expression system is it produced in?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-11602530\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 61%|██████    | 122/200 [10:02<06:58,  5.36s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the marketed name for Cetuximab, and what is its primary therapeutic use?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux. It is an epidermal growth factor receptor binding FAB, used primarily in cancer treatment for its ability to bind the N-terminal portion of human EGFr (epidermal growth factor receptor).\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "2. question: What is the mechanism of action of Dornase alfa, and what condition is it primarily used to treat?\n",
      "   answer: Dornase alfa is a biosynthetic form of the human DNase I enzyme. It cleaves extracellular DNA into smaller nucleotide fragments, reducing sputum viscosity and viscoelasticity, which is particularly beneficial in treating cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B linked to interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the marketed formulation of Lepirudin, and why was its production ceased?\n",
      "   answer: Lepirudin was marketed under the name Refludan. Its production was ceased by Bayer effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "5. question: Identify a biosimilar agent to Dornase alfa and its form of administration.\n",
      "   answer: The marketed formulations of Dornase alfa include Pulmozyme and Pulmozyme 1mg/ml, which are typically administered via inhalation to reduce sputum viscosity in cystic fibrosis patients.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "[{'question': 'What is the marketed name for Cetuximab, and what is its primary therapeutic use?', 'answer': 'Cetuximab is marketed under the brand name Erbitux. It is an epidermal growth factor receptor binding FAB, used primarily in cancer treatment for its ability to bind the N-terminal portion of human EGFr (epidermal growth factor receptor).', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'What is the mechanism of action of Dornase alfa, and what condition is it primarily used to treat?', 'answer': 'Dornase alfa is a biosynthetic form of the human DNase I enzyme. It cleaves extracellular DNA into smaller nucleotide fragments, reducing sputum viscosity and viscoelasticity, which is particularly beneficial in treating cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B linked to interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed formulation of Lepirudin, and why was its production ceased?', 'answer': 'Lepirudin was marketed under the name Refludan. Its production was ceased by Bayer effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Identify a biosimilar agent to Dornase alfa and its form of administration.', 'answer': 'The marketed formulations of Dornase alfa include Pulmozyme and Pulmozyme 1mg/ml, which are typically administered via inhalation to reduce sputum viscosity in cystic fibrosis patients.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 62%|██████▏   | 123/200 [10:11<07:56,  6.19s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its target in the human body?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor (EGFR) in humans, which is known to be its site of action.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What is the primary therapeutic use of Dornase alfa, and how does it achieve its effect?\n",
      "   answer: Dornase alfa is used in the management of cystic fibrosis. It achieves its effect by cleaving extracellular DNA, which reduces sputum viscosity and viscoelasticity, facilitating easier clearance of mucus from the airways.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition and production method of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Etanercept produced, and what are its components?\n",
      "   answer: Etanercept is a dimeric fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the significance of Lepirudin's modification compared to natural hirudin, and why is it no longer produced?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. Bayer ceased its production effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its target in the human body?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor (EGFR) in humans, which is known to be its site of action.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the primary therapeutic use of Dornase alfa, and how does it achieve its effect?', 'answer': 'Dornase alfa is used in the management of cystic fibrosis. It achieves its effect by cleaving extracellular DNA, which reduces sputum viscosity and viscoelasticity, facilitating easier clearance of mucus from the airways.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition and production method of Denileukin diftitox?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what are its components?', 'answer': 'Etanercept is a dimeric fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': \"What is the significance of Lepirudin's modification compared to natural hirudin, and why is it no longer produced?\", 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. Bayer ceased its production effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 62%|██████▏   | 124/200 [10:16<07:27,  5.88s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in humans?\n",
      "   answer: Cetuximab works by binding to the epidermal growth factor receptor (EGFR) on human cells. This interaction inhibits the receptor's activation and subsequent signaling pathways that promote cell proliferation. Cetuximab is specifically composed of the Fv regions of the murine EGFr monoclonal antibody and human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is associated with Prothrombin as a target, and what type of drug is it?\n",
      "   answer: Lepirudin is associated with Prothrombin as a target. It is a biotech drug that is identical to natural hirudin, with slight modifications. It is produced via yeast cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the biosynthetic origin of Dornase alfa and its therapeutic use?\n",
      "   answer: Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used therapeutically to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the marketed name of Cetuximab, and what is its estimated cost for an eight-week treatment course in the United States?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company. In the United States, the estimated cost for an eight-week treatment course of cetuximab is approximately $30,790.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced using an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in humans?', 'answer': \"Cetuximab works by binding to the epidermal growth factor receptor (EGFR) on human cells. This interaction inhibits the receptor's activation and subsequent signaling pathways that promote cell proliferation. Cetuximab is specifically composed of the Fv regions of the murine EGFr monoclonal antibody and human IgG1 heavy and kappa light chain constant regions.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is associated with Prothrombin as a target, and what type of drug is it?', 'answer': 'Lepirudin is associated with Prothrombin as a target. It is a biotech drug that is identical to natural hirudin, with slight modifications. It is produced via yeast cells.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the biosynthetic origin of Dornase alfa and its therapeutic use?', 'answer': 'Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used therapeutically to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed name of Cetuximab, and what is its estimated cost for an eight-week treatment course in the United States?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company. In the United States, the estimated cost for an eight-week treatment course of cetuximab is approximately $30,790.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced using an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-7879937\n",
      "No table mapping found for passage Target-12360109\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 64%|██████▎   | 127/200 [10:23<04:45,  3.91s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the therapeutic use of Dornase alfa, and under what brand names is it marketed?\n",
      "   answer: Dornase alfa is used as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity, which is particularly beneficial for individuals with cystic fibrosis. It is marketed under the brand names Pulmozyme and Pulmozyme 1mg/ml.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "2. question: How is Etanercept produced, and what is its molecular structure?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component includes the CH2 domain, CH3 domain, and hinge region, but not the CH1 domain of IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the mechanism of action for Cetuximab, and what is its marketed name?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFr) binding FAB. It is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. Cetuximab is marketed under the brand name Erbitux.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "4. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His, followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the key differences between Lepirudin and natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the therapeutic use of Dornase alfa, and under what brand names is it marketed?', 'answer': 'Dornase alfa is used as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity, which is particularly beneficial for individuals with cystic fibrosis. It is marketed under the brand names Pulmozyme and Pulmozyme 1mg/ml.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'How is Etanercept produced, and what is its molecular structure?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component includes the CH2 domain, CH3 domain, and hinge region, but not the CH1 domain of IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the mechanism of action for Cetuximab, and what is its marketed name?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFr) binding FAB. It is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. Cetuximab is marketed under the brand name Erbitux.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His, followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the key differences between Lepirudin and natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 64%|██████▍   | 128/200 [10:35<06:43,  5.60s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the target mechanism of action for Cetuximab in humans?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, where it has a known action.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the unique feature of Lepirudin compared to natural hirudin, and how is it produced?\n",
      "   answer: Lepirudin differs from natural hirudin by having leucine substituted for isoleucine at the N-terminal end and lacking a sulfate group on the tyrosine at position 63. It is produced via yeast cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Dornase alfa produced, and what is its function in cystic fibrosis patients?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its function in cystic fibrosis patients is to cleave extracellular DNA, reducing sputum viscosity and improving viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the structure and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What drug is associated with the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\"?\n",
      "   answer: The drug associated with the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\" is linked to the parent key \"DB00007.\"\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the target mechanism of action for Cetuximab in humans?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, where it has a known action.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the unique feature of Lepirudin compared to natural hirudin, and how is it produced?', 'answer': 'Lepirudin differs from natural hirudin by having leucine substituted for isoleucine at the N-terminal end and lacking a sulfate group on the tyrosine at position 63. It is produced via yeast cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Dornase alfa produced, and what is its function in cystic fibrosis patients?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its function in cystic fibrosis patients is to cleave extracellular DNA, reducing sputum viscosity and improving viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structure and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What drug is associated with the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\"?', 'answer': 'The drug associated with the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\" is linked to the parent key \"DB00007.\"', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 64%|██████▍   | 129/200 [10:45<07:49,  6.62s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab and which receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the N-terminal portion of the human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: What are the components of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug targets prothrombin in humans, and what is its mechanism of action?\n",
      "   answer: Lepirudin targets prothrombin in humans. It is identical to natural hirudin, except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It inhibits thrombin directly.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "4. question: What is the primary therapeutic use of Dornase alfa and how does it achieve its effect?\n",
      "   answer: Dornase alfa is used in the management of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity, thereby improving pulmonary function in patients with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: How is Denileukin diftitox produced, and what are its components?\n",
      "   answer: Denileukin diftitox is produced in an E. coli expression system. It is a cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by sequences for interleukin-2 (IL-2; Ala 1-Thr 133).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab and which receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the N-terminal portion of the human EGFR.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What are the components of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein that consists of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug targets prothrombin in humans, and what is its mechanism of action?', 'answer': 'Lepirudin targets prothrombin in humans. It is identical to natural hirudin, except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It inhibits thrombin directly.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'What is the primary therapeutic use of Dornase alfa and how does it achieve its effect?', 'answer': 'Dornase alfa is used in the management of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity, thereby improving pulmonary function in patients with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Denileukin diftitox produced, and what are its components?', 'answer': 'Denileukin diftitox is produced in an E. coli expression system. It is a cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by sequences for interleukin-2 (IL-2; Ala 1-Thr 133).', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 65%|██████▌   | 130/200 [10:55<08:32,  7.32s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the brand name for the drug Cetuximab, and what is its primary therapeutic use?\n",
      "   answer: The brand name for Cetuximab is Erbitux. Cetuximab is an epidermal growth factor receptor binding FAB, used in oncology to treat certain types of cancer by binding to the epidermal growth factor receptor on cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "2. question: Which drug is produced using yeast cells and what is its marketed name?\n",
      "   answer: Lepirudin is produced using yeast cells, and it is marketed under the name Refludan.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the mechanism of action of Dornase alfa, and what condition is it primarily used to treat?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. It is primarily used in the treatment of cystic fibrosis to help reduce the thickness of mucus in the lungs.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the methodological approach used to produce Denileukin diftitox, and what is its brand name?\n",
      "   answer: Denileukin diftitox is produced using a recombinant DNA-derived process composed of diphtheria toxin fragments and interleukin-2 sequences. It is marketed under the brand name Ontak.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Describe the composition and mechanism of action of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1. It acts by inhibiting tumor necrosis factor (TNF), which is involved in systemic inflammation and is used to treat autoimmune diseases such as rheumatoid arthritis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the brand name for the drug Cetuximab, and what is its primary therapeutic use?', 'answer': 'The brand name for Cetuximab is Erbitux. Cetuximab is an epidermal growth factor receptor binding FAB, used in oncology to treat certain types of cancer by binding to the epidermal growth factor receptor on cancer cells.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Which drug is produced using yeast cells and what is its marketed name?', 'answer': 'Lepirudin is produced using yeast cells, and it is marketed under the name Refludan.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the mechanism of action of Dornase alfa, and what condition is it primarily used to treat?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. It is primarily used in the treatment of cystic fibrosis to help reduce the thickness of mucus in the lungs.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the methodological approach used to produce Denileukin diftitox, and what is its brand name?', 'answer': 'Denileukin diftitox is produced using a recombinant DNA-derived process composed of diphtheria toxin fragments and interleukin-2 sequences. It is marketed under the brand name Ontak.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and mechanism of action of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor linked to the Fc portion of human IgG1. It acts by inhibiting tumor necrosis factor (TNF), which is involved in systemic inflammation and is used to treat autoimmune diseases such as rheumatoid arthritis.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-26064350\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 66%|██████▌   | 132/200 [11:01<06:26,  5.69s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the main therapeutic use of Cetuximab and how does it exert its effect?\n",
      "   answer: Cetuximab is used for targeting the epidermal growth factor receptor (EGFR) in humans. It acts by binding to the EGFR, which is known to be involved in the growth and spread of cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the biological source of Dornase alfa and what is its primary clinical application?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells. It is primarily used in patients with cystic fibrosis to reduce sputum viscosity and viscoelasticity by breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the composition and mechanism of action of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It acts as a cytotoxic agent.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What target does Lepirudin act on in humans, and what is its mechanism of action?\n",
      "   answer: Lepirudin targets prothrombin in humans. It functions as an anticoagulant by directly inhibiting thrombin, which is an enzyme crucial for blood clotting.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the main therapeutic use of Cetuximab and how does it exert its effect?', 'answer': 'Cetuximab is used for targeting the epidermal growth factor receptor (EGFR) in humans. It acts by binding to the EGFR, which is known to be involved in the growth and spread of cancer cells.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the biological source of Dornase alfa and what is its primary clinical application?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells. It is primarily used in patients with cystic fibrosis to reduce sputum viscosity and viscoelasticity by breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition and mechanism of action of Denileukin diftitox?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It acts as a cytotoxic agent.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What target does Lepirudin act on in humans, and what is its mechanism of action?', 'answer': 'Lepirudin targets prothrombin in humans. It functions as an anticoagulant by directly inhibiting thrombin, which is an enzyme crucial for blood clotting.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 66%|██████▋   | 133/200 [11:08<06:37,  5.93s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which target does it affect in humans?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, where it binds to the N-terminal portion of human EGFR with high specificity due to its composition, which includes the Fv regions of the murine EGFR monoclonal antibody.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "   \n",
      "2. question: What is the production system used for the drug Dornase alfa, and what is its therapeutic function?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its therapeutic function is to enzymatically cleave extracellular DNA, reducing sputum viscosity and viscoelasticity, which is beneficial for individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the composition and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "   \n",
      "4. question: What is the known action of Lepirudin in humans, and which target does it interact with?\n",
      "   answer: Lepirudin has a known action in humans as it interacts with the target Prothrombin. It is a recombinant form of hirudin, which acts as a direct thrombin inhibitor.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What type of drug is Denileukin diftitox, and what is its production method?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein. It is composed of diphtheria toxin fragments and interleukin-2, and it is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the production system used for the drug Dornase alfa, and what is its therapeutic function?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its therapeutic function is to enzymatically cleave extracellular DNA, reducing sputum viscosity and viscoelasticity, which is beneficial for individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Lepirudin in humans, and which target does it interact with?', 'answer': 'Lepirudin has a known action in humans as it interacts with the target Prothrombin. It is a recombinant form of hirudin, which acts as a direct thrombin inhibitor.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of drug is Denileukin diftitox, and what is its production method?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein. It is composed of diphtheria toxin fragments and interleukin-2, and it is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 67%|██████▋   | 134/200 [11:16<07:03,  6.42s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR), which is located on human cells. This binding inhibits the receptor's activity, potentially leading to decreased tumor growth and proliferation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the clinical use of Dornase alfa in patients with cystic fibrosis?\n",
      "   answer: Dornase alfa is used in patients with cystic fibrosis to reduce sputum viscosity and viscoelasticity. It achieves this by enzymatically breaking down extracellular DNA, which is released by degenerating leukocytes during inflammatory responses.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the structural composition of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: For which drug has Bayer ceased production, and what is its state?\n",
      "   answer: Bayer ceased the production of Lepirudin, marketed as Refludan, effective May 31, 2012. Lepirudin is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the known targets of Cetuximab in humans, and what is the certainty of its action on these targets?\n",
      "   answer: Cetuximab is known to target the epidermal growth factor receptor (EGFR) in humans, with a confirmed action on this receptor. Additionally, it has unknown action on the low affinity immunoglobulin gamma Fc region receptor III-B, complement C1q subcomponent subunit A, and complement C1q subcomponent subunit B.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which receptor does it target?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR), which is located on human cells. This binding inhibits the receptor's activity, potentially leading to decreased tumor growth and proliferation.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the clinical use of Dornase alfa in patients with cystic fibrosis?', 'answer': 'Dornase alfa is used in patients with cystic fibrosis to reduce sputum viscosity and viscoelasticity. It achieves this by enzymatically breaking down extracellular DNA, which is released by degenerating leukocytes during inflammatory responses.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the structural composition of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'For which drug has Bayer ceased production, and what is its state?', 'answer': 'Bayer ceased the production of Lepirudin, marketed as Refludan, effective May 31, 2012. Lepirudin is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the known targets of Cetuximab in humans, and what is the certainty of its action on these targets?', 'answer': 'Cetuximab is known to target the epidermal growth factor receptor (EGFR) in humans, with a confirmed action on this receptor. Additionally, it has unknown action on the low affinity immunoglobulin gamma Fc region receptor III-B, complement C1q subcomponent subunit A, and complement C1q subcomponent subunit B.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 68%|██████▊   | 135/200 [11:21<06:26,  5.95s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is specifically composed of the Fv regions of the 225 murine EGFr monoclonal antibody, which targets the N-terminal portion of human EGFr, with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What is the known target of Lepirudin in humans?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: Which drug is linked to the FDA-approved product titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension\"?\n",
      "   answer: The drug linked to the FDA-approved product titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension\" is associated with the parent key DB00007.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "4. question: What is the origin of the protein used in the production of Dornase alfa?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: How is Etanercept produced, and what is its composition?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, containing the CH2 domain, the CH3 domain, and hinge region, but not the CH1 domain.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It is specifically composed of the Fv regions of the 225 murine EGFr monoclonal antibody, which targets the N-terminal portion of human EGFr, with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known target of Lepirudin in humans?', 'answer': 'Lepirudin targets prothrombin in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is linked to the FDA-approved product titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension\"?', 'answer': 'The drug linked to the FDA-approved product titled \"Lupron Depot-Ped (leuprolide acetate) depot suspension\" is associated with the parent key DB00007.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What is the origin of the protein used in the production of Dornase alfa?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what is its composition?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1, containing the CH2 domain, the CH3 domain, and hinge region, but not the CH1 domain.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-19188392\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 68%|██████▊   | 137/200 [11:37<07:08,  6.81s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in humans?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, as indicated by its known action with the receptor. This interaction is important for its therapeutic effects in treating certain cancers.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the state and type of Lepirudin, and what is its significance in its application?\n",
      "   answer: Lepirudin is a biotech drug in a liquid state. Its liquid form is significant for its use as an injectable anticoagulant, which is crucial in preventing thrombosis in patients.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the production system used for Etanercept, and why is this relevant?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This production method is relevant because it allows for the large-scale production of biologically active proteins used in treating autoimmune diseases.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What are the therapeutic targets for Cetuximab other than the epidermal growth factor receptor?\n",
      "   answer: Besides the epidermal growth factor receptor, Cetuximab also targets the Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1q subcomponent subunit A, and Complement C1q subcomponent subunit B, although the actions on these targets are unknown.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: How is Dornase alfa produced, and what is its primary application?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary application is to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in humans?', 'answer': 'Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, as indicated by its known action with the receptor. This interaction is important for its therapeutic effects in treating certain cancers.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the state and type of Lepirudin, and what is its significance in its application?', 'answer': 'Lepirudin is a biotech drug in a liquid state. Its liquid form is significant for its use as an injectable anticoagulant, which is crucial in preventing thrombosis in patients.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the production system used for Etanercept, and why is this relevant?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This production method is relevant because it allows for the large-scale production of biologically active proteins used in treating autoimmune diseases.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the therapeutic targets for Cetuximab other than the epidermal growth factor receptor?', 'answer': 'Besides the epidermal growth factor receptor, Cetuximab also targets the Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1q subcomponent subunit A, and Complement C1q subcomponent subunit B, although the actions on these targets are unknown.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Dornase alfa produced, and what is its primary application?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary application is to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 69%|██████▉   | 138/200 [11:43<06:56,  6.71s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with the transporter \"P-glycoprotein 1\" and what is its relevance in humans?\n",
      "   answer: The drug associated with the transporter \"P-glycoprotein 1\" is identified by the drugbank keys DB00027 and DB00091. In humans, P-glycoprotein 1 is a transporter with an unknown action, suggesting that its role in drug transport or metabolism is not fully understood.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the mechanism of action for Dornase alfa, and what condition is it used to treat?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. It is used to treat cystic fibrosis by breaking down the extracellular DNA released by degenerating leukocytes during inflammatory responses.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which transporter is associated with DB00091, and what is its known action?\n",
      "   answer: The transporters associated with DB00091 are P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. All these transporters have an unknown action, indicating that their specific roles in drug transport or metabolism have not been clearly defined.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: What is the therapeutic application of Cetuximab, and how is it produced?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB, used as a therapeutic agent in cancer treatment. It is produced by recombining the Fv regions of the 225 murine EGFr monoclonal antibody with human IgG1 heavy and kappa light chain constant regions, and marketed under the brand Erbitux®.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the significance of the FDA-approved link for the drug associated with DB00007, and what are some of its formulations?\n",
      "   answer: The FDA-approved link provides detailed labeling information for various formulations of the drug associated with DB00007, which is Leuprolide acetate. Some of its formulations include Lupaneta Pack for intramuscular and oral use, Lupron Depot suspension, Lupron Depot-Ped suspension, and Fensolvi suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'Which drug is associated with the transporter \"P-glycoprotein 1\" and what is its relevance in humans?', 'answer': 'The drug associated with the transporter \"P-glycoprotein 1\" is identified by the drugbank keys DB00027 and DB00091. In humans, P-glycoprotein 1 is a transporter with an unknown action, suggesting that its role in drug transport or metabolism is not fully understood.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the mechanism of action for Dornase alfa, and what condition is it used to treat?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. It is used to treat cystic fibrosis by breaking down the extracellular DNA released by degenerating leukocytes during inflammatory responses.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which transporter is associated with DB00091, and what is its known action?', 'answer': 'The transporters associated with DB00091 are P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. All these transporters have an unknown action, indicating that their specific roles in drug transport or metabolism have not been clearly defined.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the therapeutic application of Cetuximab, and how is it produced?', 'answer': 'Cetuximab is an epidermal growth factor receptor binding FAB, used as a therapeutic agent in cancer treatment. It is produced by recombining the Fv regions of the 225 murine EGFr monoclonal antibody with human IgG1 heavy and kappa light chain constant regions, and marketed under the brand Erbitux®.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the significance of the FDA-approved link for the drug associated with DB00007, and what are some of its formulations?', 'answer': 'The FDA-approved link provides detailed labeling information for various formulations of the drug associated with DB00007, which is Leuprolide acetate. Some of its formulations include Lupaneta Pack for intramuscular and oral use, Lupron Depot suspension, Lupron Depot-Ped suspension, and Fensolvi suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 70%|██████▉   | 139/200 [11:49<06:33,  6.45s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which human protein does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, specifically binding to the N-terminal portion of the EGFR, which is its known action.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: How is Dornase alfa produced, and what is its therapeutic use in cystic fibrosis?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, used to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in cystic fibrosis patients.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What are the components of Etanercept and how is it synthesized?\n",
      "   answer: Etanercept is composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system and consists of 934 amino acids.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the unique structural characteristic of Lepirudin compared to natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. \n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which human protein does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, specifically binding to the N-terminal portion of the EGFR, which is its known action.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'How is Dornase alfa produced, and what is its therapeutic use in cystic fibrosis?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, used to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in cystic fibrosis patients.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the components of Etanercept and how is it synthesized?', 'answer': 'Etanercept is composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system and consists of 934 amino acids.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique structural characteristic of Lepirudin compared to natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-14576103\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 70%|███████   | 141/200 [11:57<05:22,  5.46s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with the P-glycoprotein 1 transporter, and is there a known action?\n",
      "   answer: The drugs associated with the P-glycoprotein 1 transporter are Lepirudin (DB00027) and Dornase alfa (DB00091). The known action for these interactions is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the organism associated with the Canalicular multispecific organic anion transporter 1, and which drug is linked to this transporter?\n",
      "   answer: The Canalicular multispecific organic anion transporter 1 is associated with humans, and the drug linked to this transporter is Dornase alfa (DB00067).\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the primary state of the drug Cetuximab as described in the database?\n",
      "   answer: The primary state of the drug Cetuximab (DB00002) is liquid.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug has a synthesis reference related to crystal and method patents, and what is the nature of the protein described?\n",
      "   answer: The drug Etanercept (DB00005) has a synthesis reference related to crystal and method patents. It is described as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drug is associated with the P-glycoprotein 1 transporter, and is there a known action?', 'answer': 'The drugs associated with the P-glycoprotein 1 transporter are Lepirudin (DB00027) and Dornase alfa (DB00091). The known action for these interactions is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the organism associated with the Canalicular multispecific organic anion transporter 1, and which drug is linked to this transporter?', 'answer': 'The Canalicular multispecific organic anion transporter 1 is associated with humans, and the drug linked to this transporter is Dornase alfa (DB00067).', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the primary state of the drug Cetuximab as described in the database?', 'answer': 'The primary state of the drug Cetuximab (DB00002) is liquid.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug has a synthesis reference related to crystal and method patents, and what is the nature of the protein described?', 'answer': 'The drug Etanercept (DB00005) has a synthesis reference related to crystal and method patents. It is described as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 71%|███████   | 142/200 [12:04<05:47,  5.99s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which human transporter is associated with the drug identified by the primary key DB00091 and has a known action status?\n",
      "   answer: The transporter associated with the drug identified by the primary key DB00091 is the \"P-glycoprotein 1\" in humans, but its known action status is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab, and what type of drug is it classified as?\n",
      "   answer: Cetuximab is in a liquid state and is classified as a biotech drug.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which transporter is involved with the drug that uses the organism \"Humans\" and has a position of 6?\n",
      "   answer: The transporter involved with the drug is \"Ileal sodium/bile acid cotransporter\" when the organism is \"Humans\" and it is at position 6.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: What is the description of Lepirudin, and what is its CAS number?\n",
      "   answer: Lepirudin is described as identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Its CAS number is 138068-37-8.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug produced in a Chinese hamster ovary (CHO) cell expression system is described as a dimeric fusion protein?\n",
      "   answer: Etanercept is the drug produced in a Chinese hamster ovary (CHO) cell expression system and is described as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which human transporter is associated with the drug identified by the primary key DB00091 and has a known action status?', 'answer': 'The transporter associated with the drug identified by the primary key DB00091 is the \"P-glycoprotein 1\" in humans, but its known action status is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and what type of drug is it classified as?', 'answer': 'Cetuximab is in a liquid state and is classified as a biotech drug.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which transporter is involved with the drug that uses the organism \"Humans\" and has a position of 6?', 'answer': 'The transporter involved with the drug is \"Ileal sodium/bile acid cotransporter\" when the organism is \"Humans\" and it is at position 6.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the description of Lepirudin, and what is its CAS number?', 'answer': 'Lepirudin is described as identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Its CAS number is 138068-37-8.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug produced in a Chinese hamster ovary (CHO) cell expression system is described as a dimeric fusion protein?', 'answer': 'Etanercept is the drug produced in a Chinese hamster ovary (CHO) cell expression system and is described as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 72%|███████▏  | 143/200 [12:12<06:05,  6.41s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's normal function, which can interfere with the growth and survival of cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: How is Lepirudin produced and what is its current production status?\n",
      "   answer: Lepirudin is produced via yeast cells and is identical to natural hirudin except for certain molecular substitutions. Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the therapeutic use of Dornase alfa and how does it function?\n",
      "   answer: Dornase alfa is used in the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, reducing sputum viscosity and viscoelasticity, thereby helping to clear mucus from the lungs.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the primary target of Lepirudin and what role does it play in the body?\n",
      "   answer: The primary target of Lepirudin is prothrombin in humans. Prothrombin is a critical factor in the blood coagulation process, and by inhibiting it, Lepirudin acts as an anticoagulant.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the composition of Etanercept and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's normal function, which can interfere with the growth and survival of cancer cells.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Lepirudin produced and what is its current production status?', 'answer': 'Lepirudin is produced via yeast cells and is identical to natural hirudin except for certain molecular substitutions. Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the therapeutic use of Dornase alfa and how does it function?', 'answer': 'Dornase alfa is used in the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, reducing sputum viscosity and viscoelasticity, thereby helping to clear mucus from the lungs.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary target of Lepirudin and what role does it play in the body?', 'answer': 'The primary target of Lepirudin is prothrombin in humans. Prothrombin is a critical factor in the blood coagulation process, and by inhibiting it, Lepirudin acts as an anticoagulant.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the composition of Etanercept and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 72%|███████▏  | 144/200 [12:19<06:09,  6.60s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which receptor does it target in humans?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: Which drug in the database is used in the treatment of cystic fibrosis and what is its mechanism of action?\n",
      "   answer: Dornase alfa is used in the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: For which organism is Prothrombin a known target, and which drug interacts with it?\n",
      "   answer: Prothrombin is a known target in humans, and the drug Lepirudin interacts with it.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What is the unique identifier (UNII) for Etanercept, and what is its composition?\n",
      "   answer: The unique identifier (UNII) for Etanercept is OP401G7OJC. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug is described as having a recombinant DNA-derived cytotoxic protein, and what are its components?\n",
      "   answer: Denileukin diftitox is described as having a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which receptor does it target in humans?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'Which drug in the database is used in the treatment of cystic fibrosis and what is its mechanism of action?', 'answer': 'Dornase alfa is used in the treatment of cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'For which organism is Prothrombin a known target, and which drug interacts with it?', 'answer': 'Prothrombin is a known target in humans, and the drug Lepirudin interacts with it.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the unique identifier (UNII) for Etanercept, and what is its composition?', 'answer': 'The unique identifier (UNII) for Etanercept is OP401G7OJC. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is described as having a recombinant DNA-derived cytotoxic protein, and what are its components?', 'answer': 'Denileukin diftitox is described as having a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-2729995\n",
      "No table mapping found for passage Target-19845433\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 74%|███████▎  | 147/200 [12:28<04:08,  4.69s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab binds to the epidermal growth factor receptor (EGFR). Its mechanism involves inhibiting the receptor, which is part of a signaling pathway that promotes cell growth and division. This makes Cetuximab useful in treating certain cancers by preventing tumor growth.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: How is Lepirudin produced and what is its primary target?\n",
      "   answer: Lepirudin is produced via yeast cells and it is identical to natural hirudin except for a few molecular differences. Its primary target is prothrombin in humans, where it acts as a direct thrombin inhibitor.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the unique characteristic of the drug Dornase alfa in its mechanism of action?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA to 5′-phosphodinucleotide and 5′-phosphooligonucleotide end products without affecting intracellular DNA, which helps reduce sputum viscosity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the structure and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the significance of the known action status for the target Epidermal growth factor receptor concerning Cetuximab?\n",
      "   answer: The known action status for the target Epidermal growth factor receptor concerning Cetuximab is \"yes,\" indicating that Cetuximab's binding and inhibition of this receptor is a well-established and significant aspect of its therapeutic mechanism in treating cancers.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the primary mechanism of action for Cetuximab?', 'answer': 'Cetuximab binds to the epidermal growth factor receptor (EGFR). Its mechanism involves inhibiting the receptor, which is part of a signaling pathway that promotes cell growth and division. This makes Cetuximab useful in treating certain cancers by preventing tumor growth.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Lepirudin produced and what is its primary target?', 'answer': 'Lepirudin is produced via yeast cells and it is identical to natural hirudin except for a few molecular differences. Its primary target is prothrombin in humans, where it acts as a direct thrombin inhibitor.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the unique characteristic of the drug Dornase alfa in its mechanism of action?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA to 5′-phosphodinucleotide and 5′-phosphooligonucleotide end products without affecting intracellular DNA, which helps reduce sputum viscosity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the structure and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the significance of the known action status for the target Epidermal growth factor receptor concerning Cetuximab?', 'answer': 'The known action status for the target Epidermal growth factor receptor concerning Cetuximab is \"yes,\" indicating that Cetuximab\\'s binding and inhibition of this receptor is a well-established and significant aspect of its therapeutic mechanism in treating cancers.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 74%|███████▍  | 148/200 [12:35<04:20,  5.01s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) in humans, as indicated by its known action with this target. This binding inhibits the function of the receptor, which is essential in the growth and proliferation of cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug targets prothrombin in humans, and what is its primary use?\n",
      "   answer: Lepirudin targets prothrombin in humans. It is a recombinant hirudin derivative used as an anticoagulant, particularly in patients with heparin-induced thrombocytopenia, to prevent complications from thrombosis.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: How is Etanercept manufactured, and what is its composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the therapeutic use of Dornase alfa, and what technology is used for its production?\n",
      "   answer: Dornase alfa is used therapeutically to reduce sputum viscosity and viscoelasticity in patients with cystic fibrosis. It is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the state of the drug Cetuximab, and under what brand is it marketed?\n",
      "   answer: Cetuximab is in a liquid state and is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary mechanism of action for Cetuximab?', 'answer': 'Cetuximab functions by binding to the epidermal growth factor receptor (EGFR) in humans, as indicated by its known action with this target. This binding inhibits the function of the receptor, which is essential in the growth and proliferation of cancer cells.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug targets prothrombin in humans, and what is its primary use?', 'answer': 'Lepirudin targets prothrombin in humans. It is a recombinant hirudin derivative used as an anticoagulant, particularly in patients with heparin-induced thrombocytopenia, to prevent complications from thrombosis.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Etanercept manufactured, and what is its composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the therapeutic use of Dornase alfa, and what technology is used for its production?', 'answer': 'Dornase alfa is used therapeutically to reduce sputum viscosity and viscoelasticity in patients with cystic fibrosis. It is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the state of the drug Cetuximab, and under what brand is it marketed?', 'answer': 'Cetuximab is in a liquid state and is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 74%|███████▍  | 149/200 [12:41<04:28,  5.27s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which human receptor does it target?\n",
      "   answer: Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on human cells. It binds specifically to the N-terminal portion of the human EGFR and is utilized in the treatment of certain cancers.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug targets prothrombin in humans, and what is its known action?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action is known. It acts as an anticoagulant by inhibiting thrombin, which plays a key role in blood clotting.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: Describe the molecular composition and production method of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the production origin and therapeutic use of Dornase alfa?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the unique feature of Lepirudin compared to natural hirudin, and why was its production ceased?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. Production of Lepirudin (Refludan) was ceased by Bayer effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which human receptor does it target?', 'answer': 'Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on human cells. It binds specifically to the N-terminal portion of the human EGFR and is utilized in the treatment of certain cancers.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug targets prothrombin in humans, and what is its known action?', 'answer': 'Lepirudin targets prothrombin in humans, and its action is known. It acts as an anticoagulant by inhibiting thrombin, which plays a key role in blood clotting.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the molecular composition and production method of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the production origin and therapeutic use of Dornase alfa?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique feature of Lepirudin compared to natural hirudin, and why was its production ceased?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. Production of Lepirudin (Refludan) was ceased by Bayer effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 75%|███████▌  | 150/200 [12:46<04:20,  5.22s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the organism associated with P-glycoprotein 1, and for which drugs is it a known transporter?\n",
      "   answer: P-glycoprotein 1 is associated with humans. It is a known transporter for the drugs with parent keys DB00027 and DB00091.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: Which drug has an FDA label linked to both Lupaneta Pack and Lupron Depot products?\n",
      "   answer: The drug with the parent key DB00007 is linked to FDA labels for both Lupaneta Pack (for intramuscular and oral use) and Lupron Depot (leuprolide acetate) depot suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "3. question: Describe the mechanism of Dornase alfa and its therapeutic indication.\n",
      "   answer: Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity, which is beneficial for individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What type of protein is Etanercept and what is its production method?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the differences in the molecular structure of Lepirudin compared to natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the organism associated with P-glycoprotein 1, and for which drugs is it a known transporter?', 'answer': 'P-glycoprotein 1 is associated with humans. It is a known transporter for the drugs with parent keys DB00027 and DB00091.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Which drug has an FDA label linked to both Lupaneta Pack and Lupron Depot products?', 'answer': 'The drug with the parent key DB00007 is linked to FDA labels for both Lupaneta Pack (for intramuscular and oral use) and Lupron Depot (leuprolide acetate) depot suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Describe the mechanism of Dornase alfa and its therapeutic indication.', 'answer': 'Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity, which is beneficial for individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What type of protein is Etanercept and what is its production method?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the differences in the molecular structure of Lepirudin compared to natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 76%|███████▌  | 151/200 [12:54<04:56,  6.06s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab's mechanism of action involves binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's activity, which is crucial for the growth and proliferation of certain types of cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the indication for Dornase alfa?\n",
      "   answer: Dornase alfa is indicated for use in individuals with cystic fibrosis. It acts by enzymatically cleaving extracellular DNA, reducing the viscosity and viscoelasticity of sputum, which helps improve lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the production method for Etanercept?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein that includes the extracellular ligand-binding portion of the human tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which organism is targeted by Lepirudin, and what is its known action?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action on the target is known. The drug is used as an anticoagulant by directly inhibiting thrombin.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: How is Cetuximab marketed, and what is its approximate cost for an eight-week course in the United States?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company. In the United States, an eight-week course of Cetuximab costs approximately $30,790.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab?', 'answer': \"Cetuximab's mechanism of action involves binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's activity, which is crucial for the growth and proliferation of certain types of cancer cells.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the indication for Dornase alfa?', 'answer': 'Dornase alfa is indicated for use in individuals with cystic fibrosis. It acts by enzymatically cleaving extracellular DNA, reducing the viscosity and viscoelasticity of sputum, which helps improve lung function.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the production method for Etanercept?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein that includes the extracellular ligand-binding portion of the human tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which organism is targeted by Lepirudin, and what is its known action?', 'answer': 'Lepirudin targets prothrombin in humans, and its action on the target is known. The drug is used as an anticoagulant by directly inhibiting thrombin.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Cetuximab marketed, and what is its approximate cost for an eight-week course in the United States?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company. In the United States, an eight-week course of Cetuximab costs approximately $30,790.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-19185566\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 76%|███████▋  | 153/200 [13:01<03:49,  4.89s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets and binds to the N-terminal portion of the human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-drug, drugbank-targets\n",
      "\n",
      "2. question: How is Dornase alfa produced, and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary therapeutic use is to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What type of drug is Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a biotech drug that is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which organism is targeted by Lepirudin, and what is its known action?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the unique structural characteristic of Cetuximab compared to a typical monoclonal antibody?\n",
      "   answer: Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions, differentiating it from typical monoclonal antibodies.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets and binds to the N-terminal portion of the human EGFR.', 'text': 'None', 'table': 'drugbank-drug, drugbank-targets'}, {'question': 'How is Dornase alfa produced, and what is its primary therapeutic use?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary therapeutic use is to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What type of drug is Etanercept, and how is it produced?', 'answer': 'Etanercept is a biotech drug that is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which organism is targeted by Lepirudin, and what is its known action?', 'answer': 'Lepirudin targets prothrombin in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the unique structural characteristic of Cetuximab compared to a typical monoclonal antibody?', 'answer': 'Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions, differentiating it from typical monoclonal antibodies.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-9390115\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 78%|███████▊  | 155/200 [13:11<03:44,  4.99s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Dornase alfa, and what condition is it used to treat?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products without affecting intracellular DNA. It is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis, where extracellular DNA accumulates during inflammatory responses to infections.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What are the marketed mixtures for Cetuximab, and what is its primary therapeutic use?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux. It is an epidermal growth factor receptor (EGFR) binding Fab, used primarily in the treatment of certain types of cancer, such as colorectal cancer and head and neck cancer, through its action on the EGFR.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "3. question: What is the state of the drug Etanercept, and what technology is used for its production?\n",
      "   answer: Etanercept is in a liquid state. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This dimeric fusion protein consists of portions of the human tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is produced in yeast cells and was discontinued by Bayer in 2012?\n",
      "   answer: Lepirudin is produced in yeast cells and was discontinued by Bayer effective May 31, 2012. It is identical to natural hirudin, except for specific substitutions at the N-terminal end of the molecule.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the ingredients in the drug mixture marketed as \"Ontak,\" and what is its origin?\n",
      "   answer: The drug mixture marketed as \"Ontak\" contains the ingredient Denileukin diftitox. This drug is a recombinant DNA-derived cytotoxic protein composed of sequences for diphtheria toxin fragments and interleukin-2 (IL-2), produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "[{'question': 'What is the mechanism of action for Dornase alfa, and what condition is it used to treat?', 'answer': \"Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It cleaves extracellular DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products without affecting intracellular DNA. It is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis, where extracellular DNA accumulates during inflammatory responses to infections.\", 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the marketed mixtures for Cetuximab, and what is its primary therapeutic use?', 'answer': 'Cetuximab is marketed under the brand name Erbitux. It is an epidermal growth factor receptor (EGFR) binding Fab, used primarily in the treatment of certain types of cancer, such as colorectal cancer and head and neck cancer, through its action on the EGFR.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'What is the state of the drug Etanercept, and what technology is used for its production?', 'answer': 'Etanercept is in a liquid state. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. This dimeric fusion protein consists of portions of the human tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is produced in yeast cells and was discontinued by Bayer in 2012?', 'answer': 'Lepirudin is produced in yeast cells and was discontinued by Bayer effective May 31, 2012. It is identical to natural hirudin, except for specific substitutions at the N-terminal end of the molecule.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the ingredients in the drug mixture marketed as \"Ontak,\" and what is its origin?', 'answer': 'The drug mixture marketed as \"Ontak\" contains the ingredient Denileukin diftitox. This drug is a recombinant DNA-derived cytotoxic protein composed of sequences for diphtheria toxin fragments and interleukin-2 (IL-2), produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 78%|███████▊  | 156/200 [13:23<04:47,  6.53s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab in humans?\n",
      "   answer: Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, which plays a role in cell proliferation and survival. By binding to EGFR, Cetuximab inhibits the receptor's activation and downstream signaling pathways.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the production method of Dornase alfa, and what is its role in treating cystic fibrosis?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It acts as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, cleaving extracellular DNA to reduce sputum viscosity in patients with cystic fibrosis, thus improving lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the target organism for Lepirudin, and what known action does it have?\n",
      "   answer: Lepirudin targets prothrombin in humans, and its known action is to inhibit its activity, which is crucial in the prevention of thrombosis.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: How is Etanercept produced, and what is its composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the FDA-approved use of Lupron Depot, and what is its active ingredient?\n",
      "   answer: Lupron Depot, which contains the active ingredient leuprolide acetate, is FDA-approved for use as a depot suspension for conditions requiring suppression of gonadotropins, such as prostate cancer and endometriosis.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action of Cetuximab in humans?', 'answer': \"Cetuximab targets the epidermal growth factor receptor (EGFR) in humans, which plays a role in cell proliferation and survival. By binding to EGFR, Cetuximab inhibits the receptor's activation and downstream signaling pathways.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the production method of Dornase alfa, and what is its role in treating cystic fibrosis?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It acts as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, cleaving extracellular DNA to reduce sputum viscosity in patients with cystic fibrosis, thus improving lung function.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the target organism for Lepirudin, and what known action does it have?', 'answer': 'Lepirudin targets prothrombin in humans, and its known action is to inhibit its activity, which is crucial in the prevention of thrombosis.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Etanercept produced, and what is its composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein composed of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved use of Lupron Depot, and what is its active ingredient?', 'answer': 'Lupron Depot, which contains the active ingredient leuprolide acetate, is FDA-approved for use as a depot suspension for conditions requiring suppression of gonadotropins, such as prostate cancer and endometriosis.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-7720517\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 79%|███████▉  | 158/200 [13:28<03:29,  4.98s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What are the known targets for Cetuximab and their organism of origin?\n",
      "   answer: Cetuximab targets the Epidermal growth factor receptor in humans. Additionally, there are unknown actions with Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1q subcomponent subunit A, and Complement C1q subcomponent subunit B, all originating from humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the production method of Dornase alfa, and what is its primary use in cystic fibrosis?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is primarily used to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Etanercept's structure characterized, and what production system is used?\n",
      "   answer: Etanercept is characterized as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the nature of Denileukin diftitox and its production system.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drugs from the sample have FDA labels available, and what are their states?\n",
      "   answer: The drugs with available FDA labels in the sample are Lepirudin and Cetuximab, both in a liquid state. Dornase alfa and Denileukin diftitox also have FDA labels available and are in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What are the known targets for Cetuximab and their organism of origin?', 'answer': 'Cetuximab targets the Epidermal growth factor receptor in humans. Additionally, there are unknown actions with Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1q subcomponent subunit A, and Complement C1q subcomponent subunit B, all originating from humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the production method of Dornase alfa, and what is its primary use in cystic fibrosis?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is primarily used to cleave extracellular DNA, reducing sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': \"How is Etanercept's structure characterized, and what production system is used?\", 'answer': 'Etanercept is characterized as a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the nature of Denileukin diftitox and its production system.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drugs from the sample have FDA labels available, and what are their states?', 'answer': 'The drugs with available FDA labels in the sample are Lepirudin and Cetuximab, both in a liquid state. Dornase alfa and Denileukin diftitox also have FDA labels available and are in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-9834040\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 80%|████████  | 160/200 [13:35<02:54,  4.37s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and what is its primary target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. The primary target of Cetuximab is the Epidermal growth factor receptor (EGFR) in humans, where it acts by binding to the N-terminal portion of human EGFR with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the production method for Dornase alfa, and what is its therapeutic use?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its therapeutic use involves cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis, thereby improving respiratory function by breaking down the extracellular DNA released by degenerating leukocytes during inflammatory responses.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Describe the composition and production system of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His, followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced using an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the structural composition of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the known action of Lepirudin, and what organism is its target associated with?\n",
      "   answer: Lepirudin's known action is associated with its target, Prothrombin, in humans. It acts as an anticoagulant, inhibiting thrombin to prevent clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and what is its primary target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. The primary target of Cetuximab is the Epidermal growth factor receptor (EGFR) in humans, where it acts by binding to the N-terminal portion of human EGFR with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the production method for Dornase alfa, and what is its therapeutic use?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its therapeutic use involves cleaving extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis, thereby improving respiratory function by breaking down the extracellular DNA released by degenerating leukocytes during inflammatory responses.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and production system of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His, followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced using an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the structural composition of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component contains the CH2 domain, the CH3 domain, and the hinge region but not the CH1 domain of IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Lepirudin, and what organism is its target associated with?', 'answer': \"Lepirudin's known action is associated with its target, Prothrombin, in humans. It acts as an anticoagulant, inhibiting thrombin to prevent clot formation.\", 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 80%|████████  | 161/200 [13:40<02:54,  4.47s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the target of Cetuximab and what is its known action in humans?\n",
      "   answer: Cetuximab targets the Epidermal Growth Factor Receptor (EGFR) in humans, and the known action is \"yes,\" indicating that it is an established target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Describe the molecular composition of Etanercept and its production method.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the organism source for the production of Dornase alfa and what is its primary therapeutic action?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary therapeutic action is to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug has the target Prothrombin, and is the action known?\n",
      "   answer: The drug Lepirudin targets Prothrombin in humans, and the action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the description and therapeutic use of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is used for its cytotoxic properties.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the target of Cetuximab and what is its known action in humans?', 'answer': 'Cetuximab targets the Epidermal Growth Factor Receptor (EGFR) in humans, and the known action is \"yes,\" indicating that it is an established target.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the molecular composition of Etanercept and its production method.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the organism source for the production of Dornase alfa and what is its primary therapeutic action?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. Its primary therapeutic action is to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug has the target Prothrombin, and is the action known?', 'answer': 'The drug Lepirudin targets Prothrombin in humans, and the action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the description and therapeutic use of Denileukin diftitox?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2). It is used for its cytotoxic properties.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 81%|████████  | 162/200 [13:45<02:58,  4.71s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary target of Cetuximab and what is its known action?\n",
      "   answer: The primary target of Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its known action is confirmed as \"yes,\" indicating that Cetuximab specifically binds to this target.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the mechanism of action of Dornase alfa in individuals with cystic fibrosis?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. This mechanism helps in managing the condition in cystic fibrosis patients by breaking down the extracellular DNA released by degenerating leukocytes.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the state of the drug Lepirudin, and what notable event occurred regarding its production?\n",
      "   answer: Lepirudin is in a liquid state. Notably, Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the organism source for the production of Etanercept, and what is its structural composition?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which FDA-approved drug products are related to Leuprolide acetate according to their links, and what is a common route of administration for these products?\n",
      "   answer: The FDA-approved drug products related to Leuprolide acetate include Lupaneta Pack, Lupron Depot, Lupron Depot-Ped, and Fensolvi. A common route of administration for these products is via depot suspension, which is typically administered intramuscularly.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the primary target of Cetuximab and what is its known action?', 'answer': 'The primary target of Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its known action is confirmed as \"yes,\" indicating that Cetuximab specifically binds to this target.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the mechanism of action of Dornase alfa in individuals with cystic fibrosis?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity. This mechanism helps in managing the condition in cystic fibrosis patients by breaking down the extracellular DNA released by degenerating leukocytes.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the state of the drug Lepirudin, and what notable event occurred regarding its production?', 'answer': 'Lepirudin is in a liquid state. Notably, Bayer ceased the production of Lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the organism source for the production of Etanercept, and what is its structural composition?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which FDA-approved drug products are related to Leuprolide acetate according to their links, and what is a common route of administration for these products?', 'answer': 'The FDA-approved drug products related to Leuprolide acetate include Lupaneta Pack, Lupron Depot, Lupron Depot-Ped, and Fensolvi. A common route of administration for these products is via depot suspension, which is typically administered intramuscularly.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 82%|████████▏ | 163/200 [13:51<03:01,  4.91s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, targeting the N-terminal portion of human EGFR. It is used to block the action of the epidermal growth factor receptor in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: How is Lepirudin synthesized, and what is its current production status?\n",
      "   answer: Lepirudin is produced via yeast cells and is identical to natural hirudin except for specific amino acid substitutions. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the therapeutic use of Dornase alfa, and how does it function in cystic fibrosis patients?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients by cleaving extracellular DNA into smaller fragments, thus reducing the viscosity and viscoelasticity of the sputum. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the structural composition of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the known and unknown targets of Cetuximab in humans?\n",
      "   answer: The known target of Cetuximab is the epidermal growth factor receptor (EGFR) in humans. The unknown targets include Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1q subcomponent subunit A, and Complement C1q subcomponent subunit B.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB, targeting the N-terminal portion of human EGFR. It is used to block the action of the epidermal growth factor receptor in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How is Lepirudin synthesized, and what is its current production status?', 'answer': 'Lepirudin is produced via yeast cells and is identical to natural hirudin except for specific amino acid substitutions. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the therapeutic use of Dornase alfa, and how does it function in cystic fibrosis patients?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients by cleaving extracellular DNA into smaller fragments, thus reducing the viscosity and viscoelasticity of the sputum. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the structural composition of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the known and unknown targets of Cetuximab in humans?', 'answer': 'The known target of Cetuximab is the epidermal growth factor receptor (EGFR) in humans. The unknown targets include Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1q subcomponent subunit A, and Complement C1q subcomponent subunit B.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-23385314\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 82%|████████▎ | 165/200 [13:57<02:23,  4.11s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and what receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, which is involved in the regulation of cell growth and division.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Describe the production method and therapeutic use of Dornase alfa.\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA released by degenerating leukocytes.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug listed in the tables is used to target prothrombin in humans, and what is its marketed name?\n",
      "   answer: Lepirudin targets prothrombin in humans. However, Bayer ceased its production under the marketed name Refludan as of May 31, 2012.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What is the composition and production method of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the known action of Denileukin diftitox, and how is it produced?\n",
      "   answer: Denileukin diftitox is a cytotoxic protein with no known specific action listed in the tables. It is composed of sequences for diphtheria toxin fragments and interleukin-2 (IL-2) and is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and what receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, which is involved in the regulation of cell growth and division.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Describe the production method and therapeutic use of Dornase alfa.', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used to reduce sputum viscosity in individuals with cystic fibrosis by enzymatically breaking down extracellular DNA released by degenerating leukocytes.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug listed in the tables is used to target prothrombin in humans, and what is its marketed name?', 'answer': 'Lepirudin targets prothrombin in humans. However, Bayer ceased its production under the marketed name Refludan as of May 31, 2012.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the composition and production method of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Denileukin diftitox, and how is it produced?', 'answer': 'Denileukin diftitox is a cytotoxic protein with no known specific action listed in the tables. It is composed of sequences for diphtheria toxin fragments and interleukin-2 (IL-2) and is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-10445380\n",
      "No table mapping found for passage Target-11563993\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 84%|████████▍ | 168/200 [14:01<01:32,  2.89s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What are the known human transporters associated with the drug identified by DB00091, and what is their known action?\n",
      "   answer: The drug identified by DB00091 is associated with the following human transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. For all these transporters, the known action is listed as unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab, and when was its information last updated?\n",
      "   answer: The drug Cetuximab is in a liquid state, and its information was last updated on July 1, 2020.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Is there any known action for P-glycoprotein 1 transporter when associated with the drug DB00027?\n",
      "   answer: The known action for P-glycoprotein 1 transporter when associated with the drug DB00027 is unknown.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: Which FDA-approved drug products are related to the drug with the parent key DB00007?\n",
      "   answer: The FDA-approved drug products related to the drug with the parent key DB00007 include Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "5. question: What is the state and description of the drug Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is in a liquid state. It is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What are the known human transporters associated with the drug identified by DB00091, and what is their known action?', 'answer': 'The drug identified by DB00091 is associated with the following human transporters: P-glycoprotein 1, Bile salt export pump, and Ileal sodium/bile acid cotransporter. For all these transporters, the known action is listed as unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab, and when was its information last updated?', 'answer': 'The drug Cetuximab is in a liquid state, and its information was last updated on July 1, 2020.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Is there any known action for P-glycoprotein 1 transporter when associated with the drug DB00027?', 'answer': 'The known action for P-glycoprotein 1 transporter when associated with the drug DB00027 is unknown.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Which FDA-approved drug products are related to the drug with the parent key DB00007?', 'answer': 'The FDA-approved drug products related to the drug with the parent key DB00007 include Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What is the state and description of the drug Denileukin diftitox?', 'answer': 'Denileukin diftitox is in a liquid state. It is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 84%|████████▍ | 169/200 [14:06<01:42,  3.31s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab functions as an epidermal growth factor receptor (EGFR) binding FAB, targeting the epidermal growth factor receptor. This interaction is known to occur in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug among the provided samples is known to reduce sputum viscosity in cystic fibrosis patients, and how does it achieve this?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, thereby reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the main structural difference between Lepirudin and natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which organism is used for the production of Dornase alfa, and what technology is employed?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the composition of Denileukin diftitox and the expression system used for its production?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which receptor does it target?', 'answer': 'Cetuximab functions as an epidermal growth factor receptor (EGFR) binding FAB, targeting the epidermal growth factor receptor. This interaction is known to occur in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug among the provided samples is known to reduce sputum viscosity in cystic fibrosis patients, and how does it achieve this?', 'answer': 'Dornase alfa is used to reduce sputum viscosity in cystic fibrosis patients. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, thereby reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the main structural difference between Lepirudin and natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which organism is used for the production of Dornase alfa, and what technology is employed?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition of Denileukin diftitox and the expression system used for its production?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 85%|████████▌ | 170/200 [14:15<02:10,  4.34s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the target of Cetuximab, and what is its known action in humans?\n",
      "   answer: The target of Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its known action is confirmed as \"yes,\" indicating it interacts effectively with this receptor.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: How does Dornase alfa reduce sputum viscosity in patients with cystic fibrosis?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA into 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products. This enzymatic breakdown of extracellular DNA reduces sputum viscosity and viscoelasticity in patients with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What type of protein is Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the composition and mechanism of action of Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system and works by targeting cells that express the IL-2 receptor, delivering the diphtheria toxin to induce cell death.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drugs listed have a \"liquid\" state and are produced using recombinant DNA technology?\n",
      "   answer: Lepirudin, Cetuximab, Dornase alfa, Denileukin diftitox, and Etanercept are all in a liquid state and are produced using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the target of Cetuximab, and what is its known action in humans?', 'answer': 'The target of Cetuximab is the Epidermal Growth Factor Receptor (EGFR) in humans, and its known action is confirmed as \"yes,\" indicating it interacts effectively with this receptor.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'How does Dornase alfa reduce sputum viscosity in patients with cystic fibrosis?', 'answer': \"Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, which cleaves extracellular DNA into 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products. This enzymatic breakdown of extracellular DNA reduces sputum viscosity and viscoelasticity in patients with cystic fibrosis.\", 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What type of protein is Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the composition and mechanism of action of Denileukin diftitox?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system and works by targeting cells that express the IL-2 receptor, delivering the diphtheria toxin to induce cell death.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drugs listed have a \"liquid\" state and are produced using recombinant DNA technology?', 'answer': 'Lepirudin, Cetuximab, Dornase alfa, Denileukin diftitox, and Etanercept are all in a liquid state and are produced using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 86%|████████▌ | 171/200 [14:34<03:47,  7.85s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the organism source for the P-glycoprotein 1 transporter associated with the drug primary key DB00091?\n",
      "   answer: The P-glycoprotein 1 transporter associated with the drug primary key DB00091 is sourced from humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: Which drug has been linked to the Canalicular multispecific organic anion transporter 1?\n",
      "   answer: The drug linked to the Canalicular multispecific organic anion transporter 1 is associated with the primary key DB00067.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "3. question: What is the known action status of the Ileal sodium/bile acid cotransporter for the drug with primary key DB00091?\n",
      "   answer: The known action status of the Ileal sodium/bile acid cotransporter for the drug with primary key DB00091 is \"unknown.\"\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: Which FDA-approved drug product titles are associated with the drug with primary key DB00007?\n",
      "   answer: The FDA-approved drug product titles associated with the drug with primary key DB00007 are \"FDA Approved Drug Products: Lupaneta Pack for intramuscular and oral use,\" \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension,\" \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension,\" and \"FDA Approved Drug Products: Fensolvi (leuprolide acetate) suspension.\"\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the organism source for the P-glycoprotein 1 transporter associated with the drug primary key DB00091?', 'answer': 'The P-glycoprotein 1 transporter associated with the drug primary key DB00091 is sourced from humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Which drug has been linked to the Canalicular multispecific organic anion transporter 1?', 'answer': 'The drug linked to the Canalicular multispecific organic anion transporter 1 is associated with the primary key DB00067.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the known action status of the Ileal sodium/bile acid cotransporter for the drug with primary key DB00091?', 'answer': 'The known action status of the Ileal sodium/bile acid cotransporter for the drug with primary key DB00091 is \"unknown.\"', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Which FDA-approved drug product titles are associated with the drug with primary key DB00007?', 'answer': 'The FDA-approved drug product titles associated with the drug with primary key DB00007 are \"FDA Approved Drug Products: Lupaneta Pack for intramuscular and oral use,\" \"FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension,\" \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension,\" and \"FDA Approved Drug Products: Fensolvi (leuprolide acetate) suspension.\"', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-15843491\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 86%|████████▋ | 173/200 [14:43<02:57,  6.56s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab in humans?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and verified as it is a targeted action of the drug.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the clinical significance of Dornase alfa in the treatment of cystic fibrosis?\n",
      "   answer: Dornase alfa is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It works by enzymatically breaking down extracellular DNA, which is released by degenerating leukocytes during inflammatory responses to infections.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the FDA-approved application method for Lupron Depot?\n",
      "   answer: Lupron Depot is approved for use as a depot suspension for intramuscular administration.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "4. question: What are the primary molecular targets of Cetuximab, and what is their known action status?\n",
      "   answer: Cetuximab primarily targets the epidermal growth factor receptor (EGFR) in humans with a known action status, as well as several complement components and receptors, although the action on these is unknown.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: What is the composition of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab in humans?', 'answer': 'Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) in humans. This interaction is known and verified as it is a targeted action of the drug.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the clinical significance of Dornase alfa in the treatment of cystic fibrosis?', 'answer': 'Dornase alfa is used to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis. It works by enzymatically breaking down extracellular DNA, which is released by degenerating leukocytes during inflammatory responses to infections.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved application method for Lupron Depot?', 'answer': 'Lupron Depot is approved for use as a depot suspension for intramuscular administration.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What are the primary molecular targets of Cetuximab, and what is their known action status?', 'answer': 'Cetuximab primarily targets the epidermal growth factor receptor (EGFR) in humans with a known action status, as well as several complement components and receptors, although the action on these is unknown.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the composition of Etanercept, and how is it produced?', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-19436613\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 88%|████████▊ | 175/200 [14:51<02:17,  5.50s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which receptor does it target?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's function and is associated with the drug's therapeutic effects.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the source organism for the production of Dornase alfa, and what is its primary use?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It is primarily used to cleave extracellular DNA in the lungs of patients with cystic fibrosis, reducing sputum viscosity and improving lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug described in the tables is a recombinant DNA-derived cytotoxic protein, and what are its components?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein. It is composed of amino acid sequences from diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2).\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the FDA-approved route of administration for Lupron Depot?\n",
      "   answer: Lupron Depot is approved for administration as a depot suspension, which is typically given intramuscularly.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "5. question: What is the state of Lepirudin, and why was its production ceased?\n",
      "   answer: Lepirudin is in a liquid state. Bayer ceased its production effective May 31, 2012, although the specific reasons for discontinuation are not detailed in the provided data.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which receptor does it target?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's function and is associated with the drug's therapeutic effects.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the source organism for the production of Dornase alfa, and what is its primary use?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. It is primarily used to cleave extracellular DNA in the lungs of patients with cystic fibrosis, reducing sputum viscosity and improving lung function.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug described in the tables is a recombinant DNA-derived cytotoxic protein, and what are its components?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein. It is composed of amino acid sequences from diphtheria toxin fragments A and B, followed by sequences for interleukin-2 (IL-2).', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved route of administration for Lupron Depot?', 'answer': 'Lupron Depot is approved for administration as a depot suspension, which is typically given intramuscularly.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What is the state of Lepirudin, and why was its production ceased?', 'answer': 'Lepirudin is in a liquid state. Bayer ceased its production effective May 31, 2012, although the specific reasons for discontinuation are not detailed in the provided data.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 88%|████████▊ | 176/200 [14:57<02:15,  5.67s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with the transporter \"P-glycoprotein 1\" and what is its organism?\n",
      "   answer: The drug associated with the transporter \"P-glycoprotein 1\" is Lepirudin (DB00027), and the organism is humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state and description of Cetuximab according to the drugbank-drug table?\n",
      "   answer: Cetuximab is in a liquid state and is described as an epidermal growth factor receptor binding FAB. It is composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the known action of the transporter \"Bile salt export pump\" and which drug is it associated with?\n",
      "   answer: The known action of the transporter \"Bile salt export pump\" is unknown, and it is associated with the drug Dornase alfa (DB00091).\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: Which drug has an FDA label associated with the title \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension\"?\n",
      "   answer: The drug with an FDA label associated with the title \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension\" is linked to the parent key DB00007.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "5. question: What is the CAS number and description of Dornase alfa?\n",
      "   answer: The CAS number of Dornase alfa is 143831-71-4. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary cells, and is used to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drug is associated with the transporter \"P-glycoprotein 1\" and what is its organism?', 'answer': 'The drug associated with the transporter \"P-glycoprotein 1\" is Lepirudin (DB00027), and the organism is humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state and description of Cetuximab according to the drugbank-drug table?', 'answer': 'Cetuximab is in a liquid state and is described as an epidermal growth factor receptor binding FAB. It is composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of the transporter \"Bile salt export pump\" and which drug is it associated with?', 'answer': 'The known action of the transporter \"Bile salt export pump\" is unknown, and it is associated with the drug Dornase alfa (DB00091).', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'Which drug has an FDA label associated with the title \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension\"?', 'answer': 'The drug with an FDA label associated with the title \"FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension\" is linked to the parent key DB00007.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'What is the CAS number and description of Dornase alfa?', 'answer': 'The CAS number of Dornase alfa is 143831-71-4. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary cells, and is used to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 88%|████████▊ | 177/200 [15:02<02:05,  5.45s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab, and which target does it bind to?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, where it binds to the N-terminal portion of human EGFR.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Can you describe the production method and clinical use of Dornase alfa?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used in cystic fibrosis patients to reduce sputum viscosity and viscoelasticity by cleaving extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the primary therapeutic target of Lepirudin, and what is its known action?\n",
      "   answer: Lepirudin targets prothrombin in humans and has a known action, which involves inhibiting the conversion of prothrombin to thrombin, thereby exerting its anticoagulant effect.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What are the FDA-approved products related to leuprolide acetate, and what are their administration methods?\n",
      "   answer: The FDA-approved products related to leuprolide acetate include Lupaneta Pack for intramuscular and oral use, Lupron Depot as a depot suspension, Lupron Depot-Ped as a depot suspension, and Fensolvi as a suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action for Cetuximab, and which target does it bind to?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, where it binds to the N-terminal portion of human EGFR.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Can you describe the production method and clinical use of Dornase alfa?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is used in cystic fibrosis patients to reduce sputum viscosity and viscoelasticity by cleaving extracellular DNA.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the primary therapeutic target of Lepirudin, and what is its known action?', 'answer': 'Lepirudin targets prothrombin in humans and has a known action, which involves inhibiting the conversion of prothrombin to thrombin, thereby exerting its anticoagulant effect.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the FDA-approved products related to leuprolide acetate, and what are their administration methods?', 'answer': 'The FDA-approved products related to leuprolide acetate include Lupaneta Pack for intramuscular and oral use, Lupron Depot as a depot suspension, Lupron Depot-Ped as a depot suspension, and Fensolvi as a suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-15378559\n",
      "No table mapping found for passage Target-15233703\n",
      "No table mapping found for passage Target-17635183\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 90%|█████████ | 181/200 [15:07<00:58,  3.06s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and which human receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, specifically the N-terminal portion of human EGFr.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Can you describe the synthesis process and state of Etanercept?\n",
      "   answer: Etanercept is a dimeric fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug has a known action on prothrombin, and in which organism is this action observed?\n",
      "   answer: Lepirudin has a known action on prothrombin in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What is the FDA label information available for Dornase alfa?\n",
      "   answer: The FDA label for Dornase alfa can be accessed at the link: //s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00003.pdf?1410715221.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the molecular description of Denileukin diftitox, and what type of protein is it?\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is a fusion protein.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and which human receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the epidermal growth factor receptor in humans, specifically the N-terminal portion of human EGFr.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Can you describe the synthesis process and state of Etanercept?', 'answer': 'Etanercept is a dimeric fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug has a known action on prothrombin, and in which organism is this action observed?', 'answer': 'Lepirudin has a known action on prothrombin in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the FDA label information available for Dornase alfa?', 'answer': 'The FDA label for Dornase alfa can be accessed at the link: //s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00003.pdf?1410715221.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the molecular description of Denileukin diftitox, and what type of protein is it?', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of amino acid sequences for diphtheria toxin fragments A and B followed by sequences for interleukin-2 (IL-2). It is a fusion protein.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 91%|█████████ | 182/200 [15:11<00:59,  3.31s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary target of Cetuximab in humans, and is the action known?\n",
      "   answer: The primary target of Cetuximab in humans is the Epidermal Growth Factor Receptor (EGFR), and the action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is the marketed name of Cetuximab, and who manufactures it?\n",
      "   answer: Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the mechanism of action of Dornase alfa, and what condition does it help manage?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, reducing sputum viscosity and viscoelasticity. It is used to manage cystic fibrosis, where extracellular DNA from degenerating leukocytes contributes to sputum viscosity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is produced using genetically modified Chinese hamster ovary (CHO) cells, and what is its function?\n",
      "   answer: Both Dornase alfa and Etanercept are produced using genetically modified Chinese hamster ovary (CHO) cells. Dornase alfa functions by cleaving extracellular DNA to reduce sputum viscosity in cystic fibrosis, while Etanercept is a dimeric fusion protein that inhibits tumor necrosis factor (TNF) activity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary target of Cetuximab in humans, and is the action known?', 'answer': 'The primary target of Cetuximab in humans is the Epidermal Growth Factor Receptor (EGFR), and the action is known.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the marketed name of Cetuximab, and who manufactures it?', 'answer': 'Cetuximab is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the mechanism of action of Dornase alfa, and what condition does it help manage?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, reducing sputum viscosity and viscoelasticity. It is used to manage cystic fibrosis, where extracellular DNA from degenerating leukocytes contributes to sputum viscosity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is produced using genetically modified Chinese hamster ovary (CHO) cells, and what is its function?', 'answer': 'Both Dornase alfa and Etanercept are produced using genetically modified Chinese hamster ovary (CHO) cells. Dornase alfa functions by cleaving extracellular DNA to reduce sputum viscosity in cystic fibrosis, while Etanercept is a dimeric fusion protein that inhibits tumor necrosis factor (TNF) activity.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 92%|█████████▏| 183/200 [15:18<01:07,  3.95s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab according to its target proteins?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells, which is a confirmed known action. This binding inhibits the receptor's activation and downstream signaling pathways that promote cell proliferation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug targets prothrombin and what is its mechanism of action?\n",
      "   answer: Lepirudin targets prothrombin in humans and has a known action. Lepirudin is an anticoagulant that specifically inhibits thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is crucial for clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What are the unique structural features of Dornase alfa and its therapeutic use?\n",
      "   answer: Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary cells. It is used therapeutically to cleave extracellular DNA in cystic fibrosis patients, reducing sputum viscosity and improving lung function.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the type and state of the drug Etanercept, and how is it produced?\n",
      "   answer: Etanercept is a biotech drug that is in a liquid state. It is a dimeric fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab according to its target proteins?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells, which is a confirmed known action. This binding inhibits the receptor's activation and downstream signaling pathways that promote cell proliferation.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug targets prothrombin and what is its mechanism of action?', 'answer': 'Lepirudin targets prothrombin in humans and has a known action. Lepirudin is an anticoagulant that specifically inhibits thrombin, thereby preventing the conversion of fibrinogen to fibrin, which is crucial for clot formation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What are the unique structural features of Dornase alfa and its therapeutic use?', 'answer': 'Dornase alfa is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary cells. It is used therapeutically to cleave extracellular DNA in cystic fibrosis patients, reducing sputum viscosity and improving lung function.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the type and state of the drug Etanercept, and how is it produced?', 'answer': 'Etanercept is a biotech drug that is in a liquid state. It is a dimeric fusion protein produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of the extracellular ligand-binding portion of the human 75 kilodalton tumor necrosis factor receptor linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-drug_mixtures.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 92%|█████████▏| 184/200 [15:36<01:50,  6.93s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab, and how is it marketed?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB that is composed of the Fv regions of the murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, combined with human IgG1 heavy and kappa light chain constant regions. It is marketed under the brand name Erbitux® by Eli Lilly and Company.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "2. question: What is the marketed name of the drug Dornase alfa, and what is its primary therapeutic use?\n",
      "   answer: Dornase alfa is marketed under the brand name Pulmozyme. It is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme, used primarily to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity, which is particularly beneficial in the treatment of cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "3. question: Describe the composition and production process of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the FDA-approved indication for the drug mixture marketed as Refludan?\n",
      "   answer: Refludan is the marketed name for Lepirudin. While the specific FDA-approved indications are not listed in the tables, Lepirudin is known to be an anticoagulant used to treat heparin-induced thrombocytopenia.\n",
      "   text: None\n",
      "   table: drugbank-drug_mixtures\n",
      "\n",
      "5. question: How is Etanercept produced, and what is its structural composition?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component includes the CH2 and CH3 domains and hinge region but lacks the CH1 domain of IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action of Cetuximab, and how is it marketed?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB that is composed of the Fv regions of the murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr, combined with human IgG1 heavy and kappa light chain constant regions. It is marketed under the brand name Erbitux® by Eli Lilly and Company.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the marketed name of the drug Dornase alfa, and what is its primary therapeutic use?', 'answer': 'Dornase alfa is marketed under the brand name Pulmozyme. It is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme, used primarily to cleave extracellular DNA to reduce sputum viscosity and viscoelasticity, which is particularly beneficial in the treatment of cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'Describe the composition and production process of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the FDA-approved indication for the drug mixture marketed as Refludan?', 'answer': 'Refludan is the marketed name for Lepirudin. While the specific FDA-approved indications are not listed in the tables, Lepirudin is known to be an anticoagulant used to treat heparin-induced thrombocytopenia.', 'text': 'None', 'table': 'drugbank-drug_mixtures'}, {'question': 'How is Etanercept produced, and what is its structural composition?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component includes the CH2 and CH3 domains and hinge region but lacks the CH1 domain of IgG1.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 92%|█████████▎| 185/200 [15:42<01:42,  6.81s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the FDA-approved route of administration for Lupaneta Pack?\n",
      "   answer: The FDA-approved route of administration for Lupaneta Pack is via intramuscular and oral use.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "2. question: Which drug targets the Epidermal Growth Factor Receptor (EGFR) in humans?\n",
      "   answer: Cetuximab targets the Epidermal Growth Factor Receptor (EGFR) in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the primary mechanism of action for Dornase alfa in cystic fibrosis patients?\n",
      "   answer: Dornase alfa acts by cleaving extracellular DNA, reducing sputum viscosity and viscoelasticity, which helps in managing cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the unique identifying CAS number for Etanercept?\n",
      "   answer: The CAS number for Etanercept is 185243-69-0.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What is the known action of Lepirudin on its target, Prothrombin, in humans?\n",
      "   answer: Lepirudin is known to act on its target, Prothrombin, in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the FDA-approved route of administration for Lupaneta Pack?', 'answer': 'The FDA-approved route of administration for Lupaneta Pack is via intramuscular and oral use.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Which drug targets the Epidermal Growth Factor Receptor (EGFR) in humans?', 'answer': 'Cetuximab targets the Epidermal Growth Factor Receptor (EGFR) in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the primary mechanism of action for Dornase alfa in cystic fibrosis patients?', 'answer': 'Dornase alfa acts by cleaving extracellular DNA, reducing sputum viscosity and viscoelasticity, which helps in managing cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique identifying CAS number for Etanercept?', 'answer': 'The CAS number for Etanercept is 185243-69-0.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the known action of Lepirudin on its target, Prothrombin, in humans?', 'answer': 'Lepirudin is known to act on its target, Prothrombin, in humans.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-15640381\n",
      "No table mapping found for passage Target-26952092\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 94%|█████████▍| 188/200 [15:47<00:51,  4.27s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the EGFR, as indicated by its known action with the epidermal growth factor receptor in humans.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug has Prothrombin as its target and what is its primary function?\n",
      "   answer: Lepirudin targets Prothrombin in humans, and it is used as an anticoagulant due to its ability to inhibit thrombin.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "3. question: What is the production method and primary function of Dornase alfa?\n",
      "   answer: Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. Its primary function is to cleave extracellular DNA, which helps reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Describe the composition and therapeutic use of Etanercept.\n",
      "   answer: Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is used to modulate immune responses by inhibiting the activity of TNF, which is involved in systemic inflammation.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the main components and production system for Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the mechanism of action for Cetuximab?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It targets the EGFR, as indicated by its known action with the epidermal growth factor receptor in humans.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug has Prothrombin as its target and what is its primary function?', 'answer': 'Lepirudin targets Prothrombin in humans, and it is used as an anticoagulant due to its ability to inhibit thrombin.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the production method and primary function of Dornase alfa?', 'answer': 'Dornase alfa is produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. Its primary function is to cleave extracellular DNA, which helps reduce sputum viscosity and viscoelasticity in individuals with cystic fibrosis.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Describe the composition and therapeutic use of Etanercept.', 'answer': 'Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. It is used to modulate immune responses by inhibiting the activity of TNF, which is involved in systemic inflammation.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the main components and production system for Denileukin diftitox?', 'answer': 'Denileukin diftitox is composed of the amino acid sequences for diphtheria toxin fragments A and B, followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 94%|█████████▍| 189/200 [15:55<00:55,  5.04s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab?\n",
      "   answer: Cetuximab is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) on human cells. By blocking EGFR, Cetuximab interferes with the receptor's role in the growth and proliferation of cancer cells. This action is specific to EGFR, making it a targeted therapy for certain types of cancer.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What is Lepirudin used for, and how is it produced?\n",
      "   answer: Lepirudin is a recombinant form of hirudin that serves as an anticoagulant. It is used to prevent blood clots, particularly in patients with heparin-induced thrombocytopenia. Lepirudin is produced via yeast cells, and it differs from natural hirudin by having a leucine for isoleucine substitution at the N-terminal end and lacking a sulfate group on tyrosine at position 63.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: How is Dornase alfa produced, and what is its clinical application?\n",
      "   answer: Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. Clinically, Dornase alfa is used in the treatment of cystic fibrosis to reduce sputum viscosity and improve lung function by cleaving extracellular DNA, which accumulates due to degenerating leukocytes during infection-related inflammation.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the target of Etanercept, and how is it produced?\n",
      "   answer: Etanercept targets the human tumor necrosis factor receptor (TNFR), specifically the extracellular ligand-binding portion of the 75 kilodalton (p75) TNFR. It is a dimeric fusion protein linked to the Fc portion of human IgG1, produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. Etanercept is used to treat autoimmune diseases by acting as a TNF inhibitor.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: What are the known targets for Cetuximab, and what is their role?\n",
      "   answer: The known target for Cetuximab is the epidermal growth factor receptor (EGFR) in humans. EGFR plays a critical role in cell growth and proliferation. Cetuximab binds to EGFR, inhibiting its activation, which is essential in controlling the growth of certain cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action of Cetuximab?', 'answer': \"Cetuximab is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) on human cells. By blocking EGFR, Cetuximab interferes with the receptor's role in the growth and proliferation of cancer cells. This action is specific to EGFR, making it a targeted therapy for certain types of cancer.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is Lepirudin used for, and how is it produced?', 'answer': 'Lepirudin is a recombinant form of hirudin that serves as an anticoagulant. It is used to prevent blood clots, particularly in patients with heparin-induced thrombocytopenia. Lepirudin is produced via yeast cells, and it differs from natural hirudin by having a leucine for isoleucine substitution at the N-terminal end and lacking a sulfate group on tyrosine at position 63.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Dornase alfa produced, and what is its clinical application?', 'answer': 'Dornase alfa is a biosynthetic form of the human deoxyribonuclease I (DNase I) enzyme, produced using recombinant DNA technology in genetically modified Chinese hamster ovary (CHO) cells. Clinically, Dornase alfa is used in the treatment of cystic fibrosis to reduce sputum viscosity and improve lung function by cleaving extracellular DNA, which accumulates due to degenerating leukocytes during infection-related inflammation.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the target of Etanercept, and how is it produced?', 'answer': 'Etanercept targets the human tumor necrosis factor receptor (TNFR), specifically the extracellular ligand-binding portion of the 75 kilodalton (p75) TNFR. It is a dimeric fusion protein linked to the Fc portion of human IgG1, produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. Etanercept is used to treat autoimmune diseases by acting as a TNF inhibitor.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What are the known targets for Cetuximab, and what is their role?', 'answer': 'The known target for Cetuximab is the epidermal growth factor receptor (EGFR) in humans. EGFR plays a critical role in cell growth and proliferation. Cetuximab binds to EGFR, inhibiting its activation, which is essential in controlling the growth of certain cancer cells.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-14674789\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 96%|█████████▌| 191/200 [16:01<00:38,  4.30s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action of Cetuximab and what specific receptor does it target?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the epidermal growth factor receptor (EGFR) on human cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What type of production system is used for manufacturing Dornase alfa?\n",
      "   answer: Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the unique characteristic of Lepirudin compared to natural hirudin?\n",
      "   answer: Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: How is Etanercept produced, and what does its molecular structure consist of?\n",
      "   answer: Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug from the provided data is identified as targeting Prothrombin, and what is its known action?\n",
      "   answer: Lepirudin targets Prothrombin in humans, and its action is known.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "[{'question': 'What is the mechanism of action of Cetuximab and what specific receptor does it target?', 'answer': 'Cetuximab is an epidermal growth factor receptor (EGFR) binding FAB. It specifically targets the epidermal growth factor receptor (EGFR) on human cells.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of production system is used for manufacturing Dornase alfa?', 'answer': 'Dornase alfa is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the unique characteristic of Lepirudin compared to natural hirudin?', 'answer': 'Lepirudin is identical to natural hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'How is Etanercept produced, and what does its molecular structure consist of?', 'answer': 'Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug from the provided data is identified as targeting Prothrombin, and what is its known action?', 'answer': 'Lepirudin targets Prothrombin in humans, and its action is known.', 'text': 'None', 'table': 'drugbank-targets'}]\n",
      "No table mapping found for passage Target-11159797\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 96%|█████████▋| 193/200 [16:06<00:25,  3.64s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drug is associated with the transporter \"P-glycoprotein 1\" in humans?\n",
      "   answer: The drug associated with the transporter \"P-glycoprotein 1\" in humans is identified by the parent keys DB00027 and DB00091.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the state of the drug Cetuximab according to the drugbank-drug table?\n",
      "   answer: The state of the drug Cetuximab is liquid.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drugs are linked to the organism \"Humans\" for the transporter \"Canalicular multispecific organic anion transporter 1\"?\n",
      "   answer: The drug linked to the organism \"Humans\" for the transporter \"Canalicular multispecific organic anion transporter 1\" is identified by the parent key DB00067.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "4. question: What is the CAS number of the drug Etanercept, and how is it produced?\n",
      "   answer: The CAS number of the drug Etanercept is 185243-69-0, and it is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: Which drug has a description mentioning its use in cystic fibrosis, and what is its mechanism?\n",
      "   answer: The drug with a description mentioning its use in cystic fibrosis is Dornase alfa. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drug is associated with the transporter \"P-glycoprotein 1\" in humans?', 'answer': 'The drug associated with the transporter \"P-glycoprotein 1\" in humans is identified by the parent keys DB00027 and DB00091.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the state of the drug Cetuximab according to the drugbank-drug table?', 'answer': 'The state of the drug Cetuximab is liquid.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drugs are linked to the organism \"Humans\" for the transporter \"Canalicular multispecific organic anion transporter 1\"?', 'answer': 'The drug linked to the organism \"Humans\" for the transporter \"Canalicular multispecific organic anion transporter 1\" is identified by the parent key DB00067.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the CAS number of the drug Etanercept, and how is it produced?', 'answer': 'The CAS number of the drug Etanercept is 185243-69-0, and it is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug has a description mentioning its use in cystic fibrosis, and what is its mechanism?', 'answer': 'The drug with a description mentioning its use in cystic fibrosis is Dornase alfa. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA to reduce sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-21691256\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-transporters.csv', 'drugbank-drugs_links.csv', 'drugbank-drug.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 98%|█████████▊| 195/200 [16:13<00:17,  3.50s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: Which drugs are associated with the transporter P-glycoprotein 1, and what is their organism of action?\n",
      "   answer: The drugs associated with the transporter P-glycoprotein 1 are linked to the parent keys DB00027 and DB00091. Both of these drugs have their action in humans.\n",
      "   text: None\n",
      "   table: drugbank-transporters\n",
      "\n",
      "2. question: What is the description and state of the drug Cetuximab?\n",
      "   answer: Cetuximab is an epidermal growth factor receptor binding FAB. It is composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions. Cetuximab is marketed under the brand Erbitux® by Eli Lilly and Company. It is in a liquid state.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the mechanism of action for Dornase alfa, and what clinical condition does it help manage?\n",
      "   answer: Dornase alfa is a biosynthetic form of the human deoxyribonuclease I enzyme, which cleaves extracellular DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products without affecting intracellular DNA. It helps manage cystic fibrosis by reducing sputum viscosity and viscoelasticity through the enzymatic breakdown of extracellular DNA.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: Which drug is linked to the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\"?\n",
      "   answer: The drug linked to the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\" has the parent key DB00007.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "\n",
      "5. question: Describe the composition and production method of Denileukin diftitox.\n",
      "   answer: Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'Which drugs are associated with the transporter P-glycoprotein 1, and what is their organism of action?', 'answer': 'The drugs associated with the transporter P-glycoprotein 1 are linked to the parent keys DB00027 and DB00091. Both of these drugs have their action in humans.', 'text': 'None', 'table': 'drugbank-transporters'}, {'question': 'What is the description and state of the drug Cetuximab?', 'answer': 'Cetuximab is an epidermal growth factor receptor binding FAB. It is composed of the Fv regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant regions. Cetuximab is marketed under the brand Erbitux® by Eli Lilly and Company. It is in a liquid state.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the mechanism of action for Dornase alfa, and what clinical condition does it help manage?', 'answer': \"Dornase alfa is a biosynthetic form of the human deoxyribonuclease I enzyme, which cleaves extracellular DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products without affecting intracellular DNA. It helps manage cystic fibrosis by reducing sputum viscosity and viscoelasticity through the enzymatic breakdown of extracellular DNA.\", 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug is linked to the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\"?', 'answer': 'The drug linked to the FDA label titled \"Lupron Depot (leuprolide acetate) depot suspension\" has the parent key DB00007.', 'text': 'None', 'table': 'drugbank-drugs_links'}, {'question': 'Describe the composition and production method of Denileukin diftitox.', 'answer': 'Denileukin diftitox is a recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B followed by the sequences for interleukin-2 (IL-2). It is produced in an E. coli expression system.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "No table mapping found for passage Target-8742231\n",
      "No table mapping found for passage Target-21336182\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 99%|█████████▉| 198/200 [16:19<00:05,  2.95s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the primary therapeutic mechanism of action for Cetuximab?\n",
      "   answer: Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's function, which is involved in the proliferation of cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: Which drug is indicated for reducing sputum viscosity in cystic fibrosis patients, and what is its mechanism?\n",
      "   answer: Dornase alfa is indicated for reducing sputum viscosity in patients with cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, thereby reducing sputum viscosity and viscoelasticity.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: What is the common production method used for the drug Denileukin diftitox?\n",
      "   answer: Denileukin diftitox is produced using recombinant DNA technology in an E. coli expression system. It is a cytotoxic protein composed of sequences from diphtheria toxin fragments and interleukin-2.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "4. question: What is the main target of Lepirudin and its relevance in clinical practice?\n",
      "   answer: Lepirudin targets Prothrombin in humans, which is relevant in clinical practice because it acts as an anticoagulant by directly inhibiting thrombin, thereby preventing clot formation.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "5. question: Which drug is marketed under the brand Erbitux® and what is its main component?\n",
      "   answer: Cetuximab is marketed under the brand Erbitux®. It is primarily composed of the Fv (variable) regions of the murine EGFr monoclonal antibody and the human IgG1 heavy and kappa light chain constant regions.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "[{'question': 'What is the primary therapeutic mechanism of action for Cetuximab?', 'answer': \"Cetuximab acts by binding to the epidermal growth factor receptor (EGFR) on human cells. This binding inhibits the receptor's function, which is involved in the proliferation of cancer cells.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is indicated for reducing sputum viscosity in cystic fibrosis patients, and what is its mechanism?', 'answer': 'Dornase alfa is indicated for reducing sputum viscosity in patients with cystic fibrosis. It is a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme that cleaves extracellular DNA, thereby reducing sputum viscosity and viscoelasticity.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the common production method used for the drug Denileukin diftitox?', 'answer': 'Denileukin diftitox is produced using recombinant DNA technology in an E. coli expression system. It is a cytotoxic protein composed of sequences from diphtheria toxin fragments and interleukin-2.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'What is the main target of Lepirudin and its relevance in clinical practice?', 'answer': 'Lepirudin targets Prothrombin in humans, which is relevant in clinical practice because it acts as an anticoagulant by directly inhibiting thrombin, thereby preventing clot formation.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'Which drug is marketed under the brand Erbitux® and what is its main component?', 'answer': 'Cetuximab is marketed under the brand Erbitux®. It is primarily composed of the Fv (variable) regions of the murine EGFr monoclonal antibody and the human IgG1 heavy and kappa light chain constant regions.', 'text': 'None', 'table': 'drugbank-drug'}]\n",
      "Debug - Available tables: dict_keys(['drugbank-drug_trans_links', 'drugbank-enzymes_polypeptides_ext_id', 'drugbank-drug_manufacturers', 'drugbank-drug_sequences', 'drugbank-drug_external_links', 'drugbank-drug_international_brands', 'drugbank-drug_mixtures', 'drugbank-drug_packagers', 'drugbank-drug_reactions_enzymes', 'drugbank-drug_enzymes_articles', 'drugbank-targets', 'drugbank-drug_carriers_textbooks', 'drugbank-drug_trans_textbooks', 'drugbank-carriers_polypeptides_ext_id', 'drugbank-drugs_attachments', 'drugbank-drug_carriers_articles', 'drugbank-enzymes_polypeptides', 'drugbank-drug_trans_articles', 'drugbank-drug_experimental_properties', 'drugbank-transporters_polypeptides_ext_id', 'drugbank-drug_dosages', 'drugbank-drug_syn', 'drugbank-drug_targ_textbooks', 'drugbank-drug_enzymes_attachments', 'drugbank-drug_carriers_links', 'drugbank-drug_salts', 'drugbank-drugs_articles', 'drugbank-targets_actions', 'drugbank-drug_patents', 'drugbank-drug_affected_organisms', 'drugbank-query_ddi_table', 'drugbank-drug_pharmacology', 'drugbank-transporters_polypeptides_go', 'drugbank-carriers_polypeptides_go', 'drugbank-transporters_actions', 'drugbank-snp_adverse_reactions', 'drugbank-drug_food_interactions', 'drugbank-drugs_textbooks', 'drugbank-drug', 'drugbank-drug_enzymes_textbooks', 'drugbank-drug_targ_articles', 'drugbank-enzymes_actions', 'drugbank-transporters_polypeptides_syn', 'drugbank-drug_prices', 'drugbank-drugs_links', 'drugbank-carriers', 'drugbank-targets_polypeptides_ext_id', 'drugbank-drug_products', 'drugbank-drug_reactions', 'drugbank-drug_classifications', 'drugbank-transporters', 'drugbank-drug_external_identifiers', 'drugbank-transporters_polypeptides_pfams', 'drugbank-drug_groups', 'drugbank-drug_ahfs_codes', 'drugbank-carriers_polypeptides_syn', 'drugbank-targets_polypeptides_syn', 'drugbank-drug_snp_effects', 'drugbank-carriers_polypeptides', 'drugbank-enzymes_polypeptides_syn', 'drugbank-transporters_polypeptides', 'drugbank-carriers_polypeptides_pfams', 'drugbank-drug_atc_codes', 'drugbank-carriers_actions', 'drugbank-drug_pathway_enzymes', 'drugbank-enzymes', 'drugbank-enzymes_polypeptides_pfams', 'drugbank-drug_enzymes_links', 'drugbank-drug_targ_attachments', 'drugbank-drug_drug_interactions', 'drugbank-targets_polypeptides_go', 'drugbank-drug_targ_links', 'drugbank-drug_pathway', 'drugbank-drug_carriers_attachments', 'drugbank-drug_pathway_drugs', 'drugbank-drug_categories', 'drugbank-drug_pdb_entries', 'drugbank-targets_polypeptides', 'drugbank-drug_trans_attachments', 'drugbank-drug_calculated_properties', 'drugbank-enzymes_polypeptides_go', 'drugbank-targets_polypeptides_pfams'])\n",
      "Debug - Looking for table_names: ['drugbank-drugs_links.csv', 'drugbank-drug.csv', 'drugbank-targets.csv']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 200/200 [16:26<00:00,  4.93s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. question: What is the mechanism of action for Cetuximab in targeting cancer cells?\n",
      "   answer: Cetuximab works by binding to the epidermal growth factor receptor (EGFR) on cancer cells. This binding inhibits the receptor's action, which is crucial for cancer cell proliferation and survival. By blocking EGFR, Cetuximab interferes with the growth and spread of cancer cells.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "2. question: What type of drug is Dornase alfa, and what is its primary clinical use?\n",
      "   answer: Dornase alfa is a biotech drug that acts as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It is primarily used to reduce sputum viscosity in patients with cystic fibrosis by enzymatically breaking down extracellular DNA present in the sputum.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "3. question: Which drug listed is known to target prothrombin and what is its primary application?\n",
      "   answer: Lepirudin targets prothrombin, which is a key protein in the coagulation cascade. It is primarily used as an anticoagulant in conditions where thrombin inhibition is desired, such as in the treatment of heparin-induced thrombocytopenia.\n",
      "   text: None\n",
      "   table: drugbank-targets\n",
      "\n",
      "4. question: What is the synthesis method of Etanercept, and how is it produced?\n",
      "   answer: Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein linking the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) with the Fc portion of human IgG1.\n",
      "   text: None\n",
      "   table: drugbank-drug\n",
      "\n",
      "5. question: For which drugs does leuprolide acetate serve as the active ingredient, according to the FDA-approved products?\n",
      "   answer: Leuprolide acetate serves as the active ingredient in several FDA-approved products, including Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.\n",
      "   text: None\n",
      "   table: drugbank-drugs_links\n",
      "[{'question': 'What is the mechanism of action for Cetuximab in targeting cancer cells?', 'answer': \"Cetuximab works by binding to the epidermal growth factor receptor (EGFR) on cancer cells. This binding inhibits the receptor's action, which is crucial for cancer cell proliferation and survival. By blocking EGFR, Cetuximab interferes with the growth and spread of cancer cells.\", 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What type of drug is Dornase alfa, and what is its primary clinical use?', 'answer': 'Dornase alfa is a biotech drug that acts as a biosynthetic form of human deoxyribonuclease I (DNase I) enzyme. It is primarily used to reduce sputum viscosity in patients with cystic fibrosis by enzymatically breaking down extracellular DNA present in the sputum.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'Which drug listed is known to target prothrombin and what is its primary application?', 'answer': 'Lepirudin targets prothrombin, which is a key protein in the coagulation cascade. It is primarily used as an anticoagulant in conditions where thrombin inhibition is desired, such as in the treatment of heparin-induced thrombocytopenia.', 'text': 'None', 'table': 'drugbank-targets'}, {'question': 'What is the synthesis method of Etanercept, and how is it produced?', 'answer': 'Etanercept is produced using recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It is a dimeric fusion protein linking the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) with the Fc portion of human IgG1.', 'text': 'None', 'table': 'drugbank-drug'}, {'question': 'For which drugs does leuprolide acetate serve as the active ingredient, according to the FDA-approved products?', 'answer': 'Leuprolide acetate serves as the active ingredient in several FDA-approved products, including Lupaneta Pack for intramuscular and oral use, Lupron Depot (leuprolide acetate) depot suspension, Lupron Depot-Ped (leuprolide acetate) depot suspension, and Fensolvi (leuprolide acetate) suspension.', 'text': 'None', 'table': 'drugbank-drugs_links'}]\n",
      "No table mapping found for passage Target-17495414\n",
      "Generated 628 question-answer pairs\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "if __name__ == \"__main__\":\n",
    "    main()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "cmdl",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
